
<html lang="en"     class="pb-page"  data-request-id="bce3c495-c454-4c1f-8ede-7b21cc05813a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01620;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Matthew G.  Bursavich" /></meta><meta name="dc.Creator" content="Bryce A.  Harrison" /></meta><meta name="dc.Creator" content="Raksha  Acharya" /></meta><meta name="dc.Creator" content="Donald E.  Costa" /></meta><meta name="dc.Creator" content="Emily A.  Freeman" /></meta><meta name="dc.Creator" content="Hilliary E.  Hodgdon" /></meta><meta name="dc.Creator" content="Lori A.  Hrdlicka" /></meta><meta name="dc.Creator" content="Hong  Jin" /></meta><meta name="dc.Creator" content="Sudarshan  Kapadnis" /></meta><meta name="dc.Creator" content="Jeffrey S.  Moffit" /></meta><meta name="dc.Creator" content="Deirdre A.  Murphy" /></meta><meta name="dc.Creator" content="Scott  Nolan" /></meta><meta name="dc.Creator" content="Holger  Patzke" /></meta><meta name="dc.Creator" content="Cuyue  Tang" /></meta><meta name="dc.Creator" content="Melody  Wen" /></meta><meta name="dc.Creator" content="Gerhard  Koenig" /></meta><meta name="dc.Creator" content="Jean-François  Blain" /></meta><meta name="dc.Creator" content="Duane A.  Burnett" /></meta><meta name="dc.Description" content="Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and critical consideration of conf..." /></meta><meta name="Description" content="Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and critical consideration of conf..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 10, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01620" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01620" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01620" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01620" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01620" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0019.jpeg" /></meta><meta property="og:description" content="Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and critical consideration of conformational restriction. Oxadiazine lead 47 possesses good in vitro potency with excellent predicted CNS drug-like properties and desirable ADME/PK profile. This lead compound demonstrated robust Aβ42 reductions and subsequent Aβ37 increases in both rodent brain and CSF at 30 mg/kg dosed orally." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01620"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01620">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01620&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01620&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01620&amp;href=/doi/10.1021/acs.jmedchem.6b01620" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2383-2400</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00965" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01759" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+G.++Bursavich">Matthew G. Bursavich</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4934-7323" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryce+A.++Harrison">Bryce A. Harrison</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raksha++Acharya">Raksha Acharya</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+E.++Costa">Donald E. Costa</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emily+A.++Freeman">Emily A. Freeman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilliary+E.++Hodgdon">Hilliary E. Hodgdon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori+A.++Hrdlicka">Lori A. Hrdlicka</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Jin">Hong Jin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sudarshan++Kapadnis">Sudarshan Kapadnis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+S.++Moffit">Jeffrey S. Moffit</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deirdre+A.++Murphy">Deirdre A. Murphy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Nolan">Scott Nolan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holger++Patzke">Holger Patzke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cuyue++Tang">Cuyue Tang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melody++Wen">Melody Wen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerhard++Koenig">Gerhard Koenig</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Fran%C3%A7ois++Blain">Jean-François Blain</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duane+A.++Burnett">Duane A. Burnett</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1444-7802" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">FORUM Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#620f0316164c0017101103140b010a220f0d10120a0b01161a4c010d0f"><span class="__cf_email__" data-cfemail="127f7366663c7067606173647b717a527f7d60627a7b71666a3c717d7f">[email protected]</span></a>. Phone: 781-996-0955.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01620&amp;href=/doi/10.1021%2Facs.jmedchem.6b01620" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2383–2400</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 November 2016</li><li><span class="item_label"><b>Published</b> online</span>10 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01620" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01620</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2383%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BG.%2BBursavich%252C%2BBryce%2BA.%2BHarrison%252C%2BRaksha%2BAcharya%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D6%26contentID%3Dacs.jmedchem.6b01620%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BOxadiazine%2BGamma%2BSecretase%2BModulators%2Bfor%2BFamilial%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2400%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01620"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2134</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01620" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;G. Bursavich&quot;},{&quot;first_name&quot;:&quot;Bryce&quot;,&quot;last_name&quot;:&quot;A. Harrison&quot;},{&quot;first_name&quot;:&quot;Raksha&quot;,&quot;last_name&quot;:&quot;Acharya&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;E. Costa&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;A. Freeman&quot;},{&quot;first_name&quot;:&quot;Hilliary&quot;,&quot;last_name&quot;:&quot;E. Hodgdon&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;A. Hrdlicka&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Sudarshan&quot;,&quot;last_name&quot;:&quot;Kapadnis&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;S. Moffit&quot;},{&quot;first_name&quot;:&quot;Deirdre&quot;,&quot;last_name&quot;:&quot;A. Murphy&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Nolan&quot;},{&quot;first_name&quot;:&quot;Holger&quot;,&quot;last_name&quot;:&quot;Patzke&quot;},{&quot;first_name&quot;:&quot;Cuyue&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Melody&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Gerhard&quot;,&quot;last_name&quot;:&quot;Koenig&quot;},{&quot;first_name&quot;:&quot;Jean-François&quot;,&quot;last_name&quot;:&quot;Blain&quot;},{&quot;first_name&quot;:&quot;Duane&quot;,&quot;last_name&quot;:&quot;A. Burnett&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2383-2400&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01620&quot;},&quot;abstract&quot;:&quot;Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and critical consideration of conformational restriction. Oxadiazine lead 47 possesses good in vitro potency with excellent predicted CNS drug-like properties and desirable ADME/PK profile. This lead compound demonstrated robust Aβ42 reductions and subsequent Aβ37 increases in both rodent brain and CSF at 30 mg/kg dosed orally.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01620&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01620" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01620&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01620" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01620&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01620" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01620&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01620&amp;href=/doi/10.1021/acs.jmedchem.6b01620" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01620" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01620" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01620%26sid%3Dliteratum%253Aachs%26pmid%3D28230986%26genre%3Darticle%26aulast%3DBursavich%26date%3D2017%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BOxadiazine%2BGamma%2BSecretase%2BModulators%2Bfor%2BFamilial%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D6%26spage%3D2383%26epage%3D2400%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/jmcmar.2017.60.issue-6/20170323/jmcmar.2017.60.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and critical consideration of conformational restriction. Oxadiazine lead <b>47</b> possesses good in vitro potency with excellent predicted CNS drug-like properties and desirable ADME/PK profile. This lead compound demonstrated robust Aβ<sub>42</sub> reductions and subsequent Aβ<sub>37</sub> increases in both rodent brain and CSF at 30 mg/kg dosed orally.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the 100+ years since the German physician Alois Alzheimer first described Alzheimer’s disease (AD), a vast amount of pharmaceutical research has been undertaken to address this devastating neurodegenerative disorder that leads to loss of cognition, loss of motor function, and ultimately death. Currently, AD affects approximately 5.3 million people in the United States, with estimated costs expected to grow to $1.1 trillion by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD is the sixth leading cause of death in America and a significant burden to patients, caregivers, and society as a whole. While current therapies including NMDA receptor antagonists and acetylcholinesterase inhibitors demonstrate temporary symptomatic treatment, they do not have an effect on disease progression. There is an urgent need for new therapies that will affect the course of the disease to prevent, or at least delay, the onset of cognitive decline and ultimate death due to this disease.</div><div class="NLM_p">The amyloid hypothesis, formulated more than 20 years ago, ascribes a central role for beta-amyloid (Aβ) AD.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Several mutations in the amyloid precursor protein (APP) have been reported to be associated with familial AD (FAD),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> while a specific mutation appears to protect against the disease,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> further supporting the central role of Aβ in the disease pathology. The Aβ peptides are produced by the sequential proteolysis of APP by beta amyloid cleavage enzyme 1 (BACE1) and gamma secretase (GS), resulting in peptides of various lengths, of which the longer 42 amino acid Aβ<sub>42</sub> is believed to be the most toxic. Gamma secretase is an enzyme complex consisting of four different proteins, one of which is presenilin (PS). Presenilin has been described as the catalytic subunit of GS<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> and, interestingly, mutations in the two presenilin genes have been associated with FAD.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> The consequence of many FAD-causing PS mutations is a decreased catalytic activity of GS<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> with partial loss-of-function contributing to the increased Aβ<sub>42</sub>:Aβ<sub>40</sub> ratio observed in FAD.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><div class="NLM_p">Compounds that could modify GS activity to produce less Aβ<sub>42</sub> without affecting total Aβ levels were first described in 2001 by Weggen et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> These compounds, termed gamma secretase modulators (GSMs), offered a new, potentially safer alternative to gamma secretase inhibitors (GSIs) to reduce toxic Aβ<sub>42</sub>. Moreover, they have the opposite effect on GS kinetics than PS mutations,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> suggesting they might have a profound impact on disease development in PS mutation carriers. Much research has been devoted to GSMs over the past 15 years to afford many examples of very potent compounds targeting this unique intramembrane cleaving protease.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a> Unfortunately these very potent compounds typically possess poor CNS drug-like properties as measured by fraction sp<sup>3</sup> character (Fsp<sup>3</sup> values),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> molecular weight (MW), lipophilicity (cLogP), and CNS multiparameter optimization (MPO) scores.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">In our effort to discover novel, potent, and efficacious GSMs that possess good CNS drug-like properties for proof-of-mechanism studies in human clinical trials, we focused our initial design efforts on E2012 (<b>1</b>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the early GSM from the Eisai group (EC<sub>50</sub> = 83 nM) that demonstrated dose-dependent plasma reductions of Aβ<sub>40</sub> and Aβ <sub>42</sub> in phase 1 studies.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> On the basis of a survey of the GSM literature, we hypothesized the importance of the central amide hydrogen bond acceptor but also wanted to remove the cinnamide group, a potential Michael acceptor and undesirable structural feature.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> These initial hypotheses led to our amide designs as shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. The key hydrogen bond acceptor is attached directly to the methoxyphenyl ring, and the aminoether linker places the pendent phenyl in a similar location as the <i>p</i>-fluoro phenyl of <b>1</b>. Similar hypotheses and designs have been communicated independently from the Pfizer,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Janssen,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Amgen,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and Dainippon Sumitomo<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> groups. From our initial amides <b>I</b>, we further investigated (1) heteroaryl replacements for the imidazole, (2) nonaromatic replacements for the methoxyphenyl ring, and (3) cyclic amines to induce a conformational restriction into the amino ether linkage. Focused libraries afforded compound <b>II</b>, which demonstrated good in vitro potency (EC<sub>50</sub> = 35 nM) with greatly reduced aromaticity (increased Fsp<sup>3</sup> value to 0.50). Unfortunately, this compound also possesses high molecular weight (497), high cLogP (4.6), and a low calculated CNS MPO score (3.2).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Because of the nonoptimal predicted CNS drug-like properties, as well as potential for amide hydrolysis, we designed a series of novel oxadiazines as described in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. The oxadiazine moiety mimics the required hydrogen bond acceptor of the amide<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> while also imparting a key conformational constraint into the pendant alkyl chain to potentially lock the compound into its putative bioactive conformation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial amide design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Initial oxadiazine design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the initial oxadiazines <b>IV</b> began from commercially available <i>tert</i>-butyl (<i>S</i>)-4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We initially prepared both oxadiazine enantiomers starting from both <i>R</i> and <i>S</i> alcohols <b>1</b> (synthesis not shown with the <i>R</i>-alcohol). The commercially available primary alcohol derived from Garner’s aldehyde was reacted with either 4-fluoro-2-methylphenol or 4-chloro-2-(trifluoromethyl)phenol in a Mitsunobu reaction to afford aryl ether <b>2</b> in good yields (70 and 77%, respectively). The amino alcohol protecting groups were removed with trifluoroacetic acid in dichloromethane and the amine reprotected with the <i>p</i>-methoxyl benzyl group to afford <b>3</b> in good yields over two steps. Amine coupling with the in situ generated acid chlorides of 4-bromo-3-methoxybenzoic acid provided amides <b>4</b> in 59 and 95% yield, respectively. Conversion of the primary hydroxyl to the alkoxylamines <b>5</b> was achieved via Mitsunobu reaction with <i>N</i>-hydroxyphthalimide and subsequent deprotection with hydrazine in high yields over two steps. The key cyclization step in the synthesis to successfully form the oxadiazine was realized in moderate yields (45 and 55%, respectively) with dehydrative P<sub>2</sub>O<sub>5</sub> conditions in <i>i</i>-PrOH to afford oxadiazine <b>6</b>. Suzuki or Buchwald conditions successfully installed the R<sup>1</sup> heteroaryl groups to afford <b>7</b>, and the <i>p</i>-methoxybenzyl protecting groups were removed with acidic conditions in a microwave reactor to afford the desired oxadiazines <b>8</b>–<b>11</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>S</i>)-Aryl Ether Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 4-Fluoro-2-methylphenol or 4-chloro-2-(trifluoromethyl)phenol, DIAD, PPh<sub>3</sub>, THF, 70% and 77%; (b) a. TFA, DCM, b. TEA, MgSO<sub>4</sub>, <i>p</i>-anisaldehyde, then NaBH<sub>4</sub>, 71 and 68% over two steps; (c) 4-bromo-3-methoxybenzoic acid, DMF/oxalyl chloride, DCM, 59% and 95%; (d) a. <i>N-</i>hydroxyphthalimide, DIAD, PPh<sub>3</sub>, THF, b. hydrazine hydrate, EtOH, 85% and 91% over two steps; (e) P<sub>2</sub>O<sub>5</sub>, <i>i</i>-PrOH, 45% and 55%; (f) 4-methylimidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, 67% and 57%; (g) (2-methylpyridin-4-yl)boronic acid, Cs<sub>2</sub>CO<sub>3,</sub> PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, 68% and 60%; (h) TFA, DCE, 59–84%.</p></p></figure><div class="NLM_p">To investigate the importance of the oxadiazine N–H, we embarked on the related synthesis in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Here, ring opening of aryl ether <b>2</b> under <i>p</i>-toluenesulfonic acid conditions provided the Boc-protected amino alcohol, which was protected with TBDMS-Cl and alkylated with methyl iodide to provide <b>12</b> in good yields over three steps. Compound <b>13</b> was realized in high yields via deprotection of the TBDMS group, Mitsunobu reaction with <i>N</i>-hydroxyphthalimide, and subsequent N-Boc deprotection. Amine coupling with the in situ generated acid chloride of 4-bromo-3-methoxybenzoic acid followed by hydroxyphthalimide deprotection with hydrazine provided <b>14</b> in high yields over two steps. Dehydrative cyclization to successfully form the oxadiazine heterocycle <b>15</b> was accomplished in low yield (29%) with P<sub>2</sub>O<sub>5</sub> in <i>i</i>-PrOH. Buchwald reaction conditions successfully installed the 4-methylimidazole to afford <i>N</i>-methyl oxadiazine (<i>S</i>)-<b>16</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Methyl (<i>S</i>)-Aryl Ether Oxadiazine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) a. <i>p</i>-TsOH-H<sub>2</sub>O, MeOH, b. TBS-Cl, imidazole, DCM, c. MeI, KHMDS, THF/DMF, 63% over three steps; (b) a. HCl, MeOH/THF, b. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, THF, c. 4 N HCl in dioxane, DCM, 72% over three steps; (c) a. 4-bromo-3-methoxybenzoic acid DCM/DMF/oxalyl chloride, b. hydrazine hydrate, EtOH, 40% over two steps; (d) P<sub>2</sub>O<sub>5</sub>, <i>i</i>-PrOH, 29%; (e) 4-methylimidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, 53%.</p></p></figure><div class="NLM_p">Next, we determined the Aβ<sub>42</sub> lowering potency (EC<sub>50</sub>) in H4 cells overexpressing WT human APP751 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The initial compound (<i>R</i>)-<b>8</b> demonstrated only low micromolar potency, but its (<i>S</i>)-enantiomer (<i>S</i>)-<b>8</b> showed a 12-fold improvement (Aβ<sub>42</sub> EC<sub>50</sub> = 230 nM), demonstrating a high eudysmic ratio. Replacement of the 4-methyl-imidazol-1-yl with 2-methylpyridin-4-yl demonstrated a similar preference for the <i>S</i>-enantiomer comparing (<i>R</i>)-<b>9</b> with (<i>S</i>)-<b>9</b> (Aβ<sub>42</sub> EC<sub>50</sub> 6,446 vs 109 nM). Incorporation of the more lipophilic 2-CF<sub>3</sub>, 4-Cl phenyl in compound (<i>S</i>)-<b>10</b> improved the potency 2-fold relative to compound (<i>S</i>)-<b>8</b>. Replacing the 4-methyl-imidazol-1-yl with 2-methylpyridin-4-yl to afford compound (<i>S</i>)-<b>11</b> demonstrated a 2-fold reduction in potency relative to (<i>S</i>)-<b>10</b>. Addition of an N-Me to the more lipophilic (<i>S</i>)-<b>10</b> afforded an equipotent analogue in (<i>S</i>)-<b>16</b> (Aβ<sub>42</sub> EC<sub>50</sub> = 109 and 113 nM, respectively), albeit at an even higher cLogP (4.3 vs 4.6). Unfortunately, none of these initial compounds demonstrated reduction of brain Aβ<sub>42</sub> in mice when dosed orally at 30 mg/kg.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activity of Aryl Ether Oxadiazine GSMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Aβ<sub>42</sub> EC<sub>50</sub> values were determined in H4 cells overexpressing WT human APP751. Aβ<sub>42</sub> EC<sub>50</sub> values shown here are the average of <i>n</i> > 2 assays run in duplicate.</p></div></div><div></div></div><div class="NLM_p">In a strategic effort to lower the cLogP, restrict the rotation about the left-hand side of the molecule via an intramolecular hydrogen bond, and potentially improve the potency, we initiated the chemistry to replace the methoxyphenyl with a 2-methoxypyridine group first disclosed by the Eisai group (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Here we only focused on the more potent (<i>S</i>)-oxadiazines. PMB-protected amino alcohols <b>3</b> were coupled with the in situ generated acid chloride of the commercially available 5-bromo-6-methoxypicolinic acid to provide amides <b>17</b> in moderate yields (78 and 59%, respectively). Conversion of the primary hydroxyl to oxadiazine <b>18</b> was accomplished via Mitsunobu reaction with <i>N</i>-hydroxyphthalimide, deprotection with hydrazine, and dehydration with P<sub>2</sub>O<sub>5</sub> in <i>i</i>-PrOH over three steps with low yields again in the key cyclization step (17 and 21%, respectively). Suzuki or Buchwald conditions successfully installed the R<sup>1</sup> heteroaryl groups and removal of the <i>p</i>-methoxybenzyl protecting group with TFA provided the desired oxadiazines <b>19</b>–<b>25</b> in moderate yields.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (<i>S</i>)-2-Methoxypyridine Aryl Ether Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 5-bromo-6-methoxypicolinic acid, DCM/DMF/oxalyl chloride, 78 and 59%; (b) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, THF, b. hydrazine hydrate, EtOH, c. P<sub>2</sub>O<sub>5</sub>, <i>i</i>-PrOH, 12 and 15% over 3 steps; (c) a. 4-methylimidazole or 4-chloroimidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, b. TFA/DCE, 77–47% over two steps; (d) a. heteroarylboronic acid, Cs<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, b. TFA/DCE, 86-31% over two steps.</p></p></figure><div class="NLM_p">Rewardingly, the initial methoxypyridine compound <b>19</b> demonstrated in a 5-fold potency improvement (Aβ<sub>42</sub> EC<sub>50</sub> = 51 nM) at a lower cLogP (3.2) relative to (<i>S</i>)-<b>8</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The SAR of the left-hand side heterocycle was further explored with compounds <b>20</b>–<b>24</b>. Both compound <b>20</b> and <b>21</b> provided moderately potent analogues (Aβ<sub>42</sub> EC<sub>50</sub> = 98 and 72 nM, respectively) but at the expense of significantly higher cLogP (3.9). All three of these potent analogues were further profiled for stability in rat hepatocytes and demonstrated very high turnover rates which appeared to correlate with increasing cLogP. Replacement of the methyl imidazole with other five-member heterocycles provided compounds <b>22</b>–<b>24</b>, which all demonstrated reduced cellular potency. Turning our attention back to the aryl ether, combining the more lipophilic 2-CF<sub>3</sub>, 4-Cl phenyl with the more potent 4-methylimidazole provided compound <b>25</b> which demonstrated an approximate 10-fold potency improvement relative to compound (<i>S</i>)-<b>8</b> (Aβ<sub>42</sub> EC<sub>50</sub> = 27 and 230 nM, respectively). This potency improvement comes with the expense of a higher cLogP (4.1) and demonstrated the expected high clearance in rat hepatocytes. Not surprisingly, orally dosing this relatively rat unstable compound (rat CL<sub>int,u</sub> = 3830 mL min<sup>–1</sup> kg<sup>–1</sup>) at 30 mg/kg afforded only minimal exposure and demonstrated no brain Aβ<sub>42</sub> reduction in vivo.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity of Aryl Ether Pyrimidine Oxadiazine GSMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Aβ<sub>42</sub> EC<sub>50</sub> values were determined in H4 cells overexpressing WT human APP751. Aβ<sub>42</sub> EC<sub>50</sub> values shown here are the average of <i>n</i> > 2 assays run in duplicate.</p></div></div><div></div></div><div class="NLM_p">In continuing to explore the alkyl-substituted aryl ether oxadiazines, we engineered another conformational constraint to further restrict the rotation of the pendant aryl group as shown below in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. To mimic the potentially bioactive 3-dimensional presentation of the aryl motif in <b>V</b>, we designed a series of piperidine aryl ethers <b>VI</b>. In this design, there are only five rotatable bonds in the scaffold compared to the seven rotatable bonds found in the initial amide designs. To mimic another possible bioactive 3-dimensional presentation of the aryl motif in <b>VII</b>, we also designed a series of <i>N</i>-aryl substituted piperazines <b>VIII</b>. With the piperazine scaffold, there are now only four rotatable bonds compared to the initial amides.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategies incorporated into fused piperidine and piperazine scaffolds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The racemic synthesis of piperidine ether oxadiazine GSMs began from commercially available 2-(hydroxymethyl)pyridin-3-ol is described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The primary alcohol of pyridine <b>26</b> was protected with TBDMS-Cl, reduced to the piperidine with 60 psi of H<sub>2</sub> gas over PtO<sub>2</sub>, then protected with Boc<sub>2</sub>O to afford piperidinol <b>27</b> as a mixture of cis enantiomers. Piperidinol <b>27</b> was reacted with either 4-fluoro-2-methylphenol or 4-chloro-2-(trifluoromethyl)phenol in a Mitsunobu reaction to afford aryl ether <b>28</b>. The silyl protecting group was removed with TBAF, the amine protecting group removed with TFA in DCM and the resulting amine coupled with the in situ generated acid chloride of 5-bromo-6-methoxypicolinic acid to provide amides <b>29</b>. Conversion of the primary hydroxyl to the alkoxyamine <b>30</b> was achieved via Mitsunobu reaction with <i>N-</i>hydroxyphthalimide and subsequent deprotection with hydrazine. Successful oxadiazine formation was realized with dehydrative P<sub>2</sub>O<sub>5</sub> conditions in <i>i-</i>PrOH and further purification via preparative chiral HPLC afforded <b>31a(+)</b>, <b>31a(−)</b>, <b>31b(+)</b>, and <b>31b(−)</b>. Suzuki or Buchwald coupling conditions with each enantiomer successfully installed the R<sup>1</sup> heteroaryl groups to afford the desired oxadiazines <b>32–34(+)</b> and <b>32–34(−)</b>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Piperidine Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBDMS-Cl, imidazole, DMF, 48%; (b) H<sub>2</sub>, PtO<sub>2</sub>, EtOH, 87%; (c) Boc<sub>2</sub>O, TEA, DCM, 63%; (d) 4-fluoro-2-methylphenol or 4-chloro-2-(trifluoromethyl)phenol, DIAD, PPh<sub>3</sub>, DCM, 78 or 85%; (e) a. TBAF, THF, b. TFA, DCM, c. 5-bromo-6-methoxypicolinic acid, DMF/oxalyl chloride, DCM then TEA, THF, 32 and 57% over three steps; (f) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, toluene, b. hydrazine hydrate, EtOH, 69 and 87% over two steps; (g) POCl<sub>3</sub>, <i>I</i>-PrOH, 35 and 56%; (h) 4-methyl imidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, 74–65%; (i) (2-methylpyridin-4-yl)boronic acid, Cs<sub>2</sub>CO<sub>3,</sub> PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, 61–56%.</p></p></figure><div class="NLM_p">The racemic synthesis of <i>N</i>-aryl piperazine oxadiazine GSMs began from commercially available <i>tert-</i>butyl 2-(hydroxymethyl)piperazine-1-carboxylate as described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The primary alcohol of piperazine <b>35</b> was protected with TBDMS-Cl then coupled with 2-bromo-5-chlorobenzotrifluoride using Pd<sub>2</sub>(dba)<sub>3</sub> and DavePhos to afford <i>N</i>-aryl piperazine <b>36</b>. Both the amine and primary alcohol protecting groups were removed with HCl, and the resulting liberated amine was coupled with 5-bromo-6-methoxypicolinic acid under HATU conditions to provide amide <b>37</b>. Conversion of the primary hydroxyl to the alkoxyamine <b>38</b> was achieved via Mitsunobu reaction with <i>N-</i>hydroxyphthalimide and subsequent hydrazine deprotection. Successful oxadiazine formation was realized with POCl<sub>3</sub> in EtOH with catalytic addition of DMAP to afford <b>39</b>. Buchwald coupling successfully installed the 4-methyl imidazole to afford the desired oxadiazines which were purified via preparative chiral HPLC to provide both <b>40(+)</b> and <b>40(−)</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of piperazine oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) a. TBDMS-Cl, imidazole, DCM, b. NaO<i>t</i>Bu, Pd<sub>2</sub>(dba)<sub>3</sub>, DavePhos, 2-bromo-5-chlorobenzotrifluoride, toluene, 70% over two steps; (b) a. HCl, MeOH/dioxane, b. 5-bromo-6-methoxypicolinic acid, DIEA, HATU, DMF, c. TBAF, DCM, 80% over three steps; (c) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, toluene, b. hydrazine hydrate, EtOH; (d) POCl<sub>3</sub>, DIEA, DMAP, EtOH; (f) 4-methyl imidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane.</p></p></figure><div class="NLM_p">Rewardingly, the initial piperidine aryl ether afforded a modestly potent analogue <b>32(+)</b> (Aβ<sub>42</sub> EC<sub>50</sub> = 197 nM) (<a class="ref internalNav" href="#tbl4" aria-label="Table 3">Table 3</a>). Here again a high eudysmic ratio was observed as the enantiomeric <b>32(−)</b> demonstrated an Aβ<sub>42</sub> EC<sub>50</sub> > 3000 nM. Replacement of the methyl imidazole with methylpyridine provided compound <b>33(+)</b>. Once again, the methylpyridine demonstrated less potency (Aβ<sub>42</sub> EC<sub>50</sub> = 240 nM) with a significantly higher and less desirable cLogP (4.6). Incorporation of the more lipophilic 2-CF<sub>3</sub>, 4-Cl phenyl in compound <b>34(+)</b> significantly improved the potency (Aβ<sub>42</sub> EC<sub>50</sub> = 15 nM) relative to compound <b>32(+)</b>, albeit at an even higher cLogP (4.8). Given this drastic improvement in potency, we further profiled compound <b>34(+)</b> in both rat and human hepatocytes. While the stability in rat hepatocytes was considerably low (rat CL<sub>int,u</sub>= 4251 mL min<sup>–1</sup> kg<sup>–1</sup>), the predicted human CL<sub>int,u</sub> was much better (human hep CL<sub>int,u</sub> = 167 mL min<sup>–1</sup> kg<sup>–1</sup>). We decided to determine the reduction of brain Aβ<sub>42</sub> in mice with this highly potent compound with promising human CL<sub>int,u</sub>. Here, dosing compound <b>34(+)</b> at 90 mg/kg in mice provides a 32% Aβ<sub>42</sub> reduction in the brain at 6 h postdose with a total concentration of 36 μM of the compound observed in the brain and a B:P of 0.6. Unfortunately, the desired potency and modest efficacy comes at the expense of increasing the cLogP (4.8). The related <i>N</i>-aryl piperazine afforded modestly potent <b>40(+)</b> (Aβ<sub>42</sub> EC<sub>50</sub> = 64 nM), which demonstrated a eudysmic ratio of 5 (<b>40(−)</b>:Aβ<sub>42</sub> EC<sub>50</sub> = 307 nM), but further work on this high cLogP analogue (4.4) was deprioritized due to the exciting results from our next set of designs.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Activity of Piperidine and Piperazine Oxadiazine GSMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0016.gif" alt="" id="GRAPHIC-d131e1437-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0017.gif" alt="" id="GRAPHIC-d131e1438-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Aβ<sub>42</sub> EC<sub>50</sub> values were determined in H4 cells overexpressing WT human APP751. Aβ<sub>42</sub> EC<sub>50</sub> values shown here are the average of <i>n</i> > 2 assays run in duplicate.</p></div></div><div></div></div><div class="NLM_p">To further explore the alkyl-substituted aryl ether pyrimidine oxadiazine GSMs, we engineered a different conformational constraint from the alkyl group to the aryl group restricting the rotation of the pendant aryl group as shown below in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. In this fashion, the alkyl ether <b>V</b> was converted to heteroaryls <b>IX</b>. Here there are only four rotatable bonds in the newly designed scaffold compared to the seven rotatable bonds found in the initial amide designs.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design strategies incorporated into heteroaryl oxadiazine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The heteroaryl oxadiazines were obtained via the stereoselective synthesis as described below in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The boronic acid <b>41</b> was converted into amino alcohol <b>42</b> via an asymmetric Petasis Borono–Mannich multicomponent reaction<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and reduction of the resulting amino acid. Protecting group swap from the sulfinamide to the PMB-protected amine afforded <b>43</b>. The secondary amine was coupled with 5-bromo-6-methoxypicolinic acid to provided amide <b>44</b>. Mitsunobu reaction with <i>N</i>-hydroxyphthalimide and subsequent deprotection with hydrazine afforded the alkoxyamine <b>45</b>. Treatment with TEA in DCE effected acyl migration to the alkoxyamine, which was then cyclized with POCl<sub>3</sub> in EtOH and catalytic addition of DMAP to provided oxadiazine <b>46</b>. Subsequent 4-methyl imidazole incorporation via Buchwald coupling afforded the key oxadiazines <b>47</b>–<b>48</b>.</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Asymmetric Synthesis of Heterocyclic Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) a. glyoxylic acid monohydrate, (<i>S</i>)-2-methylpropane-2-sulfinamide, InBr<sub>3,</sub> DCM, b. LiAlH<sub>4</sub>, THF, 21 and 16% over two steps; (b) a. 4 N HCl, dioxane, b. TEA, MgSO<sub>4</sub>, <i>p</i>-anisaldehyde, then NaBH<sub>4,</sub> MeOH, 68 and 84% over two steps; (c) NaOMe, 5-bromo-6-methoxypicolinic acid, MeOH, 78 and 82%; (d) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, toluene, b. hydrazine hydrate, EtOH, 68 and 51% over two steps; (e) a. TFA, DCE, b. POCl<sub>3</sub>, DIEA, DMAP, EtOH, 37 and 32% over two steps; (f) a. 4-methyl imidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, b. TFA, DCE, 51 and 43% over two steps.</p></p></figure><div class="NLM_p">Rewardingly, the initial benzofuran afforded potent analogue <b>47</b> (Aβ<sub>42</sub> EC<sub>50</sub> = 35 nM) now with great predicted CNS drug-like properties based on a low cLogP (2.8) and high CNS-MPO score (5.0) (<a class="ref internalNav" href="#tbl5" aria-label="Table 4">Table 4</a>). The potency of this compound is achieved with very high efficiency as measured by both LLE (4.7) and LELP (7.6) scores.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Further profiling demonstrated greatly improved stability in rat hepatocytes (CL<sub>int,u</sub> = 84 mL min<sup>–1</sup> kg<sup>–1</sup>) and predicted human stability (human hep CL<sub>int,u</sub> = 44 mL min<sup>–1</sup> kg<sup>–1</sup>). We decided to immediately determine the reduction of brain Aβ<sub>42</sub> in mice with this potent, promising compound. Dosing compound <b>47</b> orally at 30 mg/kg in mice provided a 43% reduction of brain Aβ<sub>42</sub> at 6 h with 30 μM (427 nM free) compound observed in the brain and a B:P of 1.5. Here, the free drug concentration in the brain exceeded the EC<sub>90</sub> in the cellular assays, which predicates good in vivo activity in the CNS.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> For the first time, we had combined good potency and great predicted CNS drug-like properties with in vivo efficacy. Replacement of the benzofuran with the benzothiophene provided compound <b>48</b>, a more active analogue (Aβ<sub>42</sub> EC<sub>50</sub> = 8 nM) albeit with a higher cLogP (3.7) and lower CNS-MPO score (4.1). This analogue is also highly efficient as measured by both LLE (4.4) and LELP (9.4) scores. Here the increase in lipophilicity leads to a reduction in both the rat and human hepatocyte stability (rat CL<sub>int,u</sub> = 430 mL min<sup>–1</sup> kg<sup>–1</sup> and human hep CL<sub>int,u</sub> = 322 mL min<sup>–1</sup> kg<sup>–1</sup>). We proceeded to determine the reduction of mouse brain Aβ<sub>42</sub> with this potent, promising compound. Dosing compound <b>48</b> at 30 mg/kg in our mouse model provided a 34% reduction of brain Aβ<sub>42</sub> at 6 h with 30 μM total compound (76 nM free) observed in the brain and a B:P of 2.8.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Activity of Heterocyclic Oxadiazines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0018.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="/">cLogP/MPO</th><th class="colsep0 rowsep0" align="center" char="/">LLE/LELP</th><th class="colsep0 rowsep0" align="center" char=".">rat CL<sub>int,u</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">human CL<sub>int,u</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">[brain] total (μM)</th><th class="colsep0 rowsep0" align="center" char=".">[brain] free (nM)</th><th class="colsep0 rowsep0" align="center" char=".">brain Aβ<sub>42</sub> lowering<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char="/">2.8/5.0</td><td class="colsep0 rowsep0" align="char" char="/">4.7/7.6</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">29.8</td><td class="colsep0 rowsep0" align="char" char=".">427</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char="/">3.7/4.1</td><td class="colsep0 rowsep0" align="char" char="/">4.4/9.4</td><td class="colsep0 rowsep0" align="char" char=".">430</td><td class="colsep0 rowsep0" align="char" char=".">322</td><td class="colsep0 rowsep0" align="char" char=".">30.2</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Aβ<sub>42</sub> EC<sub>50</sub> values were determined in H4 cells overexpressing WT human APP751. Aβ<sub>42</sub> EC<sub>50</sub> values shown here are the average of <i>n</i> > 2 assays run in duplicate.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Brain Aβ<sub>42</sub> lowering was measured 6 h postdose.</p></div></div></div><div class="NLM_p">Further profiling compound <b>47</b> demonstrated good aqueous solubility (84 μM) in a pH 7.4 buffer.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Permeability and Pg-P efflux potential were assessed via Caco-2 assay with compound <b>47</b>, demonstrating good permeability (<i>P</i><sub>A→B</sub> = 10 × 10<sup>–6</sup> cm/s) and minimal Pg-P efflux potential (efflux ratio = 1.1). Compound <b>47</b> also demonstrated minimal cytotoxicity (TC<sub>50</sub> > 72 μM) in HepG2 cells measuring ATP to assess viability as well as minimal hERG liability (IC<sub>50</sub> = 15 μM) in a functional patch clamp assay. The cytochrome P450 profiling of compound <b>47</b> demonstrated minimal inhibition against CYP 3A4, 2C19, and 2C8 (IC<sub>50</sub>s of 25, 17, and >25 μM, respectively) and moderate inhibition of CYP 2C9, 2D6, and 1A2 (IC<sub>50</sub>s of 8, 2, and 3 μM, respectively). Profiling for CYP3A4 time dependent inhibition was shown to be negative as inhibition concentrations from 5 to 25 μM were consistent with vehicle. No genotoxicity with or without S9 metabolic activation was observed for compound <b>47</b> in a GreenScreen assessment.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Compound <b>47</b> was also shown to possess an excellent pharmacokinetic profile in both rat and monkey (<a class="ref internalNav" href="#tbl6" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Parameters of <b>47</b> in Rat and Monkey</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (μM-h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">%<i>F</i><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wistar rat</td><td class="colsep0 rowsep0" align="char" char=".">67.8</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="center">93</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cynomolgus monkey</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="center">136 ± 34</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">10 mg/kg for po; 1 mg/kg for iv.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">AUC (area under the curve) and <i>C</i><sub>max</sub> (maximal drug concentration) obtained with po administration.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">%<i>F</i>: bioavailability.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last"><i>T</i><sub>1/2</sub> (half-life), <i>V</i><sub>ss</sub> (volume of distribution), CL (in vivo clearance) obtained with iv administration.</p></div></div></div><div class="NLM_p">Compound <b>47</b> demonstrates robust in vivo reduction of Aβ<sub>42</sub> and subsequent increase of Aβ<sub>37</sub> in rodents (<a class="ref internalNav" href="#tbl7" aria-label="Table 6">Table 6</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Dosing <b>47</b> at 30 mg/kg in mice provides a 43% reduction of Aβ<sub>42</sub> and increases Aβ<sub>37</sub> 3.2-fold in mouse brain at 6 h. To assess these effects in both brain and CSF, we dosed <b>47</b> at 30 mg/kg in rats. Here, a 30% Aβ<sub>42</sub> reduction and 2.5-fold increase in Aβ<sub>37</sub> were observed in the rat brain at 6 h. A greater effect size was noted in CSF, where compound <b>47</b> demonstrated a 58% reduction in Aβ<sub>42</sub> and a 20-fold increase in Aβ<sub>37</sub> also at 6 h. To further characterize this compound, a time course efficacy study (<a class="ref internalNav" href="#fig7" aria-label="Figure 5">Figure 5</a>) was conducted in mice dosed at 30 mg/kg. This study led to peak Aβ<sub>42</sub> reductions of 45% with a calculated Aβ<sub>42</sub>, lowering AUC<sub>1→24</sub> of 34%. Peak increases of 3.1-fold were observed for Aβ37.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vivo Efficacy Profile of <b>47</b> in Rodents</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">[brain] total (μM)</th><th class="colsep0 rowsep0" align="center" char=".">[brain] free (nM)</th><th class="colsep0 rowsep0" align="center" char=".">brain Aβ42 reduction<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">Brain Aβ37 fold increase<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ42 reduction<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ37 fold increase<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">29.8</td><td class="colsep0 rowsep0" align="char" char=".">427</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td><td class="colsep0 rowsep0" align="char" char=".">156</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Expressed as % vehicle in CSF and brain 6 h postdose.</p></div></div></div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0005.jpeg" id="GRAPHIC-d131e2252-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo time course profile of <b>47</b> in mouse brain. Aβ<sub>37</sub> (left) and Aβ<sub>42</sub> (right) in the brain of mice treated acutely with a single oral dose of 47 (30 mg/kg). Data represent the mean ± SEM of 5–8 animals per group, expressed as % vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">From initial amide designs based on <b>1</b>, we have pursued molecules with the potential to alter the course of FAD in an effort to prevent, or at least delay, the impending cognitive decline. We have focused our efforts with a keen eye to overcome the shortcoming of previous GSMs, combining the desired in vitro potency and in vivo efficacy with good CNS drug-like properties.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Through the use of an isosteric amide replacement and critical consideration of conformational restriction, we have discovered a very exciting series of oxadiazines that address these critical issues. Oxadiazine <b>47</b> possesses very good potency and efficacy with excellent predicted CNS drug-like properties as measured by low MW (389), low lipophilicity (cLogP = 2.8), high CNS-MPO score (5.0), and high LLE (4.7) and LELP (7.6) binding efficiencies. This compound also demonstrates a desirable profile across various measurements including solubility, permeability, metabolic stability, CYP inhibition, hERG liability, P-gp efflux, genotoxicity, and PK assays. This class of compounds has provided a new avenue to further develop the molecules required for proof-of-mechanism studies in the clinic. Our additional efforts to further improve potency and efficacy while maintaining this excellent CNS drug-like profile will be the subject of further discussion in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Methods</h3><div class="NLM_p">All reactions were carried out using commercial materials and reagents without further purification unless otherwise noted. All reactions were monitored by thin layer chromatography (TLC) on silica gel plates (Keiselgel 60 F254, Merck), high-performance liquid chromatography (HPLC), liquid chromatography mass spectrometry (LCMS), or ultraperformance liquid chromatography (UPLC). All products were characterized by <sup>1</sup>H NMR and mass spectrometry. <sup>1</sup>H NMR data was recorded on a JEOL ECX400 MHz or Bruker Avance II Ultra shield 500 MHz spectrometer. Chemical shifts are expressed in parts per million values (ppm) and are designated as s (singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), quint (quintet), or m (multiplet). Coupling constants (<i>J</i>) are expressed as values in hertz (Hz). Optical rotations were taken on a Rudolph Research Analytical Autopol III automatic polarimeter, model A21101 AIII/2W. Flash column chromatography was performed on silica gel using Fluorochem silica gel LC60A 40–63 μm and reagent grade solvents as eluent. All compounds submitted for in vitro testing were >95% purity (HPLC) and those for in vivo testing were >98% purity (HPLC). LCMS analysis using LCMS A, standard conditions: XTerra RP18 column, 3.0 mm × 50 mm, 3.5 μm; mobile phase A, H<sub>2</sub>O; mobile phase B, CH<sub>3</sub>CN with 0.1% formic acid (FA); 0–1 min isocratic (5% B), 1–6 min gradient (5–95% B), 6–7 min isocratic (95% B); flow rate, 1 mL/min. LCMS analysis using LCMS B, standard conditions: Ascentis Express C-18 column, 50 mm × 3.0 mm, 2.7 μm; mobile phase, 0.025% Aq TFA + 5% ACN:ACN + 5% 0.025% Aq TFA; T/B% 0.01/5, 0.5/5, 3/100, 5/100; flow rate, 1.2 mL/min. LCMS analysis using LCMS C, standard conditions: XBridge C18 column, 4.6 mm × 30 mm, 3.5 μm; mobile phase A, H<sub>2</sub>O (10.0 mM NH<sub>4</sub>HCO<sub>2</sub>); mobile phase B, CH<sub>3</sub>CN. 0.0–0.2 min isocratic (5% B), 0.2–2.0 min gradient (5–100% B), 3.0–3.0 min isocratic (100% B); flow rate, 3.0 mL/min.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>S</i>)-<i>tert</i>-Butyl 4-((4-Fluoro-2-methylphenoxy)methyl)-2,2-dimethyloxazolidine-3-carboxylate (<b>2a</b>)</h4><div class="NLM_p last">DIAD (1.70 mL, 8.68 mmol, 1.2 equiv) was added to a solution of triphenylphosphine (2.28 g, 8.68 mmol, 1.2 equiv), (<i>S</i>)-<i>tert</i>-butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate (1.83 g, 7.89 mmol, 1.0 equiv), and 4-fluoro-2-methylphenol (1.09 g, 8.68 mmol, 1.2 equiv) in THF (20 mL) at RT. The resulting mixture was then stirred for 18 h at 80 °C. The reaction mixture was diluted with EtOAc, and the organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–20% EtOAc/hexanes) to afford the desired product (1.90 g, 70%) as a colorless oil. LCMS (ES+) [M – Boc + H]<sup>+</sup>: 240.4.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>S</i>)-<i>tert</i>-Butyl 4-((4-Chloro-2-(trifluoromethyl)phenoxy)methyl)-2,2-dimethyloxazolidine-3-carboxylate (<b>2b</b>)</h4><div class="NLM_p last">DIAD (0.46 mL, 2.35 mmol, 1.1 equiv) was added to a solution of triphenylphosphine (616 mg, 2.35 mmol, 1.1 equiv), (<i>S</i>)-<i>tert</i>-butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate (495 mg, 2.14 mmol, 1.0 equiv), and 4-chloro-2-(trifluoromethyl)phenol (462 g, 2.35 mmol, 1.1 equiv) in THF (8 mL) at RT. The resulting mixture was then stirred for 18 h at 80 °C. The reaction mixture was diluted with EtOAc, and the organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–20% EtOAc/hexanes) to afford the desired product (673 mg, 77%) as a colorless oil. LCMS (ES+) [M – Boc + H]<sup>+</sup>: 310.6/312.6.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>R</i>)-3-(4-Fluoro-2-methylphenoxy)-2-(4-methoxybenzylamino)propan-1-ol (<b>3a</b>)</h4><div class="NLM_p last">A solution of (<i>S</i>)-<i>tert</i>-butyl 4-((4-fluoro-2-methylphenoxy)methyl)-2,2-dimethyloxazolidine-3-carboxylate (<b>2a</b>) (787 mg, 2.32 mmol, 1.0 equiv) in DCM (10 mL) was treated with TFA (5 mL) at RT, and the resulting mixture was stirred for 1 h at the same temperature. The reaction mixture was then concentrated and the residue was dissolved in THF (10 mL). Then 1 N aqueous HCl (10 mL) was added, and the mixture was stirred for 18 h at RT. The reaction mixture was diluted with Et<sub>2</sub>O (50 mL) and extracted twice with 1 N aqueous HCl. The aqueous phases were combined, concentrated to dryness, and coevaporated twice with MeOH to give the desired ammonium salt (516 mg, 96%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 200.3. A solution of (<i>R</i>)-2-amino-3-(4-fluoro-2-methylphenoxy)propan-1-ol hydrochloride (515 mg, 2.18 mol, 1.0 equiv) in DCM (12 mL) at ambient temperature was treated successively with triethylamine (0.61 mL, 4.36 mmol, 2.0 equiv), MgSO<sub>4</sub> (1.00 g), and <i>p</i>-anisaldehyde (0.27 mL, 2.18 mmol, 1.0 equiv). The resulting suspension was stirred for 16 h at ambient temperature and filtered through a pad of Celite which was washed with EtOAc. The filtrate was concentrated under vacuum to afford the corresponding imine intermediate. This intermediate was dissolved in MeOH (15 mL) and cooled to 0 °C. NaBH<sub>4</sub> (249 mg, 3.54 mmol, 3.0 equiv) was added portionwise over 5 min. The resulting mixture was stirred for 30 min at 0 °C and then quenched by the slow addition of a saturated aqueous solution of NaHCO<sub>3</sub>. Water and DCM were added. The layers were separated, and the aqueous layer was extracted with DCM twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated to afforded a residue that was purified by normal phase chromatography on silica (0–6% MeOH/DCM) to afford the desired amino-alcohol (516 mg, 74%) as an off-white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.27–7.24 (m, 2H), 6.88–6.85 (m, 3H), 6.81 (td, <i>J</i> = 8.3, 2.9 Hz, 1H), 6.70 (dd, <i>J</i> = 8.9, 4.5 Hz, 1H), 4.01 (dd, <i>J</i> = 9.4, 4.9 Hz, 1H), 3.95 (dd, <i>J</i> = 9.4, 6.1 Hz, 1H), 3.84 (s, 2H), 3.80 (s, 3H), 3.78 (dd, <i>J</i> = 10.9, 4.4 Hz, 1H), 3.59 (dd, <i>J</i> = 10.9, 5.3 Hz, 1H), 3.14 (dt, <i>J</i> = 10.3, 5.0 Hz, 1H), 2.19 (s, 3H). LCMS (ES+) [M + H]<sup>+</sup>: 320.5.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-3-(4-Chloro-2-(trifluoromethyl)phenoxy)-2-(4-methoxybenzylamino)propan-1-ol (<b>3b</b>)</h4><div class="NLM_p last">A solution of (<i>S</i>)-<i>tert</i>-butyl 4-((4-chloro-2-(trifluoromethyl)phenoxy)methyl)-2,2-dimethyloxazolidine-3-carboxylate (<b>2b</b>) (528 mg, 1.29 mmol, 1.0 equiv) in DCM (4 mL) was treated with TFA (2 mL) at RT, and the resulting mixture was stirred for 1 h at the same temperature. The reaction mixture was then concentrated, and the residue was dissolved in THF (4 mL). Then 1 N aqueous HCl (4 mL) was added, and the mixture was stirred for 18 h at RT. The reaction mixture was diluted with Et<sub>2</sub>O (30 mL) and extracted twice with 1 N aqueous HCl. The aqueous phases were combined, concentrated to dryness, and coevaporated twice with MeOH to give the desired ammonium salt (341 mg, 86%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 270.4/272.4. A solution of (<i>R</i>)-2-amino-3-(4-chloro-2-(trifluoromethyl)phenoxy)propan-1-ol hydrochloride (339 mg, 1.01 mol, 1.0 equiv) in DCM (10 mL) at ambient temperature was treated successively with triethylamine (0.28 mL, 2.02 mmol, 2.0 equiv), MgSO<sub>4</sub> (1.00 g), and <i>p</i>-anisaldehyde (123 μL, 1.01 mmol, 1.0 equiv). The resulting suspension was stirred for 16 h at RT and filtered through a pad of Celite which was washed with EtOAc. The filtrate was concentrated to afford the corresponding imine intermediate. This intermediate was dissolved in MeOH (8 mL) and cooled to 0 °C. NaBH<sub>4</sub> (112 mg, 3.03 mmol, 3.0 equiv) was added portionwise over 5 min. The resulting mixture was stirred for 30 min at 0 °C and then quenched by the slow addition of a saturated aqueous solution of NaHCO<sub>3</sub>. Water and EtOAc were added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated to afforded a residue that was purified by normal phase chromatography on silica (0–6% MeOH/DCM) to afford the desired amino-alcohol (312 mg, 79%) as an off-white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.55 (d, <i>J</i> = 2.6 Hz, 1H), 7.43 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.27–7.22 (m, 2H), 6.90 (d, <i>J</i> = 8.8 Hz, 1H), 6.88–6.84 (m, 2H), 4.11 (dd, <i>J</i> = 9.2, 4.6 Hz, 1H), 4.04 (dd, <i>J</i> = 9.2, 6.3 Hz, 1H), 3.82 (s, 2H), 3.80 (s, 3H), 3.77 (dd, <i>J</i> = 11.1, 4.5 Hz, 1H), 3.59 (dd, <i>J</i> = 11.1, 4.9 Hz, 1H), 3.15 (dq, <i>J</i> = 6.1, 4.7 Hz, 1H). LCMS (ES+) [M + H]<sup>+</sup>: 390.5/392.5.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-4-Bromo-<i>N</i>-(1-(4-fluoro-2-methylphenoxy)-3-hydroxypropan-2-yl)-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>4a</b>)</h4><div class="NLM_p last">A solution of 4-bromo-3-methoxybenzoic acid (411 mg, 1.78 mmol, 1.1 equiv) in DCM (8 mL) at ambient temperature was treated with a catalytic amount of DMF (1 drop) and oxalyl chloride (0.53 mL, 4.86 mmol, 3.0 equiv). The resulting mixture was stirred at ambient temperature for 1 h, at which point LCMS monitoring showed completion of the reaction. The mixture was concentrated to dryness, diluted with anhydrous THF (8 mL), concentrated again, and dried under high vacuum for 1 h. The residue was diluted with anhydrous THF (8 mL), triethylamine (0.45 mL, 3.23 mmol, 2.0 equiv) was added, and the resulting mixture was cooled to 0 °C. A solution of (<i>R</i>)-3-(4-fluoro-2-methylphenoxy)-2-(4-methoxybenzylamino)propan-1-ol (<b>3a</b>) (516 mg, 1.62 mmol, 1.0 equiv) in THF (6 mL) was quickly added, and the resulting mixture was stirred at 0 °C for 30 min. A saturated aqueous solution of NaHCO<sub>3</sub> and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–100% EtOAc/hexanes) to afford the desired amide (640 mg, 59%) as a white foam. LCMS (ES+) [M + H]<sup>+</sup>: 532.6/534.6.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-4-Bromo-<i>N</i>-(1-(4-chloro-2-(trifluoromethyl)phenoxy)-3-hydroxypropan-2-yl)-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>4b</b>)</h4><div class="NLM_p last">A solution of 4-bromo-3-methoxybenzoic acid (1.52 g, 6.58 mmol, 1.1 equiv) in DCM (30 mL) at RT was treated with a catalytic amount of DMF (1 drop) and oxalyl chloride (1.70 mL, 19.7 mmol, 3.3 equiv). The resulting mixture was stirred at RT for 1 h, at which point LCMS monitoring showed completion of the reaction. The mixture was concentrated to dryness, diluted with anhydrous THF (15 mL), concentrated again, and dried under high vacuum for 1 h. The residue was diluted with anhydrous THF (30 mL), triethylamine (2.50 mL, 17.9 mmol, 3.0 equiv) was added, and the resulting mixture was cooled to 0 °C. A solution of (<i>R</i>)-3-(4-chloro-2-(trifluoromethyl)phenoxy)-2-(4-methoxybenzylamino)propan-1-ol (<b>3b</b>) (2.33 g, 5.98 mmol, 1.0 equiv) in THF (15 mL) was quickly added, and the resulting mixture was stirred at 0 °C for 30 min. A saturated aqueous solution of NaHCO<sub>3</sub> and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–100% EtOAc/hexanes) to afford the desired amide (3.44 g, 95%) as a white foam. LCMS (ES+) [M + H]<sup>+</sup>: 602.4/604.4/606.4.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-<i>N</i>-(1-(Aminooxy)-3-(4-fluoro-2-methylphenoxy)propan-2-yl)-4-bromo-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>5a</b>)</h4><div class="NLM_p last">DIAD (0.28 mL, 1.44 mmol, 1.2 equiv) was added to a solution of triphenylphosphine (377 mg, 1.44 mmol, 1.2 equiv), (<i>R</i>)-4-bromo-<i>N</i>-(1-(4-fluoro-2-methylphenoxy)-3-hydroxypropan-2-yl)-3-methoxy-<i>N</i>-(4-methoxybenzyl)ben-zamide (<b>4a</b>) (640 mg, 1.20 mmol, 1.0 equiv), and <i>N</i>-hydroxyphtalimide (235 mg, 1.44 mmol, 1.2 equiv) in THF (10 mL) at 0 °C. The resulting mixture was kept at 0 °C for 1 h then warmed to ambient temperature and stirred for 16 h. The reaction mixture was diluted with EtOAc, and the organic layer was washed with 1 N aqueous NaOH (twice), water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–50% EtOAc/hexanes) to afford the desired product (778 mg, 96%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 677.6/679.6. A suspension of (<i>S</i>)-4-bromo-<i>N</i>-(1-(1,3-dioxoisoindolin-2-yloxy)-3-(4-fluoro-2-methylphenoxy)propan-2-yl)-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (778 mg, 1.15 mol, 1.0 equiv) in ethanol (90%, 12 mL) and THF (6 mL) at ambient temperature was treated with hydrazine hydrate (50–60%, 1.2 mL). The resulting mixture was stirred for 30 min, then water was added. The mixture was extracted with EtOAc (three times), and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–100% EtOAc/DCM) to afford the desired product (560 mg, 89%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 547.6/549.6.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-<i>N</i>-(1-(Aminooxy)-3-(4-chloro-2-(trifluoromethyl)phenoxy)propan-2-yl)-4-bromo-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>5b</b>)</h4><div class="NLM_p last">DIAD (1.35 mL, 6.85 mmol, 1.2 equiv) was added to a solution of triphenylphosphine (1.80 g, 6.85 mmol, 1.2 equiv), (<i>R</i>)-4-bromo-<i>N</i>-(1-(4-chloro-2-(trifluoromethyl)phenoxy)-3-hydroxypropan-2-yl)-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>4b</b>) (3.44 g, 5.71 mmol, 1.0 equiv), and <i>N</i>-hydroxyphthalimide (1.12 g, 6.85 mmol, 1.2 equiv) in THF (30 mL) at 0 °C. The resulting mixture was kept at 0 °C for 1 h, then warmed to RT and stirred for 16 h. The reaction mixture was diluted with EtOAc, and the organic layer was washed with 1 N aqueous NaOH (twice), water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–60% EtOAc/hexanes) to afford the desired product (3.94 g, 92%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 747.4/749.4/751.3. A suspension of (<i>S</i>)-4-bromo-<i>N</i>-(1-(4-chloro-2-(trifluoromethyl)phenoxy)-3-(1,3-dioxoisoindolin-2-yloxy)propan-2-yl)-3-methoxy-<i>N</i>-(4-methoxy-benzyl)benzamide (3.94 g, 5.27 mol, 1.0 equiv) in ethanol (90%, 20 mL) and THF (10 mL) at RT was treated with hydrazine hydrate (50–60%, 4.0 mL). The resulting mixture was stirred for 30 min and then water was added. The mixture was extracted with EtOAc (three times), and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford the desired product (3.25 g, 99%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 617.5/619.5/621.5.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-3-(4-Bromo-3-methoxyphenyl)-5-((4-fluoro-2-methylphenoxy)methyl)-4-(4-methoxy-benzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>6a</b>)</h4><div class="NLM_p last">A sealable vial was charged with (<i>S</i>)-<i>N</i>-(1-(aminooxy)-3-(4-fluoro-2-methylphenoxy)propan-2-yl)-4-bromo-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>5a</b>) (560 mg, 1.02 mmol, 1.0 equiv) and <i>i</i>-PrOH (10.0 mL). P<sub>2</sub>O<sub>5</sub> (1.45 g, 10.2 mmol, 10.0 equiv) was added at ambient temperature. The vial was sealed, and the reaction was stirred at 80 °C for 16 h. The reaction mixture was cooled to ambient temperature and diluted with EtOAc. A saturated aqueous solution of NaHCO<sub>3</sub> was added, the layers were separated, and the aqueous phase was extracted with EtOAc. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–50% EtOAc/hexanes) to afford the desired product (241 mg, 45%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.58 (d, <i>J</i> = 8.1 Hz, 1H), 7.11–7.08 (m, 2H), 7.07 (d, <i>J</i> = 1.8 Hz, 1H), 7.03 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.89–6.85 (m, 3H), 6.79 (td, <i>J</i> = 8.3, 2.7 Hz, 1H), 6.65 (dd, <i>J</i> = 8.9, 4.5 Hz, 1H), 4.39–4.35 (m, 2H), 4.23–4.20 (m, 1H), 4.09–4.00 (m, 2H), 3.89 (s, 3H), 3.81 (s, 3H), 3.74–3.70 (m, 1H), 3.58 (dd, <i>J</i> = 10.9, 2.5 Hz, 1H), 2.21 (s, 3H). LCMS (ES+) [M + H]<sup>+</sup>: 529.5/531.5.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-3-(4-Bromo-3-methoxyphenyl)-5-((4-chloro-2-(trifluoromethyl)phenoxy)methyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>6b</b>)</h4><div class="NLM_p last">A sealable vial was charged with (<i>S</i>)-<i>N</i>-(1-(aminooxy)-3-(4-chloro-2-(trifluoromethyl)phenoxy)propan-2-yl)-4-bromo-3-methoxy-<i>N</i>-(4-methoxybenzyl)benzamide (<b>5b</b>) (1.00 g, 1.62 mmol, 1.0 equiv) and IPA (15 mL). P<sub>2</sub>O<sub>5</sub> (2.30 g, 16.2 mmol, 10.0 equiv) was added at RT. The vial was sealed, and the reaction was stirred at 100 °C for 30 h. The reaction mixture was cooled to RT and diluted with EtOAc. A saturated aqueous solution of NaHCO<sub>3</sub> was added, the layers were separated, and the aqueous phase was extracted with EtOAc. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–60% EtOAc/hexanes) to afford the desired product (530 mg, 55%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.61–7.56 (m, 2H), 7.44 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.10–7.04 (m, 3H), 7.03 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.89 (d, <i>J</i> = 8.9 Hz, 1H), 6.88–6.84 (m, 2H), 4.49 (d, <i>J</i> = 15.3 Hz, 1H), 4.28 (dd, <i>J</i> = 11.0, 1.4 Hz, 1H), 4.21 (d, <i>J</i> = 15.3 Hz, 1H), 4.17–4.11 (m, 2H), 3.89 (s, 3H), 3.80 (s, 3H), 3.79–3.74 (m, 1H), 3.48 (dd, <i>J</i> = 11.0, 2.5 Hz, 1H). LCMS (ES+) [M + H]<sup>+</sup>: 599.5/601.5/603.4.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-5-((4-Fluoro-2-methylphenoxy)methyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>7a1</b>)</h4><div class="NLM_p last">To a vial charged with (<i>S</i>)-3-(4-bromo-3-methoxyphenyl)-5-((4-fluoro-2-methylphenoxy)methyl)-4-(4-methoxy-benzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>6a</b>) (99 mg, 0.187 mmol, 1.0 equiv), 4(5)-methylimidazole (18 mg, 0.224 mmol, 1.2 equiv), and K<sub>3</sub>PO<sub>4</sub> (79 mg, 0.374 mmol, 2.0 equiv) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (0.9 mL). To a second vial charged with Pd<sub>2</sub>(dba)<sub>3</sub> (8.6 mg, 0.009 mmol, 5.0 mol %) and Me<sub>4</sub>-di-<i>t</i>-BuXPhos (CAS 857356-94-6, 9.0 mg, 0.019 mmol, 10.0 mol %) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (0.9 mL). This mixture was stirred for 3 min at 120 °C to give a dark-red solution which was cooled to RT and transferred to the first vial. The reaction was degassed by bubbling with N<sub>2</sub> for 5 min and then sealed. The reaction mixture was stirred at 120 °C for 16 h. The reaction was cooled to RT and filtered through a pad of Celite which was washed thoroughly with EtOAc. The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–7% MeOH/DCM) to afford the desired product (66 mg, 67%) as an off-white solid. LCMS (ES+) [M + H]<sup>+</sup>: 531.7.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-5-((4-Chloro-2-(trifluoromethyl)phenoxy)methyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>7b1</b>)</h4><div class="NLM_p last">To a vial charged with (<i>S</i>)-3-(4-bromo-3-methoxyphenyl)-5-((4-chloro-2-(trifluoromethyl)phenoxy)methyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>6b</b>) (127 mg, 0.212 mmol, 1.0 equiv), 4(5)-methylimidazole (26 mg, 0.318 mmol, 1.5 equiv), and K<sub>3</sub>PO<sub>4</sub> (90 mg, 0.424 mmol, 2.0 equiv) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (1.2 mL). To a second vial charged with Pd<sub>2</sub>(dba)<sub>3</sub> (7.8 mg, 0.009 mmol, 4.0 mol %) and Me<sub>4</sub>-di-<i>t</i>-BuXPhos (CAS 857356-94-6, 8.2 mg, 0.017 mmol, 8.0 mol %) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (1.2 mL). This mixture was stirred for 3 min at 120 °C to give a dark-red solution which was cooled to RT and transferred to the first vial. The reaction was degassed by bubbling with N<sub>2</sub> for 5 min and then sealed. The reaction mixture was stirred at 120 °C for 16 h. The reaction was cooled to RT and filtered through a pad of Celite which was washed thoroughly with EtOAc. The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–7% MeOH/DCM) to afford the desired product (74 mg, 58%) as an off-white solid. LCMS (ES+) [M + H]<sup>+</sup>: 601.6/603.6.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-5-((4-Fluoro-2-methylphenoxy)methyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine ((<i>S</i>)-<b>8</b>)</h4><div class="NLM_p last">A solution of (<i>S</i>)-5-((4-fluoro-2-methylphenoxy)methyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-4-(4-methoxy-benzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (66 mg, 0.124 mmol, 1.0 equiv) (<b>7a1</b>) in DCE (1.0 mL) at ambient temperature was treated with TFA (1.0 mL). The resulting mixture was stirred at 125 °C for 2 h in a microwave reactor. The reaction mixture was cooled to RT, concentrated, and dissolved in EtOAc. The organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–10% MeOH/DCM) to afford the desired product (46 mg) as an off-white solid. The product was dissolved in DMF (1.5 mL) and further purified using reverse phase chromatography on C18 resin (5–100% MeCN/H<sub>2</sub>O + 0.1% HCOOH) to give the desired product, after lyophilization, as a white solid (43 mg, 84%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.73 (br s, 1H), 7.44 (d, <i>J</i> = 1.7 Hz, 1H), 7.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.20 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 6.94 (br s, 1H), 6.88 (dd, <i>J</i> = 8.9, 2.7 Hz, 1H), 6.84 (td, <i>J</i> = 8.4, 3.1 Hz, 1H), 6.77 (dd, <i>J</i> = 8.9, 4.5 Hz, 1H), 5.22 (br s, 1H), 4.16–4.06 (m, 5H), 3.89 (s, 3H), 2.29 (s, 3H), 2.23 (s, 3H). LCMS analysis using LCMS A, standard conditions: <i>T</i><sub>R</sub> = 3.62 min. LCMS (ES+) [M + H]<sup>+</sup>: 411.5; [α]<sub>D</sub> = +66.1 (<i>c</i> = 0.18, MeCN).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-5-((4-Chloro-2-(trifluoromethyl)phenoxy)methyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine ((<i>S</i>)-<b>10</b>)</h4><div class="NLM_p last">A solution of (<i>S</i>)-5-((4-chloro-2-(trifluoromethyl)phenoxy)methyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>7b1</b>) (72 mg, 0.119 mmol, 1.0 equiv) in DCE (1.0 mL) at RT was treated with TFA (1.0 mL). The resulting mixture was stirred at 125 °C for 2 h in a microwave reactor. The reaction mixture was cooled to RT, concentrated, and dissolved in EtOAc. The organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–8% MeOH/DCM) to afford the desired product (43 mg) as an off-white solid. The product was dissolved in DMF (1.5 mL) and further purified using reverse phase chromatography on C18 resin (5–100% MeCN/H<sub>2</sub>O + 0.1% HCOOH) to give the desired product, after lyophilization, as a white solid (34 mg, 59%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.78 (s, 1H), 7.58 (d, <i>J</i> = 2.6 Hz, 1H), 7.49 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.40 (d, <i>J</i> = 1.8 Hz, 1H), 7.30 (d, <i>J</i> = 8.1 Hz, 1H), 7.20 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 6.97 (d, <i>J</i> = 8.9 Hz, 1H), 6.94 (s, 1H), 5.27 (s, 1H), 4.32–4.24 (m, 1H), 4.20–4.10 (m, 3H), 4.08–4.02 (m, 1H), 3.89 (s, 3H), 2.30 (d, <i>J</i> = 0.9 Hz, 3H). LCMS analysis using LCMS A, standard conditions: <i>T</i><sub>R</sub> = 4.00 min. LCMS (ES+) [M + H]<sup>+</sup>: 481.5/483.5; [α]<sub>D</sub> = +57.1 (<i>c</i> = 0.34, MeOH).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>)-5-Bromo-<i>N</i>-(1-(4-fluoro-2-methylphenoxy)-3-hydroxypropan-2-yl)-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (<b>17a</b>)</h4><div class="NLM_p last">A solution of 5-bromo-6-methoxypicolinic acid (2.17 g, 9.36 mmol, 1.0 equiv) in DCM (50 mL) at RT was treated with a catalytic amount of DMF (1 drop) and oxalyl chloride (2.50 mL, 28.1 mmol, 3.0 equiv). The resulting mixture was stirred at RT for 1 h, at which point LCMS monitoring showed completion of the reaction. The mixture was concentrated to dryness, diluted with anhydrous THF (30 mL), concentrated again, and dried under high vacuum for 1 h. The residue was diluted with anhydrous THF (40 mL), triethylamine (3.90 mL, 28.1 mmol, 3.0 equiv) was added, and the resulting mixture was cooled to 0 °C. A solution of (<i>R</i>)-3-(4-fluoro-2-methylphenoxy)-2-(4-methoxybenzylamino)propan-1-ol (<b>3a</b>) (2.99 g, 9.36 mmol, 1.0 equiv) in THF (25 mL) was quickly added, and the resulting mixture was stirred at 0 °C for 30 min. A saturated aqueous solution of NaHCO<sub>3</sub> and EtOAc were then successively added. The layers were separated and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–50% EtOAc/DCM) to afford the desired amide (3.90g, 78%) as a white foam. LCMS (ES+) [M + H]<sup>+</sup>: 533.6/535.6.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-5-Bromo-<i>N</i>-(1-(4-chloro-2-(trifluoromethyl)phenoxy)-3-hydroxypropan-2-yl)-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (<b>17b</b>)</h4><div class="NLM_p last">A solution of 5-bromo-6-methoxypicolinic acid (800 mg, 3.45 mmol, 1.1 equiv) in DCM (15 mL) at ambient temperature was treated with a catalytic amount of DMF (1 drop) and oxalyl chloride (0.90 mL, 10.3 mmol, 3.0 equiv). The resulting mixture was stirred at ambient temperature for 1 h, at which point LCMS monitoring showed completion of the reaction. The mixture was concentrated to dryness, diluted with anhydrous THF (10 mL), concentrated again, and dried under high vacuum for 1 h. The residue was diluted with anhydrous THF (15 mL), triethylamine (1.43 mL, 10.3 mmol, 3.0 equiv) was added, and the resulting mixture was cooled to 0 °C. A solution of (<i>R</i>)-3-(4-chloro-2-(trifluoromethyl)phenoxy)-2-(4-methoxybenzylamino)propan-1-ol (<b>3b</b>) (1.22 g, 3.14 mmol, 1.0 equiv) in THF (10 mL) was quickly added, and the resulting mixture was stirred at 0 °C for 30 min. A saturated aqueous solution of NaHCO<sub>3</sub> and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–100% EtOAc/hexanes) to afford the desired amide (1.13 g, 59%) as a white foam. LCMS (ES+) [M + H]<sup>+</sup>: 603.4/605.4/607.4.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-3-(5-Bromo-6-methoxypyridin-2-yl)-5-((4-fluoro-2-methylphenoxy)methyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>18a</b>)</h4><div class="NLM_p last">DIAD (1.73 mL, 8.77 mmol, 1.2 equiv) was added to a solution of triphenylphosphine (2.30 g, 8.77 mmol, 1.2 equiv), (<i>R</i>)-5-bromo-<i>N</i>-(1-(4-fluoro-2-methylphenoxy)-3-hydroxypropan-2-yl)-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (<b>17a</b>) (3.90 g, 7.31 mmol, 1.0 equiv), and <i>N</i>-hydroxyphthalimide (1.43 g, 8.77 mmol, 1.2 equiv) in THF (30 mL) at 0 °C. The resulting mixture was kept at 0 °C for 1 h, allowed to warm to RT, and stirred for 16 h. The reaction mixture was diluted with EtOAc, and the organic layer was washed with 1 N aqueous NaOH twice, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–20% EtOAc DCM) to afford the desired product (4.14 g, 83%) as a light-brown foam. LCMS (ES+) [M + H]<sup>+</sup>: 678.2/680.2. A suspension of (<i>S</i>)-5-bromo-<i>N</i>-(1-(1,3-dioxoisoindolin-2-yloxy)-3-(4-fluoro-2-methylphenoxy)propan-2-yl)-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (4.14 g, 6.10 mol, 1.0 equiv) in ethanol (90%, 20 mL) and THF (10 mL) at 0 °C was treated with hydrazine hydrate (50–60%, 3.0 mL). The resulting mixture was stirred for 1 h, and then water was added. The mixture was extracted with EtOAc (three times), and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–70% EtOAc/DCM) to afford the desired product (2.88 mg, 86%) as a white foam. LCMS (ES+) [M + H]<sup>+</sup>: 548.2/550.2. A sealable vial was charged with (<i>S</i>)-<i>N</i>-(1-(aminooxy)-3-(4-fluoro-2-methylphenoxy)propan-2-yl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxyben-zyl)picolinamide (2.76 g, 5.03 mmol, 1.0 equiv) and IPA (40 mL). P<sub>2</sub>O<sub>5</sub> (7.14 g, 50.3 mmol, 10.0 equiv) was added at RT. The vial was sealed, and the reaction was stirred at 90 °C for 16 h. The reaction mixture was cooled to RT and diluted with EtOAc. A saturated aqueous solution of NaHCO<sub>3</sub> was added, the layers were separated, and the aqueous phase was extracted with EtOAc. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–100% EtOAc/hexanes) to afford the desired product (461 mg, 17%) as a white foam. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.86 (d, <i>J</i> = 7.8 Hz, 1H), 7.26–7.23 (m, 2H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 6.89–6.82 (m, 3H), 6.77 (td, <i>J</i> = 8.3, 2.9 Hz, 1H), 6.61 (dd, <i>J</i> = 8.9, 4.5 Hz, 1H), 4.52 (d, <i>J</i> = 15.4 Hz, 1H), 4.45–4.36 (m, 2H), 4.12–4.06 (m, 1H), 4.05–3.98 (m, 1H), 3.92 (s, 3H), 3.80 (s, <i>J</i> = 2.4 Hz, 3H), 3.72–3.62 (m, 2H), 2.19 (s, 3H). LCMS (ES+) [M + H]<sup>+</sup>: 530.2/532.2.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-3-(5-Bromo-6-methoxypyridin-2-yl)-5-((4-chloro-2-(trifluoromethyl)phenoxy)methyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>18b</b>)</h4><div class="NLM_p last">DIAD (0.44 mL, 2.25 mmol, 1.2 equiv) was added to a solution of triphenylphosphine (590 mg, 2.25 mmol, 1.2 equiv), (<i>R</i>)-5-bromo-<i>N</i>-(1-(4-chloro-2-(trifluoromethyl)phenoxy)-3-hydroxypropan-2-yl)-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (<b>17b</b>) (1.13 g, 1.87 mmol, 1.0 equiv), and <i>N</i>-hydroxyphthalimide (366 mg, 2.25 mmol, 1.2 equiv) in THF (10 mL) at 0 °C. The resulting mixture was kept at 0 °C for 1 h. The reaction mixture was diluted with EtOAc, and the organic layer was washed with 1 N aqueous NaOH (twice), water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–50% EtOAc/hexanes) to afford the desired product (1.09 g, 78%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 748.5/750.5/752.5. A suspension of (<i>S</i>)-5-bromo-<i>N</i>-(1-(4-chloro-2-(trifluoromethyl)phenoxy)-3-(1,3-dioxoisoindolin-2-yloxy)propan-2-yl)-6-methoxy-<i>N</i>-(4-methoxy-benzyl)picolinamide (1.09 g, 1.46 mol, 1.0 equiv) in ethanol (90%, 10 mL) and THF (5 mL) at RT was treated with hydrazine hydrate (50–60%, 1.0 mL). The resulting mixture was stirred for 30 min, and then water was added. The mixture was extracted with EtOAc three times, and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–3% MeOH/DCM) to afford the desired product (810 mg, 90%) as a white solid. LCMS (ES+) [M + H]<sup>+</sup>: 618.5/620.5/622.5. A sealable vial was charged with (<i>S</i>)-<i>N</i>-(1-(aminooxy)-3-(4-chloro-2-(trifluoromethyl)phenoxy)propan-2-yl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (810, 1.31 mmol, 1.0 equiv) and IPA (15 mL). P<sub>2</sub>O<sub>5</sub> (1.86 g, 13.1 mmol, 10.0 equiv) was added at RT. The vial was sealed, and the reaction was stirred at 85 °C for 16 h. The reaction mixture was cooled to ambient temperature and diluted with EtOAc. A saturated aqueous solution of NaHCO<sub>3</sub> was added, the layers were separated, and the aqueous phase was extracted with EtOAc. The organic phases were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–60% EtOAc/hexanes) to afford the desired product (180 mg, 21%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.86 (d, <i>J</i> = 7.8 Hz, 1H), 7.55 (d, <i>J</i> = 2.6 Hz, 1H), 7.41 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.25–7.21 (m, 2H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 6.89–6.82 (m, 3H), 4.58 (d, <i>J</i> = 15.5 Hz, 1H), 4.41–4.34 (m, 2H), 4.13 (qd, <i>J</i> = 9.0, 7.2 Hz, 2H), 3.92 (s, 3H), 3.80 (s, <i>J</i> = 5.3 Hz, 3H), 3.73 (tdd, <i>J</i> = 7.5, 2.1, 1.2 Hz, 1H), 3.61 (dd, <i>J</i> = 11.1, 2.3 Hz, 1H). LCMS (ES+) [M + H]<sup>+</sup>: 600.5/602.5/604.5.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-5-((4-Fluoro-2-methylphenoxy)methyl)-3-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>19</b>)</h4><div class="NLM_p last">To a vial charged with (<i>S</i>)-3-(5-bromo-6-methoxypyridin-2-yl)-5-((4-fluoro-2-methylphenoxy)methyl)-4-(4-methoxy-benzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>18a</b>) (315 mg, 0.593 mmol, 1.0 equiv), 4(5)-methylimidazole (98 mg, 1.19 mmol, 2.0 equiv), and K<sub>3</sub>PO<sub>4</sub> (252 mg, 1.19 mmol, 2.0 equiv) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (3.0 mL). To a second vial charged with Pd<sub>2</sub>(dba)<sub>3</sub> (22.0 mg, 0.024 mmol, 4.0 mol %) and Me<sub>4</sub>-di-<i>t</i>-BuXPhos (CAS 857356-94-6, 23.0 mg, 0.047 mmol, 8.0 mol %) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (3.0 mL). This mixture was stirred for 3 min at 120 °C to give a dark-red solution which was cooled to RT and transferred to the first vial. The reaction was degassed by bubbling with N<sub>2</sub> for 5 min and then sealed. The reaction mixture was stirred at 120 °C for 16 h. The reaction was cooled to RT and filtered through a pad of Celite which was washed thoroughly with EtOAc. The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–6% MeOH/DCM) to afford the desired product (216 mg, 69%) as an off-white solid. LCMS (ES+) [M + H]<sup>+</sup>: 532.4/534.4. A solution of (<i>S</i>)-5-((4-fluoro-2-methylphenoxy)methyl)-3-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-4-(4-methoxy-benzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (214 mg, 0.403 mmol, 1.0 equiv) in DCE (5.0 mL) at RT was treated with TFA (5.0 mL). The resulting mixture was stirred at 100 °C for 1 h. The reaction mixture was cooled to RT, concentrated, and dissolved in EtOAc. The organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–6% MeOH/DCM) to afford the desired product (165 mg, 99%) as an off-white solid. Then 69 mg of this material was dissolved in DMF (1.5 mL) and further purified using reverse phase chromatography on C18 resin (5–100% MeCN/H<sub>2</sub>O + 0.1% HCOOH) to give the desired product, after lyophilization, as a white solid (55 mg). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.84 (br s, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 1H), 7.64–7.59 (m, 1H), 6.98 (br s, 1H), 6.88 (dd, <i>J</i> = 8.9, 3.1 Hz, 1H), 6.83 (td, <i>J</i> = 8.4, 3.1 Hz, 1H), 6.76 (dd, <i>J</i> = 8.9, 4.5 Hz, 1H), 6.67 (br s, 1H), 4.19–4.12 (m, 3H), 4.07–4.00 (m, 5H), 2.30 (d, <i>J</i> = 0.8 Hz, 3H), 2.25 (s, 3H). LCMS analysis using LCMS A, standard conditions: <i>T</i><sub>R</sub> = 3.85 min. LCMS (ES+) [M + H]<sup>+</sup>: 412.3; [α]<sub>D</sub> = +91.9 (<i>c</i> = 0.52, MeOH).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-5-((4-Chloro-2-(trifluoromethyl)phenoxy)methyl)-3-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>25</b>)</h4><div class="NLM_p last">To a vial charged with (<i>S</i>)-3-(5-bromo-6-methoxypyridin-2-yl)-5-((4-chloro-2-(trifluoromethyl)phenoxy)me-thyl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>18b</b>) (179 mg, 0.298 mmol, 1.0 equiv), 4(5)-methylimidazole (49 mg, 0.596 mmol, 2.0 equiv), and K<sub>3</sub>PO<sub>4</sub> (127 mg, 0.596 mmol, 2.0 equiv) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (2.4 mL). To a second vial charged with Pd<sub>2</sub>(dba)<sub>3</sub> (11.0 mg, 0.012 mmol, 4.0 mol %) and Me<sub>4</sub>-di-<i>t</i>-BuXPhos (CAS 857356-94-6, 11.5 mg, 0.024 mmol, 8.0 mol %) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (2.4 mL). This mixture was stirred for 3 min at 120 °C to give a dark-red solution, which was cooled to RT and transferred to the first vial. The reaction was degassed by bubbling with N<sub>2</sub> for 5 min and then sealed. The reaction mixture was stirred at 120 °C for 16 h. The reaction was cooled to RT and filtered through a pad of Celite which was washed thoroughly with EtOAc. The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–6% MeOH/DCM) to afford the desired product (94 mg, 53%) as an off-white solid. LCMS (ES+) [M + H]<sup>+</sup>: 602.6/604.6. A solution of (<i>S</i>)-5-((4-chloro-2-(trifluoromethyl)phenoxy)methyl)-3-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyri-din-2-yl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (93 mg, 0.155 mmol, 1.0 equiv) in DCE (2.0 mL) at RT was treated with TFA (2.0 mL). The resulting mixture was stirred at 100 °C for 1 h. The reaction mixture was cooled to RT, concentrated, and dissolved in EtOAc. The organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–6% MeOH/DCM) to afford the desired product (65 mg, 88%) as an off-white solid. The product was dissolved in DMF (1.5 mL) and further purified using reverse phase chromatography on C18 resin (5–100% MeCN/H<sub>2</sub>O + 0.1% HCOOH) to give the desired product, after lyophilization, as a white solid (57 mg). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.18 (s, 1H), 7.85 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 7.57 (d, <i>J</i> = 2.6 Hz, 1H), 7.47 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 6.98 (s, 1H), 6.95 (d, <i>J</i> = 8.9 Hz, 1H), 6.76 (s, 1H), 4.27–4.14 (m, 4H), 4.06 (s, 3H), 3.97 (dd, <i>J</i> = 11.1, 2.6 Hz, 1H), 2.31 (s, 3H). LCMS analysis using LCMS A, standard conditions: <i>T</i><sub>R</sub> = 4.13 min. LCMS (ES+) [M + H]<sup>+</sup>: 482.5/484.5; [α]<sub>D</sub> = +72.8 (<i>c</i> = 0.35, MeOH).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>rac</i>)-<i>tert</i>-Butyl 2-((<i>tert</i>-Butyldimethylsilyloxy)methyl)-3-hydroxypiperidine-1-carboxylate (<b>27(±)</b>)</h4><div class="NLM_p last">A solution of 2-(hydroxymethyl)pyridin-3-ol hydrochloride (<b>26</b>) (6.0 g, 37.26 mmol, 1.0 equiv), imidazole (7.61 g, 112 mmol, 3.0 equiv), and <i>tert</i>-butyldimethylsilane (6.74 g, 44.7 mmol, 1.2 equiv) in anhydrous DMF (185 mL) was stirred for 16 h at 60 °C. Water and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–20% EtOAc/hexanes) to afford the desired pyridine (4.30 g, 48%). LCMS (ES+) [M + H]<sup>+</sup>: 240.1. A suspension of 2-((<i>tert</i>-butyldimethylsilyloxy)methyl)pyridin-3-ol (4.3 g, 18.0 mmol, 1.0 equiv) in degassed EtOH (40.0 mL) and water (20.0 mL) was treated with PtO<sub>2</sub> (850 mg). The reaction mixture was put on Parr shaker apparatus at 60 psi of H<sub>2</sub> for 16 h at RT. The reaction was filtered through a pad of Celite, which was washed thoroughly with MeOH and DCM. The filtrate was concentrated to afford the desired piperidine (3.82 g, 87%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 5.08 (s, 1H), 3.84 (s, 1H), 3.81–3.72 (m, 2H), 3.16–3.10 (m, 1H), 2.73–2.63 (m, 2H), 1.95–1.88 (m, 2H), 1.87–1.79 (m, 1H), 1.56–1.40 (m, 2H), 0.92–0.89 (m, 9H), 0.09–0.07 (m, 6H). A solution of (<i>rac</i>)-2-((<i>tert</i>-butyldimethylsilyloxy)methyl)piperidin-3-ol (3.80 g, 15.5 mmol, 1.0 equiv), triethylamine (6.47 mL, 46.5 mmol, 3.0 equiv), and BOC<sub>2</sub>O (3.72 g, 17.0 mmol, 1.1 equiv) in anhydrous DCM (55.0 mL) was stirred for 16 h at RT. Water and DCM were then successively added. The layers were separated, and the aqueous layer was extracted with DCM twice. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (5–35% EtOAc/hexanes) to afford the desired product (3.37 g, 63%). LCMS (ES+) [M + H]<sup>+</sup>: 346.3.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>rac</i>)-<i>tert</i>-Butyl 2-((<i>tert</i>-Butyldimethylsilyloxy)methyl)-3-(4-chloro-2-(trifluoromethyl) phenoxy)piperidine-1-carboxylate (<b>28b(±)</b>)</h4><div class="NLM_p last">DIAD (1.96 mL, 9.95 mmol, 1.5 equiv) was added to a solution of PPh<sub>3</sub> (2.61 g, 9.95 mmol, 1.5 equiv), (<i>rac</i>)-<i>tert</i>-butyl 2-((<i>tert</i>-butyldimethylsilyloxy)methyl)-3-hydroxypiperidine-1-carboxylate (<b>27(±)</b>) (2.29 g, 6.63 mmol, 1.0 equiv), and 4-chloro-2-(trifluoromethyl)phenol (6.51 g, 33.1 mmol, 5.0 equiv) in DCM (8.30 mL) at 0 °C. The resulting mixture was stirred at this temperature for 5 min, warmed to RT, and then heated to 60 °C for 2.5 h in a microwave reactor. An aqueous solution of NaOH 1 N was added, and the aqueous layer was extracted with DCM. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–15% EtOAc/1:1 DCM/hexanes) to afford the desired product (2.95 g, 85%). LCMS (ES+) [M – BOC + H]<sup>+</sup>: 424.6/426.6.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>rac</i>)-(5-Bromo-6-methoxypyridin-2-yl)(3-(4-chloro-2-(trifluoromethyl)phenoxy)-2-(hydroxymethyl)piperidin-1-yl)methanone (<b>29b(±)</b>)</h4><div class="NLM_p last">A solution of (<i>rac</i>)-<i>tert-</i>butyl 2-((<i>tert-</i>butyldimethylsilyloxy)methyl)-3-(4-chloro-2-(trifluoromethyl)phenoxy)piperidine-1-carboxylate (<b>28b(±)</b>) (2.95 g, 5.63 mmol, 1.0 equiv) and TBAF 1 M solution in THF (6.19 mL, 6.19 mmol, 1.1 equiv) in anhydrous THF (28.0 mL) was stirred for 16 h at RT. An aqueous solution of NaOH 1 N and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were washed with aqueous NaOH 1 N, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–5% MeOH/DCM) to afford the desired alcohol (2.09 g, 90%). LCMS (ES+) [M – BOC + H]<sup>+</sup>: 310.4/312.4. A solution of ((<i>rac</i>)-<i>tert</i>-butyl 3-(4-chloro-2-(trifluoromethyl)phenoxy)-2-(hydroxymethyl)piperidine-1-carboxylate (2.1 g, 5.09 mmol, 1.0 equiv) and TFA (1.95 mL, 25.4 mmol, 5.0 equiv) in anhydrous DCM (25.5 mL) was stirred for 16 h at RT. An aqueous solution of HCl 1 N and DCM were then successively added. The layers were separated, and the organic layer was extracted with aqueous HCl 1N. The combined aqueous layers were basified with aqueous NaOH 1 N and extracted with DCM (4 times). The combined organic layer were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford the desired amino alcohol (1.19 g, 76%) that was used directly in the next step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.56 (d, <i>J</i> = 2.6 Hz, 1H), 7.44 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 6.96 (d, <i>J</i> = 8.9 Hz, 1H), 4.64–4.59 (m, 1H), 3.75 (dd, <i>J</i> = 11.2, 8.0 Hz, 1H), 3.67 (dd, <i>J</i> = 11.2, 5.5 Hz, 1H), 3.27–3.17 (m, 2H), 2.87–2.78 (m, 1H), 2.22–2.13 (m, 1H), 1.76–1.66 (m, 2H), 1.58–1.48 (m, 1H). LCMS (ES+) [M + H]<sup>+</sup>: 310.5/312.5. A solution of 5-bromo-6-methoxypicolinic acid (898 mg, 3.87 mmol, 1.1 equiv) in DCM (17.6 mL) at ambient temperature was treated with a catalytic amount of DMF (4 drops) and oxalyl chloride (921 μL, 10.6 mmol, 3.0 equiv). The resulting mixture was stirred at ambient temperature for 1 h, at which point LCMS monitoring showed completion of the reaction. The mixture was concentrated, diluted with anhydrous THF (30.0 mL), concentrated again, and dried under high vacuum for 1 h. The residue was diluted in anhydrous THF (13.5 mL), treated with triethylamine (979 μL, 7.04 mmol, 2.0 equiv), and cooled to 0 °C. A solution of ((<i>rac</i>)-3-(4-chloro-2-(trifluoromethyl)phenoxy)piperidin-2-yl)methanol (794 mg, 3.32 mmol, 1.0 equiv) in THF (10.0 mL) was quickly added, and the resulting mixture was stirred at 0 °C for 1 h. A saturated aqueous solution of NaHCO<sub>3</sub> and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–5% MeOH/DCM) to afford the desired amide (1.53 g, 83%). LCMS (ES+) [M + H]<sup>+</sup>: 523.4/525.4/527.4.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>rac</i>)-2-(Aminooxymethyl)-3-(4-chloro-2-(trifluoromethyl)phenoxy)piperidin-1-yl)(5-bromo-6-methoxypyridin-2-yl)methanone (<b>30b(±)</b>)</h4><div class="NLM_p last">A solution of DIAD (862 μL, 4.38 mmol, 1.5 equiv) and PPh<sub>3</sub> (1.15 g, 4.38 mmol, 1.5 equiv) in DCM (10.0 mL) were stirred at ambient temperature for 20 min. To this mixture was added <i>N</i>-hydroxylphtalimide (715 mg, 4.38 mmol, 1.5 equiv) at 0 °C, followed by (5-bromo-6-methoxypyridin-2-yl)((<i>rac</i>)-3-(4-chloro-2-(trifluoromethyl)phenoxy)-2-(hydroxymethyl)piperidin-1-yl)methanone (<b>29b(±)</b>) (1.53 g, 2.92 mmol, 1.0 equiv) in DCM (10.0 mL). The resulting mixture was kept at 0 °C for 5 min, then warmed to ambient temperature and stirred for 1 h. An aqueous solution of NaOH 1 N and DCM were then successively added. The layers were separated, and the aqueous layer was extracted with DCM twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (3–20% EtOAc/1:1 DCM/hexanes) to afford the desired product (2.15 g). The final product is contaminated with reduced DIAD and was used directly in the next step. LCMS (ES+) [M + H]<sup>+</sup>: 668.4/670.4/672.4. A suspension of 2-(((<i>rac</i>)-1-(5-bromo-6-methoxypicolinoyl)-3-(4-chloro-2-(trifluoromethyl)phenoxy)piperidin-2-yl)methoxy)isoindoline-1,3-dione (1.00 g, 1.50 mmol, 1.0 equiv) in ethanol (90%, 15.0 mL) at −20 °C was treated with hydrazine hydrate (50–60%, 2.00 mL). The resulting mixture was stirred for 30 min, then water was added. The mixture was extracted with EtOAc (three times), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (1–3% MeOH/DCM) to afford the desired product (700 mg, 87%). LCMS (ES+) [M + H]<sup>+</sup>: 538.5/540.5/542.5.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>cis</i>)-4-(5-Bromo-6-methoxypyridin-2-yl)-9-(4-chloro-2-(trifluoromethyl)phenoxy)-1,6,7,8,9,9a-hexahydropyrido[1,2-<i>d</i>][1,2,4]oxadiazine (<b>31b1</b> and <b>31b2</b>)</h4><div class="NLM_p last">A solution of ((<i>rac</i>)-2-(aminooxymethyl)-3-(4-chloro-2-(trifluoromethyl)phenoxy)piperidin-1-yl)(5-bromo-6-methoxypyridin-2-yl)methanone (<b>30b(±)</b>) (700 mg, 1.30 mmol, 1.0 equiv) in anhydrous DCE (13.0 mL) was treated with POCl<sub>3</sub> (302 μL, 3.25 mmol, 2.5 equiv). The vial was sealed and heated at 100 °C for 1 h. Reaction profile show slow conversion to desired product, therefore, the temperature was increased by 10 °C every hour until 120 °C was reached (total of 3 h, 64% conversion to desired product observed). An aqueous solution NaOH 1 N and DCM were then successively added. The layers were separated, and the aqueous layer was extracted with DCM twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford the desired product (360 mg, 53%). The racemates were separated using semipreparative HPLC (Chiralpak IA column, 5 μM, 20 mm × 250 mm, 15 mL/min, 76% hexanes/12% MeOH/12% DCM) to afford <i>cis</i>-enantiomer <b>31b1</b> (117 mg, 17%, <i>t</i><sub>r</sub> = 9.60 min) and <i>cis</i>-enantiomer <b>31b2</b> (113 mg, 17%, <i>t</i><sub>r</sub> = 13.56 min). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.86 (d, <i>J</i> = 7.7 Hz, 1H), 7.57 (d, <i>J</i> = 2.5 Hz, 1H), 7.44 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.8 Hz, 1H), 6.87 (d, <i>J</i> = 8.9 Hz, 1H), 4.62 (s, 1H), 4.24 (dd, <i>J</i> = 11.5, 4.8 Hz, 1H), 4.18–4.09 (m, 1H), 4.02 (s, 3H), 3.91 (dd, <i>J</i> = 8.4, 4.7 Hz, 1H), 3.76 (d, <i>J</i> = 12.7 Hz, 1H), 2.89 (td, <i>J</i> = 12.8, 2.2 Hz, 1H), 2.29 (d, <i>J</i> = 12.5 Hz, 1H), 2.15–2.02 (m, 1H), 1.72 (t, <i>J</i> = 13.0 Hz, 1H), 1.47 (d, <i>J</i> = 13.0 Hz, 1H). LCMS (ES+) [M + H]<sup>+</sup>: 520.1/522.1/524.1</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>cis</i>)-9-(4-Chloro-2-(trifluoromethyl)phenoxy)-4-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-1,6,7,8,9,9a-hexahydropyrido[1,2-<i>d</i>][1,2,4]oxadiazine (<b>34(+)</b>)</h4><div class="NLM_p last">To a vial charged with (<i>cis</i>)-4-(5-bromo-6-methoxypyridin-2-yl)-9-(4-chloro-2-(trifluoromethyl)phenoxy)-1,6,7,8,9,9a-hexahydropyrido[1,2-<i>d</i>][1,2,4]oxadiazine (<i>cis</i>-enantiomer <b>31b1</b>, 90.0 mg, 0.17 mmol, 1.0 equiv), 4(5)-methylimidazole (28.4 mg, 0.35 mmol, 2.0 equiv), and K<sub>3</sub>PO<sub>4</sub> (73.4 mg, 0.35 mmol, 2.0 equiv) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (1.0 mL). To a second vial charged with Pd<sub>2</sub>(dba)<sub>3</sub> (6.30 mg, 0.007 mmol, 4.0 mol %) and Me<sub>4</sub>-di-<i>t</i>-BuXPhos (CAS 857356-94-6, 6.65 mg, 0.01 mmol, 8.0 mol %) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (0.80 mL). This mixture was stirred for 3 min at 120 °C to give a dark-red solution, which was cooled to RT and transferred to the first vial. The reaction was degassed by bubbling with N<sub>2</sub> for 5 min and then sealed. The reaction mixture was stirred at 120 °C for 16 h. The reaction was cooled to RT and filtered through a pad of Celite, which was washed thoroughly with EtOAc. The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–5% MeOH/DCM) to afford the desired product. This material was dissolved in DMF (1.50 mL) and further purified using reverse phase chromatography on C18 resin (5–100% MeCN/H<sub>2</sub>O + 0.1% HCOOH) to give the desired product, after lyophilization, as a white solid (58.7 mg, 65%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 8.11 (s, 1H), 7.64 (d, <i>J</i> = 7.8 Hz, 1H), 7.58 (d, <i>J</i> = 2.6 Hz, 1H), 7.45 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.43 (d, <i>J</i> = 7.8 Hz, 1H), 7.03 (s, <i>J</i> = 8.7 Hz, 1H), 6.88 (d, <i>J</i> = 8.9 Hz, 1H), 4.63 (s, 1H), 4.25 (dd, <i>J</i> = 11.5, 5.0 Hz, 1H), 4.14 (dd, <i>J</i> = 11.5, 9.1 Hz, 1H), 4.05 (s, 3H), 3.95–3.89 (m, 1H), 3.82 (d, <i>J</i> = 13.1 Hz, 1H), 2.93 (td, <i>J</i> = 12.8, 2.5 Hz, 1H), 2.39 (s, 3H), 2.32 (d, <i>J</i> = 14.3 Hz, 1H), 2.17–2.08 (m, 1H), 1.75 (tdd, <i>J</i> = 14.1, 4.0, 2.1 Hz, 1H), 1.54–1.47 (m, 1H). LCMS analysis using LCMS A, standard conditions: <i>t</i><sub>r</sub> = 4.03 min. LCMS (ES+) [M + H]<sup>+</sup>: 522.4/524.2.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate (<b>36(±)</b>)</h4><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 2-(hydroxymethyl) piperazine-1-carboxylate (35) (3 g, 14 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) under an argon atmosphere were added imidazole (2.1 g, 29 mmol) and TBDMS-chloride (4.05 g, 28 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 12 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (30 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 50 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo to obtain <i>tert</i>-butyl 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)piperazine-1-carboxylate (4 g, 87%) as a colorless syrup used in the next step without further purification. TLC: 50% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.1). To a stirred solution of <i>tert</i>-butyl 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)piperazine-1-carboxylate (3 g, 9 mmol) in toluene (30 mL) under an argon atmosphere were added 1-bromo-4-chloro-2-(trifluoromethyl)benzene (4.7 g, 18 mmol), (±)-BINAP (560 mg, 1 mmol), Pd(OAc)<sub>2</sub> (203 mg, 1 mmol), and cesium carbonate (8.8 g, 3 mmol) at room temperature and purged under an argon atmosphere for 10 min. The reaction mixture was stirred at 110 °C for 12 h in a sealed tube. After consumption of starting material (by TLC), the reaction mixture was filtered and the filtrate was concentrated in vacuo. The crude material was purified by column chromatography using 10% EtOAc/hexane to afford <i>tert</i>-butyl 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate (3.7 g, 80%) as a brown syrup. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 7.76–7.69 (m, 2H), 7.64 (d, 1H), 4.08 (br s, 1H), 3.91–3.71 (m, 3H), 3.00–2.93 (m, 3H), 2.84 (d, 1H), 2.74–2.66 (m, 1H), 1.42 (s, 9H), 0.85 (s, 9H), 0.05–0.04 (m, 6H). LCMS analysis using LCMS B, standard conditions: <i>t</i><sub>r</sub> = 4.42 min. LCMS (ES+) [M + H]<sup>+</sup>: 409 (M – Boc). TLC: 50% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.7).</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (5-Bromo-6-methoxypyridin-2-yl) (4-(4-Chloro-2-(trifluoromethyl)phenyl)-2-(hydroxymethyl)piperazin-1-yl)methanone (<b>37(±)</b>)</h4><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-4-(4-chloro-2-(trifluoromethyl) phenyl)piperazine-1-carboxylate (<b>36(±)</b>) (700 mg, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL) under an argon atmosphere was added trifluoroacetic acid (3.5 mL) at 0 °C. The reaction mixture was stirred at room temperature for 1 h. After consumption of starting material (by TLC), the reaction mixture was diluted with a saturated sodium bicarbonate solution (100 mL) and extracted with EtOAc (2 × 50 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo to afford 3-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-1-(4-chloro-2-(trifluoromethyl) phenyl)piperazine (560 mg, 99%) as a colorless syrup which was used in the next step without further purification. LCMS: 409 (M+); (column: Ascentis Express C-18 (50 mm × 3.0 mm, 2.7 μm); RT, 2.46 min; mobile phase, 0.025% Aq TFA + 5% ACN:ACN + 5% 0.025% Aq TFA; T/B%, 0.01/5, 0.5/5, 3/100, 5/100; flow rate, 1.2 mL/min) (gradient). TLC, 40% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.4). To a stirred solution of 5-bromo-6-methoxypicolinic acid (350 mg, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) under an argon atmosphere were added oxalyl chloride (347 mg, 2 mmol) and DMF (catalytic amount) at 0 °C. The reaction mixture was stirred at room temperature for 2 h. After consumption of acid (by TLC), the volatiles were evaporated in vacuo to give 5-bromo-6-methoxypicolinoyl chloride. To a stirred solution of 3-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-1-(4-chloro-2-(trifluoromethyl)phenyl)piperazine (560 mg, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) under an argon atmosphere were added diisopropylethylamine (0.73 mL, 4 mmol) and the above acid chloride in CH<sub>2</sub>Cl<sub>2</sub> (1.6 mL) at 0 °C. The reaction mixture was stirred at room temperature for 2 h. After consumption of acid (by TLC), the reaction mixture was quenched with water (20 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL). The combined organic extract was washed with water (20 mL), dried over sodium sulfate, filtered, and concentrated in vacuo to obtain (5-bromo-6-methoxypyridin-2-yl)(2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-1-yl)methanone (600 mg, crude) as a pale-yellow liquid used in the next step without further purification. LCMS: 623.9 (M<sup>+</sup>); (column: Ascentis Express C-18 (50 mm × 3.0 mm, 2.7 μm); RT, 3.98 min; mobile phase, 0.025% Aq TFA + 5% ACN:ACN + 5% 0.025% Aq TFA; T/B%, 0.01/5, 0.5/5, 3/100, 5/100; flow rate, 1.2 mL/min) (gradient). TLC, 50% EtOAc/hexanes (<i>R</i><sub>f</sub>: 0.7). To a stirred solution of (5-bromo-6-methoxypyridin-2-yl)(2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-1-yl)methanone (600 mg, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) under an argon atmosphere was added tetrabutylammonium fluoride (2 mL, 1 M in THF solution) at room temperature. The reaction mixture was stirred at room temperature for 12 h. After consumption of starting material (by TLC), the reaction mixture was diluted with saturated sodium bicarbonate solution (20 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude material was purified by column chromatography using 20% EtOAc/hexane to afford (5-bromo-6-methoxypyridin-2-yl)(4-(4-chloro-2-(trifluoromethyl)phenyl)-2-(hydroxymethyl)piperazin-1-yl)methanone (400 mg, 81%) as a white solid. LCMS analysis using LCMS B, standard conditions: <i>t</i><sub>r</sub> = 2.84 min. LCMS (ES+) [M + H]<sup>+</sup>: 509.8. TLC: 20% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.4).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (2-((Aminooxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-1-yl)(5-bromo-6-methoxypyridin-2-yl)methanone (<b>38(±)</b>)</h4><div class="NLM_p last">To a stirred solution of (5-bromo-6-methoxypyridin-2-yl)(2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-1-yl)methanone (<b>37(±)</b>) (700 mg, 1 mmol) in dry THF (7 mL) under an argon atmosphere were added molecular sieves (1 g), diisopropylazodicarboxylate (415 mg, 2 mmol), triphenylphosphine (541 mg, 2 mml), and <i>N</i>-hydroxyphthalimide (269 mg, 1 mmol) at 0 °C. The reaction mixture was warmed to room temperature and stirred for 2 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (2 × 5 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude material was purified by preparative HPLC (YMC Actus Triart C-18 (250 mm × 20 mm, 5 μ (155 mg loading; CH<sub>3</sub>CN: 0.05% TFA (0.1/90, 2/80, 10/60, 20/30, 25/10, 35/10))) to afford 2-((1-(5-bromo-6-methoxypicolinoyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-2-yl)methoxy)isoindoline-1,3-dione (350 mg, 39%) as a white solid. LCMS: 654.6 (M<sup>+</sup>); (column: Ascentis Express C-18 (50 mm × 3.0 mm, 2.7 μm); RT, 3.21 min; mobile phase, 0.025% Aq TFA + 5% ACN:ACN + 5% 0.025% Aq TFA; T/B% 0.01/5, 0.5/5, 3/100, 5/100; flow rate, 1.2 mL/min) (gradient). TLC: 50% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.7). To a stirred solution of 2-((1-(5-bromo-6-methoxypicolinoyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-2-yl)methoxy)isoindoline-1,3-dione (320 mg, 0.49 mmol) in EtOH:THF (2:1, 7.36 mL) under an argon atmosphere was added hydrazinehydrate (0.48 mL) at room temperature. The reaction mixture was stirred at room temperature for 3 h. After consumption of starting material (by TLC), the volatiles were evaporated in vacuo. The residue was dissoloved in ether, and the obtained solid was filtered. The filtrate was washed with water (30 mL) and extracted with EtOAc (2 × 20 mL). The combined oganic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo to obtain (2-((aminooxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-1-yl)(5-bromo-6-methoxypyridin-2-yl)methanone (300 mg, crude) as a white solid which was used in the next step without further purification. LCMS analysis using LCMS B, standard conditions: <i>t</i><sub>r</sub> = 2.20 min. LCMS (ES+) [M + H]<sup>+</sup>: 524.7 (M<sup>+</sup>). TLC: 50% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.7).</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-(5-Bromo-6-methoxypyridin-2-yl)-8-(4-chloro-2-(trifluoromethyl)phenyl)-1,6,7,8,9,9<i>a</i>-hexahydropyrazino[1, 2-<i>d</i>][1, 2, 4]oxadiazine (<b>39(±)</b>)</h4><div class="NLM_p last">To a stirred solution of (2-((aminooxy)methyl)-4-(4-chloro-2-(trifluoromethyl)phenyl)piperazin-1-yl)(5-bromo-6-methoxypyridin-2-yl)methanone (<b>38(±)</b>) (300 mg, 0.56 mmol) in POCl<sub>3</sub> (3 mL) under an argon atmosphere was stirred at 120 °C for 12 h in a sealed tube. After consumption of starting material (by TLC), the reaction mixture was diluted with saturated sodium bicarbonate solution (20 mL) and extracted with EtOAc (2 × 5 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo to obtain 4-(5-bromo-6-methoxypyridin-2-yl)-8-(4-chloro-2-(trifluoromethyl)phenyl)-1,6,7,8,9,9<i>a</i>-hexahydropyrazino[1,2-<i>d</i>][1,2,4]oxadiazine (350 mg, crude) as a white solid. LCMS: 506.8 (M + 2); (column: Ascentis Express C-18 (50 mm × 3.0 mm, 2.7 μm); RT, 3.15 min; mobile phase, 0.025% Aq TFA + 5% ACN:ACN + 5% 0.025% Aq TFA; T/B%, 0.01/5, 0.5/5, 3/100, 5/100; flow rate, 1.2 mL/min) (gradient). TLC: 50% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.7). To a stirred solution of 4-(5-bromo-6-methoxypyridin-2-yl)-8-(4-chloro-2-(trifluoromethyl)phenyl)-1,6,7,8,9,9<i>a</i>-hexahydropyrazino[1, 2-<i>d</i>][1,2,4]oxadiazine (350 mg, 0.64 mmol) in toluene:EtOH (2:1, 3 mL) under an argon atmosphere were added triethylamine (0.88 mL, 6.40 mmol) and dimethylaminopyridine (78 mg, 0.64 mmol) at 0 °C. The reaction mixture was stirred at 70 °C for 1 h. After consumption of starting material (by TLC), the reaction mixture was diluted with saturated sodium bicarbonate solution (20 mL) and extracted with EtOAc (2 × 5 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo to afford 4-(5-bromo-6-methoxypyridin-2-yl)-8-(4-chloro-2-(trifluoromethyl)phenyl)-1,6,7,8,9,9<i>a</i>-hexahydropyrazino[1,2-<i>d</i>][1,2,4]oxadiazine (90 mg, 28%) as a white solid. LCMS analysis using LCMS B, standard conditions: <i>t</i><sub>r</sub> = 3.06 min. LCMS (ES+) [M + H]<sup>+</sup>: 506.8 (M + 2). TLC: 50% EtOAc/hexane (<i>R</i><sub>f</sub>: 0.7).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 8-(4-Chloro-2-(trifluoromethyl)phenyl)-4-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-1,6,7,8,9,9a-hexahydropyrazino[1,2-<i>d</i>][1,2,4]oxadiazine (<b>40(+)</b> and <b>40(−)</b>)</h4><div class="NLM_p last">To a dry vial was added a suspension of Pd<sub>2</sub>(dba)<sub>3</sub> (8 mg, 0.008 mmol) and <i>tert</i>-butyl tetra methyl X-phos (8.5 mg, 0.02 mmol) in toluene:1,4-dioxane (2:1, 0.67 mL) at room temperature. The suspension was degassed with argon, heated to 120 °C, and stirred at 120 °C for 3 min. A mixture of 4-(5-bromo-6-methoxypyridin-2-yl)-8-(4-chloro-2-(trifluoromethyl) phenyl)-1,6,7,8,9,9<i>a</i>-hexahydropyrazino[1,2-<i>d</i>][1,2,4]oxadiazine (<b>39(±)</b>) (90 mg, 0.17 mmol), 4-methyl-1<i>H</i>-imidazole (17 mg, 0.21 mmol), and potassium phosphate (76 mg, 0.35 mmol) in toluene:1,4-dioxane (2:1, 0.67 mL) was degassed and the catalyst premix was added. The resulting mixture was stirred at 110 °C for 12 h in a sealed tube. After consumption of the starting material (monitored by TLC and LCMS), the reaction mixture was filtered and the filtrate was concentrated in vacuo. The crude material was purified by column chromatography using 5%MeOH/CH<sub>2</sub>Cl<sub>2</sub> to afford 8-(4-chloro-2-(trifluoromethyl)phenyl)-4-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-1,6,7,8,9,9<i>a</i>-hexahydropyrazino[1, 2-<i>d</i>][1,2,4]oxadiazine (50 mg, 55%) as a pale-yellow thick syrup which was separated using a Chiralpak-ADH column (250 mm × 20 mm, 5 μm) (20 mg loading; 0.1% DEA in <i>n</i>-hexane:EtOH (A:B, 85:15) as mobile phase) to afford <b>40(+)</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ = 7.99 (s, 1H), 7.89 (d, 1H), 7.68–7.60 (m, 2H), 7.57 (d, 1H), 7.32 (d, 1H), 7.21 (s, 1H), 4.19–4.13 (m, 1H), 4.07 (s, 3H), 4.95–4.80 (m, 2H), 4.75–4.71 (m, 1H), 3.10–2.90 (m, 5H), 2.23 (s, 3H). Mass (ESI): 507.6 [M + 1]. HPLC: RT 8.34 min. Chiral HPLC: RT = 15.47 min and <b>40(−)</b>. Mass (ESI): 507.7 [M + 1]. HPLC: RT 8.34 min. Chiral HPLC: RT = 23.98 min. Analytical conditions for <b>40(+)</b> and <b>40(−)</b>: HPLC: (column: Eclipse XDB C-18, 150 mm × 4.6 mm, 5.0 μm); mobile phase, ACN, 0.05% Aq TFA; flow rate, 1.0 mL/min; gradient programe, T/B% 0.01/90, 2/90, 8/10, 15/10; diluent, CH<sub>3</sub>CN:water. Chiral HPLC: (Chiralpak-ADH (250 mm × 4.6 mm, 5 μm; mobile phase (A) 0.1% DEA in <i>n</i>-hexane (B) EtOH (A:B, 85:15); flow rate, 1.0 mL/min).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>S</i>)-<i>N</i>-((<i>R</i>)-1-(Benzofuran-2-yl)-2-hydroxyethyl)-2-methylpropane-2-sulfinamide (<b>42a</b>)</h4><div class="NLM_p last">A suspension of benzofuran-2-ylboronic acid (<b>41a</b>) (5.0 g, 30.9 mmol, 1.0 equiv), glyoxylic acid monohydrate (3.16 g, 34.3 mmol, 1.1 equiv), and (<i>S</i>)-2-methylpropane-2-sulfinamide (4.16 g, 34.3 mmol, 1.1 equiv) in anhydrous DCM (100 mL) at ambient temperature was treated with InBr<sub>3</sub> (1.22 g, 3.43 mmol, 0.11 equiv). The resulting mixture was stirred for 16 h at ambient temperature. To the mixture was added MgSO<sub>4</sub> (3 g) and the suspension was stirred for 5 min and filtered through a pad of Celite, which was washed with EtOAc. The filtrate was concentrated under vacuum to afford the corresponding intermediate as an orange solid that was used directly in the next step. LCMS (ES+) [M + H]<sup>+</sup>: 296.1. A THF (80 mL) solution of crude (<i>S</i>)-2-(benzofuran-2-yl)-2-((<i>S</i>)-1,1-dimethylethylsulfinamido)acetic acid from the previous reaction was slowly added to a cooled (0 °C) suspension of LiAlH<sub>4</sub> (5.86 g, 154 mmol, 5.0 equiv) in THF (120 mL). The resulting mixture was stirred for 1 h at 0 °C before being diluted with Et<sub>2</sub>O (300 mL). While being maintained at 0 °C, the reaction mixture was quenched by sequential addition of water (5.60 mL), sodium hydroxide (2 N, 5.60 mL), and water (16.8 mL). The mixture was allowed to warm to RT and stirred for 1 h, and MgSO<sub>4</sub> was added. The mixture was stirred for 10 min, and the solids were filtered and rinsed thoroughly with 10% MeOH/DCM (500 mL). The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–5% MeOH/DCM) to afford the alcohol as pale-yellow oil (1.85 g, 21%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.54 (ddd, <i>J</i> = 7.6, 1.4, 0.7 Hz, 1H), 7.47–7.43 (m, 1H), 7.30–7.26 (m, 1H), 7.25–7.21 (m, 1H), 6.65 (t, <i>J</i> = 0.9 Hz, 1H), 4.69–4.64 (m, 1H), 4.14 (dd, <i>J</i> = 11.9, 3.6 Hz, 1H), 3.95–3.88 (m, 2H), 1.29 (s, 9H). LCMS (ES+) [M + H]<sup>+</sup>: 282.0.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>R</i>)-2-(Benzofuran-2-yl)-2-(4-methoxybenzylamino)ethanol (<b>43a</b>)</h4><div class="NLM_p last">(<i>S</i>)-<i>N</i>-((<i>R</i>)-1-(Benzofuran-2-yl)-2-hydroxyethyl)-2-methylpropane-2-sulfinamide (<b>42a</b>) (1.85 g, 6.58 mmol, 1.0 equiv) was dissolved in a 4 N solution of HCl in 1,4-dioxane (40.0 mL) at ambient temperature. The resulting mixture was stirred at ambient temperature for 30 min and concentrated to dryness to afford the desired hydrochloride salt which was used directly in the next step. LCMS (ES+) [M – H<sub>2</sub>O]<sup>+</sup>: 161.0. A solution of crude (<i>R</i>)-1-(benzofuran-2-yl)-2-hydroxyethanaminium chloride from previous step in DCM (40.0 mL) at ambient temperature was treated successively with triethylamine (1.83 mL, 13.2 mmol, 2.0 equiv), MgSO<sub>4</sub> (5.6 g), and anisaldehyde (800 μL, 6.58 mmol, 1.0 equiv). The resulting suspension was stirred for 16 h at ambient temperature and filtered through a pad of Celite which was washed with EtOAc. The filtrate was concentrated under vacuum to afford the corresponding imine intermediate. This intermediate was dissolved in MeOH (50.0 mL) and cooled to 0 °C. Solid NaBH<sub>4</sub> (730 mg, 19.7 mmol, 3.0 equiv) was added portionwise over 5 min. The resulting mixture was stirred for 30 min at 0 °C, then quenched by the slow addition of a saturated aqueous solution of NaHCO<sub>3</sub>. Water and DCM were added. The layers were separated, and the aqueous layer was extracted with DCM twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated to afforded a residue that was purified by normal phase chromatography on silica (0–10% MeOH/DCM) to afford the desired amino-alcohol (1.96 g, 68%) as an off-white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.55 (ddd, <i>J</i> = 7.5, 1.4, 0.7 Hz, 1H), 7.49–7.43 (m, 1H), 7.31–7.26 (m, 1H), 7.25–7.21 (m, 3H), 6.88–6.82 (m, 2H), 6.63–6.62 (m, 1H), 3.97 (dd, <i>J</i> = 8.4, 4.4 Hz, 1H), 3.89–3.73 (m, 6H), 3.70–3.61 (m, 1H). LCMS (ES+) [M + H]<sup>+</sup>: 298.1.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>R</i>)-<i>N</i>-(1-(Benzofuran-2-yl)-2-hydroxyethyl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxybenzyl) picolinamide (<b>44a</b>)</h4><div class="NLM_p last">A solution of 5-bromo-6-methoxypicolinic acid (1.08 g, 4.45 mmol, 1.05 equiv) in DCM (40.0 mL) at ambient temperature was treated with a catalytic amount of DMF (4 drops) and oxalyl chloride (1.17 mL, 13.4 mmol, 3.0 equiv). The resulting mixture was stirred at ambient temperature for 1 h, at which point LCMS monitoring showed completion of the reaction. The mixture was concentrated, diluted with anhydrous THF (20.0 mL), concentrated again, and dried under high vacuum for 1 h. The residue was diluted in anhydrous THF (20.0 mL), treated with triethylamine (1.86 mL, 13.4 mmol, 3.0 equiv), and cooled to 0 °C. A solution of (<i>R</i>)-2-(benzofuran-2-yl)-2-(4-methoxybenzylamino)ethanol (<b>43a</b>) (1.32 g, 4.45 mmol, 1.0 equiv) in THF (20.0 mL) was quickly added, and the resulting mixture was stirred at 0 °C for 30 min. A saturated aqueous solution of NaHCO<sub>3</sub> and EtOAc were then successively added. The layers were separated, and the aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–40% EtOAc/hexanes) to afford the desired amide as white foam (1.78 g, 78%). LCMS (ES+) [M + H]<sup>+</sup>: 511.2/513.2.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>R</i>)-<i>N</i>-(2-(Aminooxy)-1-(benzofuran-2-yl)ethyl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxybenzyl) picolinamide (<b>45a</b>)</h4><div class="NLM_p last">DIAD (828 μL, 4.18 mmol, 1.2 equiv) was added to a solution of triphenylphosphine (PPh<sub>3</sub>) (1.10 g, 4.18 mmol, 1.2 equiv), (<i>R</i>)-<i>N</i>-(1-(benzofuran-2-yl)-2-hydroxyethyl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (<b>44a</b>) (1.78 g, 3.48 mmol, 1.0 equiv), and <i>N</i>-hydroxylphthalimide (681 mg, 4.18 mmol, 1.2 equiv) in THF (20.0 mL) at 0 °C. The resulting mixture was kept at 0 °C for 1 h, then warmed to ambient temperature and stirred for 16 h. EtOAc was added, and the organic layer was washed with 1 N aqueous NaOH (twice), water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–40% EtOAc/hexanes) to afford the desired product as beige foam (1.61 g, 71%). LCMS (ES+) [M + H]+: 656.2/658.2. A suspension of (<i>R</i>)-<i>N</i>-(1-(benzofuran-2-yl)-2-(1,3-dioxoisoindolin-2-yloxy)ethyl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (1.61 g, 2.45 mmol, 1.0 equiv) in ethanol (90%, 15.0 mL) and THF (2.25 mL) at ambient temperature was treated with hydrazine hydrate (50–60%, 2.50 mL). The resulting mixture was stirred for 30 min, then water was added. The mixture was extracted with EtOAc (three times), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford the desired product (1.24 g, 96%) as off-white foam that was used directly in the next step. LCMS (ES+) [M + H]+: 526.0/528.0.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-5-(Benzofuran-2-yl)-3-(5-bromo-6-methoxypyridin-2-yl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>46a</b>)</h4><div class="NLM_p last">A solution of (<i>R</i>)-<i>N</i>-(2-(aminooxy)-1-(benzofuran-2-yl)ethyl)-5-bromo-6-methoxy-<i>N</i>-(4-methoxybenzyl)picolinamide (<b>45a</b>) (1.24 g, 2.34 mmol, 1.0 equiv) in DCE (20.0 mL) was treated with TFA (1.00 mL). The resulting mixture was stirred at 80 °C for 1 h, then cooled to ambient temperature and concentrated to dryness. The residue was diluted with EtOAc, washed with saturated aqueous solution of NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford the desired product (1.21 g, 98%) as pale-yellow oil that was used directly in the next step. LCMS (ES+) [M + H]<sup>+</sup>: 526.1/528.0. A solution of (<i>S</i>)-<i>N</i>-(2-(benzofuran-2-yl)-2-(4-methoxybenzylamino)ethoxy)-5-bromo-6-methoxypicolinamide (1.20 g, 2.28 mmol, 1.0 equiv) in anhydrous DCE (20.0 mL) at ambient temperature was treated with POCl<sub>3</sub> (3.2 mL, 34.3 mmol, 15.0 equiv). The vial was sealed and heated at 115 °C for 6 h. The reaction mixture was evaporated, dried under high vacuum for 10 min, dissolved in EtOH (15.0 mL), and treated with DIPEA (2.0 mL, 11.5 mmol, 5.0 equiv) and DMAP (140 mg, 1.15 mmol, 0.5 equiv). The resulting mixture was heated to 115 °C for 16 h. The reaction mixture was cooled to ambient temperature and diluted with EtOAc. The organic layer was washed with 1 N aqueous NaOH, water (twice), and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–30% EtOAc/hexanes) to afford the desired product (442 mg, 38%) as a pale-orange foam. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.88 (d, <i>J</i> = 7.8 Hz, 1H), 7.56 (ddd, <i>J</i> = 7.5, 1.4, 0.6 Hz, 1H), 7.46 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 7.31–7.27 (m, 1H), 7.25–7.22 (m, 2H), 7.21–7.17 (m, 2H), 6.86–6.82 (m, 2H), 6.79 (t, <i>J</i> = 0.8 Hz, 1H), 4.70 (d, <i>J</i> = 15.6 Hz, 1H), 4.62 (t, <i>J</i> = 2.9 Hz, 1H), 4.46 (dd, <i>J</i> = 11.1, 3.1 Hz, 1H), 4.14 (d, <i>J</i> = 15.6 Hz, 1H), 4.04 (dd, <i>J</i> = 11.1, 3.2 Hz, 1H), 3.94 (s, <i>J</i> = 5.3 Hz, 3H), 3.79 (s, 3H). LCMS (ES+) [M + H]<sup>+</sup>: 508.1/510.0.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>R</i>)-5-(Benzofuran-2-yl)-3-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>47</b>)</h4><div class="NLM_p last">To a vial charged with (<i>R</i>)-5-(benzofuran-2-yl)-3-(5-bromo-6-methoxypyridin-2-yl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (<b>46a</b>) (442 mg, 0.87 mmol, 1.0 equiv), 4(5)-methylimidazole (143 mg, 1.74 mmol, 2.0 equiv), and K<sub>3</sub>PO<sub>4</sub> (369 mg, 1.74 mmol, 2.0 equiv) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (4.00 mL). To a second vial charged with Pd<sub>2</sub>(dba)<sub>3</sub> (31.8 mg, 0.035 mmol, 4.0 mol %) and Me<sub>4</sub>-di-<i>t</i>-BuXPhos (CAS 857356-94-6, 33.4 mg, 0.07 mmol, 8.0 mol %) under N<sub>2</sub> atmosphere was added degassed 4:1 PhMe:dioxane solvent mixture (2.00 mL). This mixture was stirred for 3 min at 120 °C to give a dark-red solution which was cooled to RT and transferred to the first vial. The reaction was degassed by bubbling with N<sub>2</sub> for 5 min and then sealed. The reaction mixture was stirred at 120 °C for 16 h. The reaction was cooled to RT and filtered through a pad of Celite which was washed thoroughly with EtOAc. The filtrate was concentrated, and the residue was purified by normal phase chromatography on silica (0–5% MeOH/DCM) to afford the desired product (322 mg, 73%) as an off-white solid. LCMS (ES+) [M + H]<sup>+</sup>: 510.4. A solution of (<i>R</i>)-5-(benzofuran-2-yl)-3-(6-methoxy-5-(4-methyl-1<i>H</i>-imidazol-1-yl)pyridin-2-yl)-4-(4-methoxybenzyl)-5,6-dihydro-4<i>H</i>-1,2,4-oxadiazine (320 mg, 0.63 mmol, 1.0 equiv) in DCE (4.00 mL) at ambient temperature was treated with TFA (4.00 mL). The resulting mixture was stirred at 95 °C for 1.5 h in a microwave reactor. The reaction mixture was cooled to RT, concentrated, and dissolved in EtOAc. The organic layer was washed with 1 N aqueous NaOH and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by normal phase chromatography on silica (0–10% MeOH/DCM) to afford the desired product (225 mg) as an off-white solid. A portion (100 mg) of this material was dissolved in DMF (1.50 mL) and further purified using reverse phase chromatography on C18 resin (5–100% MeCN/H<sub>2</sub>O + 0.1% HCOOH) to give the desired product, after lyophilization, as a white solid (70.0 mg, 70%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 7.82 (d, <i>J</i> = 1.3 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.63 (d, <i>J</i> = 8.0 Hz, 1H), 7.56 (ddd, <i>J</i> = 7.7, 1.3, 0.7 Hz, 1H), 7.48 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 7.30 (ddd, <i>J</i> = 8.3, 7.3, 1.4 Hz, 1H), 7.24 (dd, <i>J</i> = 7.4, 1.0 Hz, 1H), 7.00–6.98 (m, 1H), 6.75 (t, <i>J</i> = 0.8 Hz, 1H), 6.70 (d, <i>J</i> = 2.5 Hz, 1H), 5.04 (dt, <i>J</i> = 5.6, 2.9 Hz, 1H), 4.33 (dd, <i>J</i> = 10.9, 3.7 Hz, 1H), 4.21 (dd, <i>J</i> = 11.0, 5.3 Hz, 1H), 4.05 (s, 3H), 2.30 (d, <i>J</i> = 0.9 Hz, 3H). LCMS analysis using LCMS A, standard conditions: <i>t</i><sub>r</sub> = 3.78 min. LCMS (ES+) [M + H]<sup>+</sup>: 390.3; [α]<sub>D</sub> = +435 (<i>c</i> = 0.11, MeOH).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01620">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01620" class="ext-link">10.1021/acs.jmedchem.6b01620</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Full experimental procedures and characterization of compounds <b>9</b>, <b>11</b>, <b>16</b>, <b>20</b>–<b>24</b>, <b>32</b>, <b>33</b>, and <b>48</b> as well as biological assay protocols (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_001.pdf">jm6b01620_si_001.pdf (673.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_002.csv">jm6b01620_si_002.csv (4.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01620" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew G. Bursavich</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4934-7323" title="Orcid link">http://orcid.org/0000-0003-4934-7323</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c6aba7b2b2e8a4b3b4b5a7b0afa5ae86aba9b4b6aeafa5b2bee8a5a9ab"><span class="__cf_email__" data-cfemail="7b161a0f0f55190e09081a0d1218133b1614090b1312180f0355181416">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryce A. Harrison</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raksha Acharya</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald E. Costa</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily A. Freeman</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilliary E. Hodgdon</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori A. Hrdlicka</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Jin</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudarshan Kapadnis</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey S. Moffit</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deirdre A. Murphy</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Nolan</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holger Patzke</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cuyue Tang</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melody Wen</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerhard Koenig</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-François Blain</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duane A. Burnett</span> - <span class="hlFld-Affiliation affiliation">FORUM
Pharmaceuticals, 225 Second Avenue, Waltham, Massachusetts 02451, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1444-7802" title="Orcid link">http://orcid.org/0000-0002-1444-7802</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d131e4897-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Alexandre Larivee and colleagues at Paraza Pharma as well as Drs. BVNBS Sarma, Rajender Akula, and Ramakrishna Reddy Narayana at SAI Life Sciences for synthetic efforts in support of this program.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, elimination, and toxicity</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β peptide amyloid precursor protein intracellular domains</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-amyloid cleavage enzyme 1 brain to plasma ratio, B:P</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">calculated logarithm of octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">Fsp<sup>3</sup></td><td class="NLM_def"><p class="first last">fraction sp<sup>3</sup> character</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">familial Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">GS</td><td class="NLM_def"><p class="first last">γ-secretase</p></td></tr><tr><td class="NLM_term">GSM</td><td class="NLM_def"><p class="first last">γ-secretase modulator</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LELP</td><td class="NLM_def"><p class="first last">ligand efficiency dependent lipophilicity</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">POM</td><td class="NLM_def"><p class="first last">proof-of-mechanism</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">presenilin</p></td></tr><tr><td class="NLM_term">Pen-2</td><td class="NLM_def"><p class="first last">presenilin enhancer protein 2</p></td></tr><tr><td class="NLM_term">PSEN</td><td class="NLM_def"><p class="first last">presenilin gene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>2016 Alzheimer’s Facts and Figures; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Chicago</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span><a href="http://www.alz.org/facts/overview.asp" class="extLink">http://www.alz.org/facts/overview.asp</a> (accessed October 15, 2016.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2016+Alzheimer%E2%80%99s+Facts+and+Figures%3B+Alzheimer%E2%80%99s+Association%3A+Chicago%2C+2017%3B+http%3A%2F%2Fwww.alz.org%2Ffacts%2Foverview.asp+%28accessed+October+15%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3D2016%2520Alzheimer%25E2%2580%2599s%2520Facts%2520and%2520Figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid Deposition as the Central Event in the Aetiology of Alzheimer’s Disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+Deposition+as+the+Central+Event+in+the+Aetiology+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0lgADV_jgq9bUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520Deposition%2520as%2520the%2520Central%2520Event%2520in%2520the%2520Aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Amyloid Protein and Alzheimer’s Disease</span> <span class="citation_source-journal">Sci. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><div class="note"><p class="first last">74–76, 78</p></div><span class="refDoi"> DOI: 10.1038/scientificamerican1191-68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2Fscientificamerican1191-68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1785042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1991&pages=68-71&author=D.+J.+Selkoe&title=Amyloid+Protein+and+Alzheimer%E2%80%99s+Disease&doi=10.1038%2Fscientificamerican1191-68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid protein and Alzheimer's disease</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific American</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">68-71, 74-6, 78</span>CODEN:
                <span class="NLM_cas:coden">SCAMAC</span>;
        ISSN:<span class="NLM_cas:issn">0036-8733</span>.
    </div><div class="casAbstract">A review with 5 refs. of amyloid protein in the pathogenesis of Alzheimer's disease. .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGC6YlZFUtz7Vg90H21EOLACvtfcHk0lgADV_jgq9bUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarsbo%253D&md5=a2dbf766d90dd2044d57a792faa87b82</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fscientificamerican1191-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fscientificamerican1191-68%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAmyloid%2520Protein%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DSci.%2520Am.%26date%3D1991%26volume%3D265%26spage%3D68%26epage%3D71%26doi%3D10.1038%2Fscientificamerican1191-68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartier-Harlin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with Familial Alzheimer’s Disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1038/349704a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F349704a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1671712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1991&pages=704-706&author=A.+Goateauthor=M.+C.+Chartier-Harlinauthor=M.+Mullanauthor=J.+Brownauthor=F.+Crawfordauthor=L.+Fidaniauthor=L.+Giuffraauthor=A.+Haynesauthor=N.+Irving&title=Segregation+of+a+Missense+Mutation+in+the+Amyloid+Precursor+Protein+Gene+with+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1038%2F349704a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease</span></div><div class="casAuthors">Goate, Alison; Chartier-Harlin, Marie Christine; Mullan, Mike; Brown, Jeremy; Crawford, Fiona; Fidani, Liana; Giuffra, Luis; Haynes, Andrew; Irving, Nick; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">6311</span>),
    <span class="NLM_cas:pages">704-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">To avoid the problems that heterogeneity poses for genetic anal., the authors examd. the cosegregation of Alzheimer's disease (AD) and markers along the long arm of chromosome 21 in a single family with AD confirmed by autopsy.  In this kindred, which shows linkage to chromosome 21 markers, there is a point mutation in the APP gene.  This mutation causes an amino-acid substitution (Val→Ile) close to the carboxy terminus of the β-amyloid peptide.  Screening other cases of familial AD revealed a second unrelated family in which this variant occurs.  This suggests that some cases of AD could be caused by mutations in the APP gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv7EvQ1MkXVbVg90H21EOLACvtfcHk0lgADV_jgq9bUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D&md5=5b27eb7cea61e5121c8d9f3d27fc2c0b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F349704a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F349704a0%26sid%3Dliteratum%253Aachs%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DChartier-Harlin%26aufirst%3DM.%2BC.%26aulast%3DMullan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DFidani%26aufirst%3DL.%26aulast%3DGiuffra%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DIrving%26aufirst%3DN.%26atitle%3DSegregation%2520of%2520a%2520Missense%2520Mutation%2520in%2520the%2520Amyloid%2520Precursor%2520Protein%2520Gene%2520with%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNature%26date%3D1991%26volume%3D349%26spage%3D704%26epage%3D706%26doi%3D10.1038%2F349704a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A Mutation in APP Protects against Alzheimer’s Disease and Age-Related Cognitive Decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Joenssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+Mutation+in+APP+Protects+against+Alzheimer%E2%80%99s+Disease+and+Age-Related+Cognitive+Decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljnN4gKtJed0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJoensson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520Mutation%2520in%2520APP%2520Protects%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Age-Related%2520Cognitive%2520Decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostaszewski, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberly, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Two Transmembrane Aspartates in Presenilin-1 Required for Presenilin Endoproteolysis and γ-Secretase Activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span><span class="refDoi"> DOI: 10.1038/19077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F19077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10206644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=513-517&author=M.+S.+Wolfeauthor=W.+Xiaauthor=B.+L.+Ostaszewskiauthor=T.+S.+Diehlauthor=W.+T.+Kimberlyauthor=D.+J.+Selkoe&title=Two+Transmembrane+Aspartates+in+Presenilin-1+Required+for+Presenilin+Endoproteolysis+and+%CE%B3-Secretase+Activity&doi=10.1038%2F19077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity</span></div><div class="casAuthors">Wolfe, Michael S.; Xia, Weiming; Ostaszewski, Beth L.; Diehl, Thekla S.; Kimberly, W. Taylor; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Accumulation of the amyloid-β protein (Aβ) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease.  The final step in the generation of Aβ from the β-amyloid precursor protein is an apparently intra-membranous proteolysis by the elusive γ-secretase(s).  The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters γ-secretase activity to increase the prodn. of the highly amyloidogenic Aβ42 isoform.  Moreover, deletion of presenilin-1 in mice greatly reduces γ-secretase activity, indicating that presenilin-1 mediates most of this proteolytic event.  Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Aβ prodn. and increases the amts. of the carboxy-terminal fragments of 1-amyloid precursor protein that are the substrates of γ-secretase.  We obsd. these effects in three different cell lines as well as in cell-free microsomes.  Either of the Asp → Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 → TM7 cytoplasmic loop.  In a functional presenilin-1 variant (carrying a deletion in exon 9) that is assocd. with familial Alzheimer's disease and which does not require this cleavage, the Asp 385 → Ala mutation still inhibited γ-secretase activity.  Our results indicate that the two transmembrane aspartate residues are crit. for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenilin 1 is either a unique di-aspartyl cofactor for γ-secretase or is itself γ-secretase, an auto-activated intra-membranous aspartyl protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIBUrgEzFHtbVg90H21EOLACvtfcHk0ljnN4gKtJed0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D&md5=c7b52439e0e35003e8c20242b21da860</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F19077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19077%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DKimberly%26aufirst%3DW.%2BT.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTwo%2520Transmembrane%2520Aspartates%2520in%2520Presenilin-1%2520Required%2520for%2520Presenilin%2520Endoproteolysis%2520and%2520%25CE%25B3-Secretase%2520Activity%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D513%26epage%3D517%26doi%3D10.1038%2F19077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrijvers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">A Presenilin-1-Dependent γ-Secretase-like Protease Mediates Release of Notch Intracellular Domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1038/19083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F19083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10206645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=518-522&author=B.+De+Strooperauthor=W.+Annaertauthor=P.+Cupersauthor=P.+Saftigauthor=K.+Craessaertsauthor=J.+S.+Mummauthor=E.+H.+Schroeterauthor=V.+Schrijversauthor=M.+S.+Wolfeauthor=W.+J.+Rayauthor=A.+Goateauthor=R.+Kopan&title=A+Presenilin-1-Dependent+%CE%B3-Secretase-like+Protease+Mediates+Release+of+Notch+Intracellular+Domain&doi=10.1038%2F19083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain</span></div><div class="casAuthors">De Strooper, Bart; Annaert, Wim; Cupers, Philippe; Saftig, Paul; Craessaerts, Katleen; Mumm, Jeffrey S.; Schroeter, Eric H.; Schrijvers, Vincent; Wolfe, Michael S.; Ray, William J.; Goate, Alison; Kopan, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">518-522</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Signaling through the receptor protein Notch, which is involved in crucial cell-fate decisions during development, requires ligand-induced cleavage of Notch.  This cleavage occurs within the predicted transmembrane domain, releasing the Notch intra-cellular domain (NICD), and is reminiscent of γ-secretase-mediated cleavage of β-amyloid precursor protein (APP), a crit. event in the pathogenesis of Alzheimer's disease.  A deficiency in presenilin-1 (PS1) inhibits processing of APP by γ-secretase in mammalian cells, and genetic interactions between Notch and PS1 homologs in Caenorhabditis elegans indicate that the presenilins may modulate the Notch signaling pathway.  Here we report that, in mammalian cells, PS1 deficiency also reduces the proteolytic release of NICD from a truncated Notch construct, thus identifying the specific biochem. step of the Notch signaling pathway that is affected by PS1.  Moreover, several γ-secretase inhibitors block this same step in Notch processing, indicating that related protease activities are responsible for cleavage within the predicted transmembrane domains of Notch and APP.  Thus the targeting of γ-secretase for the treatment of Alzheimer's disease may risk toxicity caused by reduced Notch signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQagjvTdUe8rVg90H21EOLACvtfcHk0ljnN4gKtJed0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D&md5=b42222d870cb32d3093addb8ccb2a5a2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F19083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19083%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DCupers%26aufirst%3DP.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DMumm%26aufirst%3DJ.%2BS.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DSchrijvers%26aufirst%3DV.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DA%2520Presenilin-1-Dependent%2520%25CE%25B3-Secretase-like%2520Protease%2520Mediates%2520Release%2520of%2520Notch%2520Intracellular%2520Domain%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D518%26epage%3D522%26doi%3D10.1038%2F19083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacmias, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piacentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaducci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Familial Alzheimer’s Disease in Kindreds with Missense Mutations in a Gene on Chromosome 1 Related to the Alzheimer’s Disease Type 3 Gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1038/376775a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F376775a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=7651536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=775-778&author=E.+I.+Rogaevauthor=R.+Sherringtonauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=Y.+Liangauthor=H.+Chiauthor=C.+Linauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=S.+Sorbiauthor=B.+Nacmiasauthor=S.+Piacentiniauthor=L.+Amaducciauthor=I.+Chumakovauthor=D.+Cohenauthor=L.+Lannfeltauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St.+George-Hyslop&title=Familial+Alzheimer%E2%80%99s+Disease+in+Kindreds+with+Missense+Mutations+in+a+Gene+on+Chromosome+1+Related+to+the+Alzheimer%E2%80%99s+Disease+Type+3+Gene&doi=10.1038%2F376775a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene</span></div><div class="casAuthors">Rogaev, E. I.; Sherrington, R.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Liang, Y.; Chi, H.; Lin, C.; Holman, K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6543</span>),
    <span class="NLM_cas:pages">775-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">We report the cloning of a novel gene (E5-1) encoded on chromosome 1 which has substantial nucleotide and amino-acid sequence similarity to the S182 gene on chromosome 14q24.3.  Mutations, including three new missense mutations in the S182 gene, are assocd. with the AD3 subtype of early-onset familial Alzheimer's disease (AD).  Both the E5-1 and the S182 proteins are predicted to be integral membrane proteins with seven-membrane-spanning domains, and a large exposed loop between the sixth and seventh transmembrane domains.  Anal. of the nucleotide sequence of the open reading frame (ORF) of the E5-1 gene led to the discovery of two missense substitutions at conserved amino-acid residues in affected members of pedigrees with a form of familial AD that has a later age of onset than the AD3 subtype (50-70 yr vs. 30-60 yr for AD3).  These observations imply that the E5-1 gene on chromosome 1 and the S182 gene on chromosome 14q24.3 are members of a family of genes (presenilins) with related functions, and indicates that mutations in conserved residues of E5-1 could also play a role in the genesis of AD.  The authors results also indicate that still other AD susceptibility genes exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopES5CZyuo6LVg90H21EOLACvtfcHk0lhqdfhJ3J9GrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D&md5=8566f773f8d12ab5339a9fb16cb8dfd5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F376775a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376775a0%26sid%3Dliteratum%253Aachs%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DPiacentini%26aufirst%3DS.%26aulast%3DAmaducci%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DFamilial%2520Alzheimer%25E2%2580%2599s%2520Disease%2520in%2520Kindreds%2520with%2520Missense%2520Mutations%2520in%2520a%2520Gene%2520on%2520Chromosome%25201%2520Related%2520to%2520the%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Type%25203%2520Gene%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D775%26epage%3D778%26doi%3D10.1038%2F376775a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foncin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinessi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanseau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinsky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasco, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da, S. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haines, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkicak-Vance, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Cloning of a Gene Bearing Missense Mutations in Early-Onset Familial Alzheimer’s Disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x"> (</span><span class="NLM_issue">6534</span><span class="NLM_x">) </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span><span class="refDoi"> DOI: 10.1038/375754a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F375754a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=7596406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=1995&pages=754-760&issue=6534&author=R.+Sherringtonauthor=E.+I.+Rogaevauthor=Y.+Liangauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=H.+Chiauthor=C.+Linauthor=G.+Liauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=J.+F.+Foncinauthor=A.+C.+Bruniauthor=M.+P.+Montesiauthor=S.+Sorbiauthor=I.+Raineroauthor=L.+Pinessiauthor=L.+Neeauthor=I.+Chumakovauthor=D.+Pollenauthor=A.+Brookesauthor=P.+Sanseauauthor=R.+J.+Polinskyauthor=W.+Wascoauthor=S.+H.+A.+Daauthor=J.+L.+Hainesauthor=M.+A.+Perkicak-Vanceauthor=R.+E.+Tanziauthor=A.+D.+Rosesauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St.+George-Hyslop&title=Cloning+of+a+Gene+Bearing+Missense+Mutations+in+Early-Onset+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1038%2F375754a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease</span></div><div class="casAuthors">Sherrington, R.; Rogaev, E. I.; Liang, Y.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Chi, H.; Lin, C.; Li, G.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">6534</span>),
    <span class="NLM_cas:pages">754-60</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Some cases of Alzheimer's disease are inherited as an autosomal dominant trait.  Genetic linkage studies have mapped a locus (AD3) assocd. with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3.  The authors have defined a minimal cosegregating region contg. the AD3 gene, and isolated at least 19 different transcripts encoded within this region.  One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein.  Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease.  Because these changes occurred in conserved domains of the gene, and are not present in normal controls, they are likely to be causative of AD3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49ubD8AKFQ7Vg90H21EOLACvtfcHk0lhqdfhJ3J9GrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D&md5=c68c5ca80245a13604d3710cb5e3ab28</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F375754a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F375754a0%26sid%3Dliteratum%253Aachs%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DFoncin%26aufirst%3DJ.%2BF.%26aulast%3DBruni%26aufirst%3DA.%2BC.%26aulast%3DMontesi%26aufirst%3DM.%2BP.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DRainero%26aufirst%3DI.%26aulast%3DPinessi%26aufirst%3DL.%26aulast%3DNee%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DPollen%26aufirst%3DD.%26aulast%3DBrookes%26aufirst%3DA.%26aulast%3DSanseau%26aufirst%3DP.%26aulast%3DPolinsky%26aufirst%3DR.%2BJ.%26aulast%3DWasco%26aufirst%3DW.%26aulast%3DDa%26aufirst%3DS.%2BH.%2BA.%26aulast%3DHaines%26aufirst%3DJ.%2BL.%26aulast%3DPerkicak-Vance%26aufirst%3DM.%2BA.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DCloning%2520of%2520a%2520Gene%2520Bearing%2520Missense%2520Mutations%2520in%2520Early-Onset%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNature%26date%3D1995%26volume%3D375%26issue%3D6534%26spage%3D754%26epage%3D760%26doi%3D10.1038%2F375754a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Decreased Aβ Secretion by Cells Expressing Familial Alzheimer’s Disease-Linked Mutant Presenilin 1</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1016/j.neures.2006.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.neures.2006.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=17210196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFOisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2007&pages=446-453&author=M.+Shimojoauthor=N.+Saharaauthor=M.+Murayamaauthor=H.+Ichinoseauthor=A.+Takashima&title=Decreased+A%CE%B2+Secretion+by+Cells+Expressing+Familial+Alzheimer%E2%80%99s+Disease-Linked+Mutant+Presenilin+1&doi=10.1016%2Fj.neures.2006.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased Aβ secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1</span></div><div class="casAuthors">Shimojo, Masafumi; Sahara, Naruhiko; Murayama, Miyuki; Ichinose, Hiroshi; Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">446-453</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Presenilin (PS) is a catalytic subunit of the γ-secretase complex that cleaves the intramembranous region of amyloid precursor protein (APP), producing amyloid β (Aβ) peptide.  Familial Alzheimer's disease (FAD) results from PS mutations, which may alter γ-secretase activity to enhance the prodn. of highly aggregable Aβ42.  The precise pathogenic effects of mutant PS remain unclear.  To exclude the effects of endogenous PS, we established cell lines from PS1/PS2-deficient (PS-/-) fibroblasts capable of stably expressing either wild-type (wt) PS1 or different mutant PS1s.  Although both wt PS1 and mutant PS1 formed γ-secretase complexes of the same size and contg. the same components, the amt. of Aβ secreted by FAD mutant PS1-expressing cells was significantly reduced.  The ratio of Aβ42 to Aβ40 (Aβ42/Aβ40) secreted by these cells, however, was significantly higher than that secreted by cells expressing wt PS1, which corroborated findings from a previous report.  The elevated Aβ42/Aβ40 ratio obsd. with mutant PS1-expressing cells may be due to reduced Aβ40 prodn. not increased Aβ42 prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroytSkAe6RD7Vg90H21EOLACvtfcHk0lhqdfhJ3J9GrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFOisrw%253D&md5=f255b1ebf67d719d3ef73e46c6d4f4db</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2006.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2006.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DMurayama%26aufirst%3DM.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DDecreased%2520A%25CE%25B2%2520Secretion%2520by%2520Cells%2520Expressing%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease-Linked%2520Mutant%2520Presenilin%25201%26jtitle%3DNeurosci.%2520Res.%26date%3D2007%26volume%3D57%26spage%3D446%26epage%3D453%26doi%3D10.1016%2Fj.neures.2006.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizoroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Enzymatic Characteristics of I213T Mutant Presenilin-1/ γ-Secretase in Cell Models and Knock-in Mouse Brains: Familial Alzheimer Disease-Linked Mutation Imapris γ-Site Cleavage of Amyloid Precursor Protein C-Terminal Fragmant B</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">16488</span><span class="NLM_x">–</span> <span class="NLM_lpage">16496</span><span class="refDoi"> DOI: 10.1074/jbc.M801279200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1074%2Fjbc.M801279200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=16488-16496&author=M.+Shimojoauthor=N.+Saharaauthor=T.+Mizorokiauthor=S.+Funamotoauthor=M.+Morishima-Kawashimaauthor=T.+Kudoauthor=M.+Takedaauthor=Y.+Iharaauthor=H.+Ichinoseauthor=A.+Takashima&title=Enzymatic+Characteristics+of+I213T+Mutant+Presenilin-1%2F+%CE%B3-Secretase+in+Cell+Models+and+Knock-in+Mouse+Brains%3A+Familial+Alzheimer+Disease-Linked+Mutation+Imapris+%CE%B3-Site+Cleavage+of+Amyloid+Precursor+Protein+C-Terminal+Fragmant+B&doi=10.1074%2Fjbc.M801279200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801279200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801279200%26sid%3Dliteratum%253Aachs%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DMizoroki%26aufirst%3DT.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DEnzymatic%2520Characteristics%2520of%2520I213T%2520Mutant%2520Presenilin-1%252F%2520%25CE%25B3-Secretase%2520in%2520Cell%2520Models%2520and%2520Knock-in%2520Mouse%2520Brains%253A%2520Familial%2520Alzheimer%2520Disease-Linked%2520Mutation%2520Imapris%2520%25CE%25B3-Site%2520Cleavage%2520of%2520Amyloid%2520Precursor%2520Protein%2520C-Terminal%2520Fragmant%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D16488%26epage%3D16496%26doi%3D10.1074%2Fjbc.M801279200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cleynenbreugel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The Mechanism of γ-Secretase Dysfunction in Familial Alzheimer Disease</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span><span class="refDoi"> DOI: 10.1038/emboj.2012.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2Femboj.2012.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2261-2274&author=L.+Chavez-Gutierrezauthor=L.+Bammensauthor=I.+Benilovaauthor=A.+Vandersteenauthor=M.+Benurwarauthor=M.+Borgersauthor=S.+Lismontauthor=L.+Zhouauthor=S.+Van+Cleynenbreugelauthor=H.+Esselmannauthor=J.+Wiltfangauthor=L.+Serneelsauthor=E.+Karranauthor=H.+Gijsenauthor=J.+Schymkowitzauthor=F.+Rousseauauthor=K.+Broersenauthor=B.+De+Strooper&title=The+Mechanism+of+%CE%B3-Secretase+Dysfunction+in+Familial+Alzheimer+Disease&doi=10.1038%2Femboj.2012.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.79%26sid%3Dliteratum%253Aachs%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVan%2BCleynenbreugel%26aufirst%3DS.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520Mechanism%2520of%2520%25CE%25B3-Secretase%2520Dysfunction%2520in%2520Familial%2520Alzheimer%2520Disease%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2261%26epage%3D2274%26doi%3D10.1038%2Femboj.2012.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span> </span><span class="NLM_article-title">γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.celrep.2012.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=23291095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=42-51&author=M.+Okochiauthor=S.+Tagamiauthor=K.+Yanagidaauthor=M.+Takamiauthor=T.+S.+Kodamaauthor=K.+Moriauthor=T.+Nakayamaauthor=Y.+Iharaauthor=M.+Takeda&title=%CE%B3-Secretase+Modulators+and+Presenilin+1+Mutants+Act+Differently+on+Presenilin%2F%CE%B3-Secretase+Function+to+Cleave+A%CE%B242+and+A%CE%B243&doi=10.1016%2Fj.celrep.2012.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43</span></div><div class="casAuthors">Okochi, Masayasu; Tagami, Shinji; Yanagida, Kanta; Takami, Mako; Kodama, Takashi S.; Mori, Kohji; Nakayama, Taisuke; Ihara, Yasuo; Takeda, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deciphering the mechanism by which the relative Aβ42(43) to total Aβ ratio is regulated is central to understanding Alzheimer disease (AD) etiol.; however, the mechanisms underlying changes in the Aβ42(43) ratio caused by familial mutations and γ-secretase modulators (GSMs) are unclear.  Here, we show in vitro and in living cells that presenilin (PS)/γ-secretase cleaves Aβ42 into Aβ38, and Aβ43 into Aβ40 or Aβ38.  Approx. 40% of Aβ38 is derived from Aβ43.  Aβ42(43) cleavage is involved in the regulation of the Aβ42(43) ratio in living cells.  GSMs increase the cleavage of PS/γ-secretase-bound Aβ42 (increase kcat) and slow its dissocn. from the enzyme (decrease kb), whereas PS1 mutants and inverse GSMs show the opposite effects.  Therefore, we suggest a concept to describe the Aβ42(43) prodn. process and propose how GSMs act, and we suggest that a loss of PS/γ-secretase function to cleave Aβ42(43) may initiate AD and might represent a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEYS_49n8hbVg90H21EOLACvtfcHk0lipWFLXjQS3ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D&md5=ca7695ce5fd0d6506b27ec00cd3a4918</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DTagami%26aufirst%3DS.%26aulast%3DYanagida%26aufirst%3DK.%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DKodama%26aufirst%3DT.%2BS.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3D%25CE%25B3-Secretase%2520Modulators%2520and%2520Presenilin%25201%2520Mutants%2520Act%2520Differently%2520on%2520Presenilin%252F%25CE%25B3-Secretase%2520Function%2520to%2520Cleave%2520A%25CE%25B242%2520and%2520A%25CE%25B243%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D42%26epage%3D51%26doi%3D10.1016%2Fj.celrep.2012.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kretner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutsmiedl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-Generation Compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">15240</span><span class="NLM_x">–</span> <span class="NLM_lpage">15251</span><span class="refDoi"> DOI: 10.1074/jbc.M110.213587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1074%2Fjbc.M110.213587" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=15240-15251&author=B.+Kretnerauthor=A.+Fukumoriauthor=A.+Gutsmiedlauthor=R.+M.+Pageauthor=T.+Luebbersauthor=G.+Galleyauthor=K.+Baumannauthor=C.+Haassauthor=H.+Steiner&title=Attenuated+A%CE%B242+Responses+to+Low+Potency+%CE%B3-Secretase+Modulators+Can+Be+Overcome+for+Many+Pathogenic+Presenilin+Mutants+by+Second-Generation+Compounds&doi=10.1074%2Fjbc.M110.213587"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.213587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.213587%26sid%3Dliteratum%253Aachs%26aulast%3DKretner%26aufirst%3DB.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DGutsmiedl%26aufirst%3DA.%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DGalley%26aufirst%3DG.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DAttenuated%2520A%25CE%25B242%2520Responses%2520to%2520Low%2520Potency%2520%25CE%25B3-Secretase%2520Modulators%2520Can%2520Be%2520Overcome%2520for%2520Many%2520Pathogenic%2520Presenilin%2520Mutants%2520by%2520Second-Generation%2520Compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D15240%26epage%3D15251%26doi%3D10.1074%2Fjbc.M110.213587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Szaruga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veugelen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepulveda-Falla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span> </span><span class="NLM_article-title">Qualitative Changes in Human γ-Secretase Underlie Familial Alzheimer’s Disease</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2013</span><span class="refDoi"> DOI: 10.1084/jem.20150892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1084%2Fjem.20150892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=2003-2013&author=M.+Szarugaauthor=S.+Veugelenauthor=M.+Benurwarauthor=S.+Lismontauthor=D.+Sepulveda-Fallaauthor=A.+Lleoauthor=N.+S.+Ryanauthor=T.+Lashleyauthor=N.+C.+Foxauthor=S.+Murayamaauthor=H.+Gijsenauthor=B.+De+Strooperauthor=L.+Chavez-Gutierrez&title=Qualitative+Changes+in+Human+%CE%B3-Secretase+Underlie+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1084%2Fjem.20150892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150892%26sid%3Dliteratum%253Aachs%26aulast%3DSzaruga%26aufirst%3DM.%26aulast%3DVeugelen%26aufirst%3DS.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DSepulveda-Falla%26aufirst%3DD.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DN.%2BS.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26atitle%3DQualitative%2520Changes%2520in%2520Human%2520%25CE%25B3-Secretase%2520Underlie%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26spage%3D2003%26epage%3D2013%26doi%3D10.1084%2Fjem.20150892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A Subset of NSAIDs Lower Amyloidogenic Abeta42 Independently of Cyclooxygenase Activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1038/35102591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F35102591" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+a+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+a+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+Subset+of+NSAIDs+Lower+Amyloidogenic+Abeta42+Independently+of+Cyclooxygenase+Activity&doi=10.1038%2F35102591"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2Ba%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2Ba%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520Subset%2520of%2520NSAIDs%2520Lower%2520Amyloidogenic%2520Abeta42%2520Independently%2520of%2520Cyclooxygenase%2520Activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216%26doi%3D10.1038%2F35102591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-Secretase Modulators: A Review of Patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1517/13543776.2011.547479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-Secretase+Modulators%3A+A+Review+of+Patents+from+2008+to+2010&doi=10.1517%2F13543776.2011.547479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0liPbvlwAMoxfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-Secretase%2520Modulators%253A%2520A%2520Review%2520of%2520Patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226%26doi%3D10.1517%2F13543776.2011.547479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-Secretase Modulators for the Treatment of Alzheimer’s Disease: A Review Focusing on Patents from 2010 to 2012</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span><span class="refDoi"> DOI: 10.1517/13543776.2013.821465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1517%2F13543776.2013.821465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=23875696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1349-1366&author=M.+Petterssonauthor=A.+F.+Stepanauthor=G.+W.+Kauffmanauthor=D.+S.+Johnson&title=Novel+%CE%B3-Secretase+Modulators+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+A+Review+Focusing+on+Patents+from+2010+to+2012&doi=10.1517%2F13543776.2013.821465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012</span></div><div class="casAuthors">Pettersson, Martin; Stepan, Antonia F.; Kauffman, Gregory W.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: γ-Secretase is the enzyme responsible for the final step of amyloid precursor protein proteolysis to generate Aβ peptides including Aβ42 which is believed to be a toxic species involved in Alzheimer's disease (AD) progression. γ-Secretase modulators (GSMs) have been shown to selectively lower Aβ42 prodn. without affecting total Aβ levels or the formation of γ-secretase substrate intracellular domains such as APP intracellular domain and Notch intracellular domain.  Therefore, GSMs have emerged as an important therapeutic strategy for the treatment of AD.  Areas covered: The literature covering novel GSMs will be reviewed focusing on patents from 2010 to 2012.  Expert opinion: During the last review period (2008 - 2010) considerable progress was made developing GSMs with improved potency for lowering Aβ42 levels, but most of the compds. resided in unfavorable central nervous system (CNS) drug space.  In this review period (2010 - 2012), there is a higher percentage of potent GSM chem. matter that resides in favorable CNS drug space.  It is anticipated that clin. candidates will emerge out of this cohort that will be able to test the GSM mechanism of action in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLi5hAAdKc7Vg90H21EOLACvtfcHk0lg95JXMcye3HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP&md5=6b43a8feb210fa87ded92a26397b754f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-Secretase%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Review%2520Focusing%2520on%2520Patents%2520from%25202010%2520to%25202012%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1349%26epage%3D1366%26doi%3D10.1517%2F13543776.2013.821465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span> </span><span class="NLM_article-title">γ-Secretase Modulators: Can We Combine Potency with Safety?</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">295207</span><span class="refDoi"> DOI: 10.1155/2012/295207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1155%2F2012%2F295207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=23365783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=295207&author=H.+J.+M.+Gijsenauthor=M.+Mercken&title=%CE%B3-Secretase+Modulators%3A+Can+We+Combine+Potency+with+Safety%3F&doi=10.1155%2F2012%2F295207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators: Can We Combine Potency with Safety?</span></div><div class="casAuthors">Gijsen Harrie J M; Mercken Marc</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">γ-Secretase modulation has been proposed as a potential disease modifying anti-Alzheimer's approach.  γ-Secretase modulators (GSMs) cause a product shift from the longer amyloid-beta (Aβ) peptide isoforms to shorter, more soluble, and less amyloidogenic isoforms, without inhibiting APP or Notch proteolytic processing.  As such, modulating γ-secretase may avoid some of the adverse effects observed with γ-secretase inhibitors.  Since the termination of the GSM tarenfurbil in 2008 due to negative phase III trial results, a considerable progress has been made towards more potent and better brain penetrable compounds.  However, an analysis of their lipophilic efficiency indices indicates that their increased potency can be largely attributed to their increased lipophilicity.  The need for early and chronic dosing with GSMs will require high-safety margins.  This will be a challenge to achieve with the current, highly lipophilic GSMs.  We will demonstrate that by focusing on the drug-like properties of GSMs, a combination of high in vitro potency and reduced lipophilicity can be achieved and does result in better tolerated compounds.  The next hurdle will be to translate this knowledge into GSMs which are highly efficacious and safe in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoRn2xTT3rypZoeNcnHOQ9fW6udTcc2eZoUCe6ZX0l97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D&md5=f3c1425fa7619625bb4dc56ee2b5f5fb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1155%2F2012%2F295207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F295207%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3D%25CE%25B3-Secretase%2520Modulators%253A%2520Can%2520We%2520Combine%2520Potency%2520with%2520Safety%253F%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D295207%26doi%3D10.1155%2F2012%2F295207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blain, J.-F.</span><span> </span><span class="NLM_article-title">Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7389</span><span class="NLM_x">–</span> <span class="NLM_lpage">7409</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01960</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01960" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7389-7409&author=M.+G.+Bursavichauthor=B.+A.+Harrisonauthor=J.-F.+Blain&title=Gamma+Secretase+Modulators%3A+New+Alzheimer%E2%80%99s+Drugs+on+the+Horizon%3F&doi=10.1021%2Facs.jmedchem.5b01960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?</span></div><div class="casAuthors">Bursavich, Matthew G.; Harrison, Bryce A.; Blain, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7389-7409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The rapidly aging population desperately requires new therapies for Alzheimer's disease.  Despite years of pharmaceutical research, limited clin. success has been realized, with several failed disease modification therapies in recent years.  On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its prodn.  In this Perspective, we focus on the development of small mols. that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concn. of the shorter non-amyloidogenic Aβ species.  After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clin. proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp3 character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEjGJ5oHdrrVg90H21EOLACvtfcHk0lgpfl_0sIKEDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D&md5=8ba1b7de2ce64903c296b7cb63c1c5d3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DBlain%26aufirst%3DJ.-F.%26atitle%3DGamma%2520Secretase%2520Modulators%253A%2520New%2520Alzheimer%25E2%2580%2599s%2520Drugs%2520on%2520the%2520Horizon%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7389%26epage%3D7409%26doi%3D10.1021%2Facs.jmedchem.5b01960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgpfl_0sIKEDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+to+Enable+Alignment+of+Druglike+Properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgpfl_0sIKEDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span> </span><span class="NLM_article-title">E2012: A novel gamma-secretase modulator-pharmacology part</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S242</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.jalz.2010.05.787" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S242&author=T.+Hashimotoauthor=A.+Ishibashiauthor=H.+Hagiwaraauthor=Y.+Murataauthor=O.+Takenakaauthor=T.+Miyagawa&title=E2012%3A+A+novel+gamma-secretase+modulator-pharmacology+part&doi=10.1016%2Fj.jalz.2010.05.787"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.787%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DMiyagawa%26aufirst%3DT.%26atitle%3DE2012%253A%2520A%2520novel%2520gamma-secretase%2520modulator-pharmacology%2520part%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS242%26doi%3D10.1016%2Fj.jalz.2010.05.787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nagy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rege, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logovinsky, V.</span><span> </span><span class="NLM_article-title">E2012, a Novel Gamma-Secretase Modulator, Decreases Plasma Amyloid-Beta Levels in Humans</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S574</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.jalz.2010.05.1958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S574&author=C.+Nagyauthor=E.+Schuckauthor=A.+Ishibashiauthor=Y.+Nakataniauthor=B.+Regeauthor=V.+Logovinsky&title=E2012%2C+a+Novel+Gamma-Secretase+Modulator%2C+Decreases+Plasma+Amyloid-Beta+Levels+in+Humans&doi=10.1016%2Fj.jalz.2010.05.1958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1958%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DC.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DNakatani%26aufirst%3DY.%26aulast%3DRege%26aufirst%3DB.%26aulast%3DLogovinsky%26aufirst%3DV.%26atitle%3DE2012%252C%2520a%2520Novel%2520Gamma-Secretase%2520Modulator%252C%2520Decreases%2520Plasma%2520Amyloid-Beta%2520Levels%2520in%2520Humans%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS574%26doi%3D10.1016%2Fj.jalz.2010.05.1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Henderson, R. F.</span><span> </span><span class="NLM_article-title">Species Differences in the Metabolism of Olefins. Implications for Risk Assessment</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">135–136</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0009-2797(01)00170-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2FS0009-2797%2801%2900170-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=11397381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135%E2%80%93136&publication_year=2001&pages=53-64&author=R.+F.+Henderson&title=Species+Differences+in+the+Metabolism+of+Olefins.+Implications+for+Risk+Assessment&doi=10.1016%2FS0009-2797%2801%2900170-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in the metabolism of olefins. Implications for risk assessment</span></div><div class="casAuthors">Henderson, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">135-136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-64</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 22 refs.  Olefinic compds. are com. valuable because they form useful polymeric substances.  The same chem. property (presence of double bonds) that makes the olefins useful may also cause them to be toxic in the body.  The double bonds of olefins can be oxidized by cytochrome P 450 enzymes to epoxides, which are electrophiles that can react with DNA and may cause alterations in the genetic information carried by that macromol.  Epoxides can be rendered inactive toward DNA by binding to proteins, by hydrolysis to diols through epoxide hydrolase enzymes (EHs), or by forming conjugates with glutathione via glutathione S-transferase (GST) activities.  The balance between the oxidizing enzymic activities and the hydrolyzing or conjugating enzymic activities in the livers of different species can influence the potential toxicity of the olefins.  The location of the enzymes and the potential for concerted reactions in which epoxides are inactivated immediately after formation will also influence the potential toxicity of the olefins.  Cytochrome P 450 enzymes and EHs are in microsomes located in the rough endoplasmic reticulum surrounding the nucleus where the DNA is located.  GST is in the cytoplasm of the cell.  In the case of 1,3-butadiene (BD), such enzymic differences may strongly influence the toxicity in different species.  The mouse, in which BD is a potent multi-site carcinogen, has the lowest microsomal EH activity of any species.  This allows the monoepoxides formed in the microsomes by cytochrome P 450 enzymes to be further oxidized to the highly genotoxic diepoxide (DEB), and both epoxides can either be released into the blood for distribution throughout the body or can react with DNA in the nucleus.  The rat, in which BD is a weak carcinogen, has much higher levels of microsomal EH, and only trace amts. of DEB enter the bloodstream.  Major BD metabolites in primates suggest that the hydrolysis pathway is even more prominent in primates than in rats.  Data suggest that BD will be much less toxic in primates than in mice.  Considering these quant. differences in metab. may help to reduce the uncertainties in extrapolating animal data on olefin toxicity to health risk assessments for humans exposed to the compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQf50n60n2iLVg90H21EOLACvtfcHk0liDmUq0d44ZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D&md5=050db0848b3020f59c9d58f5774db520</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2801%2900170-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252801%252900170-3%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DR.%2BF.%26atitle%3DSpecies%2520Differences%2520in%2520the%2520Metabolism%2520of%2520Olefins.%2520Implications%2520for%2520Risk%2520Assessment%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2001%26volume%3D135%25E2%2580%2593136%26spage%3D53%26epage%3D64%26doi%3D10.1016%2FS0009-2797%2801%2900170-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Dihydrobenzofuran Amides as Orally Bioavailable, Centrally Active γ-Secretase Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+Synthesis+of+Dihydrobenzofuran+Amides+as+Orally+Bioavailable%2C+Centrally+Active+%CE%B3-Secretase+Modulators&doi=10.1016%2Fj.bmcl.2012.02.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0liDmUq0d44ZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Dihydrobenzofuran%2520Amides%2520as%2520Orally%2520Bioavailable%252C%2520Centrally%2520Active%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911%26doi%3D10.1016%2Fj.bmcl.2012.02.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Bicyclic Heterocycles as Potent γ-Secretase Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4800</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2013.06.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4794-4800&author=D.+Oehlrichauthor=F.+J.+R.+Romboutsauthor=D.+Berthelotauthor=F.+P.+Bischoffauthor=M.+A.+J.+De+Cleynauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=M.+Merckenauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=A.+I.+Velterauthor=T.+Wuauthor=H.+J.+M.+Gijsen&title=Design+and+Synthesis+of+Bicyclic+Heterocycles+as+Potent+%CE%B3-Secretase+Modulators&doi=10.1016%2Fj.bmcl.2013.06.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.100%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Bicyclic%2520Heterocycles%2520as%2520Potent%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4794%26epage%3D4800%26doi%3D10.1016%2Fj.bmcl.2013.06.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ncube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Morin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegley, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koegler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">Discovery of 2-Methylpyridine-Based Biaryl Amides as γ-Secretase Modulators for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2013.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=24139583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6447-6454&author=J.+J.+Chenauthor=W.+Qianauthor=K.+Biswasauthor=C.+Yuanauthor=A.+Amegadzieauthor=Q.+Liuauthor=T.+Nixeyauthor=J.+Zhuauthor=M.+Ncubeauthor=R.+M.+Rzasaauthor=F.+Chavezauthor=N.+Chenauthor=F.+De+Morinauthor=S.+Rumfeltauthor=C.+M.+Tegleyauthor=J.+R.+Allenauthor=S.+Hitchcockauthor=R.+Hungateauthor=M.+D.+Bartbergerauthor=L.+Zalamedaauthor=Y.+Liuauthor=J.+D.+McCarterauthor=J.+Zhangauthor=L.+Zhuauthor=S.+Babu-Khanauthor=Y.+Luoauthor=J.+Bradleyauthor=P.+H.+Wenauthor=D.+L.+Reidauthor=F.+Koeglerauthor=C.+Deanauthor=D.+Hickmanauthor=T.+L.+Correllauthor=T.+Williamsonauthor=S.+Wood&title=Discovery+of+2-Methylpyridine-Based+Biaryl+Amides+as+%CE%B3-Secretase+Modulators+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.bmcl.2013.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Chen, Jian Jeffrey; Qian, Wenyuan; Biswas, Kaustav; Yuan, Chester; Amegadzie, Albert; Liu, Qingyian; Nixey, Thomas; Zhu, Joe; Ncube, Mqhele; Rzasa, Robert M.; Chavez, Frank, Jr.; Chen, Ning; De Morin, Frenel; Rumfelt, Shannon; Tegley, Christopher M.; Allen, Jennifer R.; Hitchcock, Stephen; Hungate, Randy; Bartberger, Michael D.; Zalameda, Leeanne; Liu, Yichin; McCarter, John D.; Zhang, Jianhua; Zhu, Li; Babu-Khan, Safura; Luo, Yi; Bradley, Jodi; Wen, Paul H.; Reid, Darren L.; Koegler, Frank; Dean, Charles, Jr.; Hickman, Dean; Correll, Tiffany L.; Williamson, Toni; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6447-6454</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">γ-Secretase modulators (GSMs) are potentially disease-modifying treatments for Alzheimer's disease.  They selectively lower pathogenic Aβ42 levels by shifting the enzyme cleavage sites without inhibiting γ-secretase activity, possibly avoiding known adverse effects obsd. with complete inhibition of the enzyme complex.  A cell-based HTS effort identified the sulfonamide 1 as a GSM lead.  Lead optimization studies identified compd. 25 with improved cell potency, PKDM properties, and it lowered Aβ42 levels in the cerebrospinal fluid (CSF) of Sprague-Dawley rats following oral administration.  Further optimization of 25 to improve cellular potency is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfacRASb057Vg90H21EOLACvtfcHk0lhiNVA5S3NQJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F&md5=6282bfb2fc57efab5a32c15872e474b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DNcube%26aufirst%3DM.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDe%2BMorin%26aufirst%3DF.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DReid%26aufirst%3DD.%2BL.%26aulast%3DKoegler%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25202-Methylpyridine-Based%2520Biaryl%2520Amides%2520as%2520%25CE%25B3-Secretase%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6447%26epage%3D6454%26doi%3D10.1016%2Fj.bmcl.2013.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teranishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, M.</span><span> </span><span class="NLM_article-title">Design and Synthesis of an Aminopiperidine Series of γ-Secretase Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2013.10.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=378-381&author=T.+Kobayashiauthor=S.+Iwamaauthor=A.+Fusanoauthor=Y.+Katoauthor=A.+Ikedaauthor=Y.+Teranishiauthor=A.+Nishiharaauthor=M.+Tobe&title=Design+and+Synthesis+of+an+Aminopiperidine+Series+of+%CE%B3-Secretase+Modulators&doi=10.1016%2Fj.bmcl.2013.10.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.063%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DFusano%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DA.%26aulast%3DTeranishi%26aufirst%3DY.%26aulast%3DNishihara%26aufirst%3DA.%26aulast%3DTobe%26aufirst%3DM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520an%2520Aminopiperidine%2520Series%2520of%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D378%26epage%3D381%26doi%3D10.1016%2Fj.bmcl.2013.10.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">JChem Cartridge was used for structure based property calculation and reporting from Oracle</p></div>. JChem 5.9.0; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=JChem+Cartridge+was+used+for+structure+based+property+calculation+and+reporting+from+Oracle.+JChem+5.9.0%3B+ChemAxon%3A+Budapest%2C+2012%3B+http%3A%2F%2Fwww.chemaxon.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJChem%25205.9.0%26pub%3DChemAxon%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mccracken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ -Secretase Modulators in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/jm201407j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502&author=Z.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+Maccossauthor=M.+B.+Mandalauthor=T.+Mccrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+Hydroxyamidines+as+Amide+Isosteres%3A+Discovery+of+Oxadiazolines+and+Oxadiazines+as+Potent+and+Highly+Efficacious+%CE%B3+-Secretase+Modulators+in+Vivo&doi=10.1021%2Fjm201407j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaccoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMccracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520Hydroxyamidines%2520as%2520Amide%2520Isosteres%253A%2520Discovery%2520of%2520Oxadiazolines%2520and%2520Oxadiazines%2520as%2520Potent%2520and%2520Highly%2520Efficacious%2520%25CE%25B3%2520-Secretase%2520Modulators%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502%26doi%3D10.1021%2Fjm201407j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCraken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1021/ml300209g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300209g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=931-935&author=X.+Huangauthor=W.+Zhouauthor=X.+Liuauthor=H.+Liauthor=G.+Sunauthor=M.+Mandalauthor=M.+Vicarelauthor=X.+Zhuauthor=C.+Bennettauthor=T.+McCrakenauthor=D.+Pissarnitskiauthor=Z.+Zhaoauthor=D.+Coleauthor=G.+Galloauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=D.+Burnettauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=A.+Buevich&title=Synthesis+and+SAR+Studies+of+Fused+Oxadiazines+as+%CE%B3-Secretase+Modulators+for+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fml300209g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Huang, Xianhai; Zhou, Wei; Liu, Xiaoxiang; Li, Hongmei; Sun, George; Mandal, Mihirbaran; Vicarel, Monica; Zhu, Xiaohong; Bennett, Chad; McCraken, Troy; Pissarnitski, Dmitri; Zhao, Zhiqiang; Cole, David; Gallo, Gioconda; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Burnett, Duane; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Buevich, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-935</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fused oxadiazines such as imidazolylbenzylidene pyridooxadiazines I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) and imidazolylbenzylidene oxazinooxadiazines I (R = F; R1 = H, F; R2 = Me; X = O) were prepd. as selective and orally bioavailable γ-secretase modulators (GSMs) derived by analogy from pyridooxadiazoline GSMs.  The effect of structural modifications on pyridooxadiazoline GSMs differed significantly from the effects of modifications to pyridooxadiazine GSMs.  I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) were found to be highly efficacious in vitro and in vivo in a no. of animal models with highly desirable phys. and pharmacol. properties.  Fused morpholine oxadiazines such as I (R = F; R1 = H, F; R2 = Me; X = O) showed improved in vitro activities and selectivities as GSMs.  The shift in specificity of APP cleavage rather than a redn. in overall γ-secretase activity and the lack of changes in substrate accumulation and Notch processing as obsd. in the animal studies of compd. I (R = R1 = F; R2 = H; X = CH2) confirm that imidazolylbenzylidene pyridooxadiazines are potent GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLJKqS8YPSLVg90H21EOLACvtfcHk0lgs649pDZLzmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L&md5=42883463705abaa95287df4ea07f8936</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300209g%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DMcCraken%26aufirst%3DT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DBuevich%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520Studies%2520of%2520Fused%2520Oxadiazines%2520as%2520%25CE%25B3-Secretase%2520Modulators%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D931%26epage%3D935%26doi%3D10.1021%2Fml300209g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><div class="note"><p class="first last">For a recent report on the synthesis of oxadiazines, please see:</p></div><span class="NLM_contrib-group">Veerman, J. J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruseker, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Esseveldt, B. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heijne, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRiner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulemans, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rijnsbergen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonneveld, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span> </span><span class="NLM_article-title">Strategic and Tactical Approaches to the Synthesis of 5,6-Dihydro-[1,2,4]oxadiazines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2200</span><span class="refDoi"> DOI: 10.3987/COM-16-13570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.3987%2FCOM-16-13570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVyrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=2166-2200&author=J.+J.+N.+Veermanauthor=Y.+N.+Brusekerauthor=B.+C.+J.+van+Esseveldtauthor=R.+Glenauthor=B.+A.+Harrisonauthor=E.+H.+Heijneauthor=J.+McRinerauthor=T.+M.+Meulemansauthor=P.+van+Rijnsbergenauthor=W.+Zonneveldauthor=M.+G.+Bursavichauthor=D.+A.+Burnett&title=Strategic+and+Tactical+Approaches+to+the+Synthesis+of+5%2C6-Dihydro-%5B1%2C2%2C4%5Doxadiazines&doi=10.3987%2FCOM-16-13570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic and tactical approaches to the synthesis of 5,6-dihydro-[1,2,4]oxadiazines</span></div><div class="casAuthors">Veerman, Johan J. N.; Bruseker, Yorik B.; van Esseveldt, Bart C. J.; Glen, Rebecca; Harrison, Bryce A.; Heijne, Erik H.; McRiner, Andrew J.; Meulemans, Tommi M.; van Rijnsbergen, Peter; Zonneveld, Wim; Bursavich, Matthew G.; Burnett, Duane A.</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2166-2200</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">1881-0942</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">Three methods were developed for the synthesis of substituted 5,6-dihydro-4H-[1,2,4]oxadiazines, e.g., I.  The desired oxadiazine rings were synthesized via reductive amination, addn. to an iminium ion intermediate and by condensation of diamines, e.g., (1S,2S)-2-(aminooxy)cyclopentan-1-amine dihydrochloride with an imidate RC(=NH)OEt (R = CH3, C6H5, cyclohexyl, 2-pyridyl).  For all methods the scope with respect to the substituents that could be introduced was explored.  It was found that the imidate condensation route was the most versatile and the products could be isolated in yields up to 91%.  This route is also suitable for the introduction of chirality on the C5 and C6 position of the oxadiazine rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkE5kzRWXkb7Vg90H21EOLACvtfcHk0lgs649pDZLzmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVyrurY%253D&md5=5eb0ca3e0ba79e4fb24193043afcb245</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3987%2FCOM-16-13570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-16-13570%26sid%3Dliteratum%253Aachs%26aulast%3DVeerman%26aufirst%3DJ.%2BJ.%2BN.%26aulast%3DBruseker%26aufirst%3DY.%2BN.%26aulast%3Dvan%2BEsseveldt%26aufirst%3DB.%2BC.%2BJ.%26aulast%3DGlen%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DHeijne%26aufirst%3DE.%2BH.%26aulast%3DMcRiner%26aufirst%3DJ.%26aulast%3DMeulemans%26aufirst%3DT.%2BM.%26aulast%3Dvan%2BRijnsbergen%26aufirst%3DP.%26aulast%3DZonneveld%26aufirst%3DW.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DStrategic%2520and%2520Tactical%2520Approaches%2520to%2520the%2520Synthesis%2520of%25205%252C6-Dihydro-%255B1%252C2%252C4%255Doxadiazines%26jtitle%3DHeterocycles%26date%3D2016%26volume%3D92%26spage%3D2166%26epage%3D2200%26doi%3D10.3987%2FCOM-16-13570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kimura, T.; Kitazawa, N.; Kaneko, T.; Sato, N.; Kawano, K.; Ito, K.; Takaishi, M.; Sasaki, T.; Yoshida, Y.; Uemura, T.; Doko, T.; Shinmyo, D.; Hasegawa, D.; Miyagawa, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of Polycyclic Compounds as Inhibitors of Amyloid β10 and 42 Production</span>. WO2009028588A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Kimura&author=N.+Kitazawa&author=T.+Kaneko&author=N.+Sato&author=K.+Kawano&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=Y.+Yoshida&author=T.+Uemura&author=T.+Doko&author=D.+Shinmyo&author=D.+Hasegawa&author=T.+Miyagawa&author=H.+Hagiwara&title=Preparation+of+Polycyclic+Compounds+as+Inhibitors+of+Amyloid+%CE%B210+and+42+Production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Polycyclic%2520Compounds%2520as%2520Inhibitors%2520of%2520Amyloid%2520%25CE%25B210%2520and%252042%2520Production%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.-H.</span><span> </span><span class="NLM_article-title">Lewis Acid Promoted Highly Diastereoselective Petasis Borono-Mannich Reaction: Efficient Synthesis of Optically Active B,γ-Unsatd. α-Amino Acids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2062</span><span class="NLM_x">–</span> <span class="NLM_lpage">2065</span><span class="refDoi"> DOI: 10.1021/ol300581n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol300581n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=2062-2065&author=Y.+Liauthor=M.-H.+Xu&title=Lewis+Acid+Promoted+Highly+Diastereoselective+Petasis+Borono-Mannich+Reaction%3A+Efficient+Synthesis+of+Optically+Active+B%2C%CE%B3-Unsatd.+%CE%B1-Amino+Acids&doi=10.1021%2Fol300581n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol300581n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol300581n%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.-H.%26atitle%3DLewis%2520Acid%2520Promoted%2520Highly%2520Diastereoselective%2520Petasis%2520Borono-Mannich%2520Reaction%253A%2520Efficient%2520Synthesis%2520of%2520Optically%2520Active%2520B%252C%25CE%25B3-Unsatd.%2520%25CE%25B1-Amino%2520Acids%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D2062%26epage%3D2065%26doi%3D10.1021%2Fol300581n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Blain, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrdlicka, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgdon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadnis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patzke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Characterization of FRM-36143 as a New γ-Secretase Modulator for the Potential Treatment of Familial Alzheimer’s Disease</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1186/s13195-016-0199-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1186%2Fs13195-016-0199-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1-14&author=J.-F.+Blainauthor=M.+G.+Bursavichauthor=E.+A.+Freemanauthor=L.+A.+Hrdlickaauthor=H.+E.+Hodgdonauthor=T.+Chenauthor=D.+E.+Costaauthor=B.+A.+Harrisonauthor=S.+Kapadnisauthor=D.+A.+Murphyauthor=S.+Nolanauthor=Z.+Tuauthor=C.+Tangauthor=D.+A.+Burnettauthor=H.+Patzkeauthor=G.+Koenig&title=Characterization+of+FRM-36143+as+a+New+%CE%B3-Secretase+Modulator+for+the+Potential+Treatment+of+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1186%2Fs13195-016-0199-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1186%2Fs13195-016-0199-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-016-0199-5%26sid%3Dliteratum%253Aachs%26aulast%3DBlain%26aufirst%3DJ.-F.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DFreeman%26aufirst%3DE.%2BA.%26aulast%3DHrdlicka%26aufirst%3DL.%2BA.%26aulast%3DHodgdon%26aufirst%3DH.%2BE.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DCosta%26aufirst%3DD.%2BE.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DKapadnis%26aufirst%3DS.%26aulast%3DMurphy%26aufirst%3DD.%2BA.%26aulast%3DNolan%26aufirst%3DS.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DPatzke%26aufirst%3DH.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520FRM-36143%2520as%2520a%2520New%2520%25CE%25B3-Secretase%2520Modulator%2520for%2520the%2520Potential%2520Treatment%2520of%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2016%26volume%3D8%26spage%3D1%26epage%3D14%26doi%3D10.1186%2Fs13195-016-0199-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">Aqueous compound solubility was determined using a kinetic solubility method in pH 7.4 phosphate buffer after 90 min incubation at room temperature.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">GreenScreen Human Cells [GADD45alpha] (growth arrest and DNA damage gene)-Green Fluorescent Protein (GFP)] assay from Gentronix, conducted at BioReliance Corporation.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhang, Jinqiang Kuang, Xuqiong Xiao, Lei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yongmin Ma</span>. </span><span class="cited-content_cbyCitation_article-title">DMSO as a Dual Carbon Synthon and Water as Oxygen Donor for the Construction of 1,3,5-Oxadiazines from Amidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (10)
                                     , 3960-3964. <a href="https://doi.org/10.1021/acs.orglett.1c01116" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01116%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDMSO%252Bas%252Ba%252BDual%252BCarbon%252BSynthon%252Band%252BWater%252Bas%252BOxygen%252BDonor%252Bfor%252Bthe%252BConstruction%252Bof%252B1%25252C3%25252C5-Oxadiazines%252Bfrom%252BAmidines%26aulast%3DZhang%26aufirst%3DYi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D31032021%26date%3D03052021%26volume%3D23%26issue%3D10%26spage%3D3960%26epage%3D3964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Wu, Michael Givskov, <span class="NLM_string-name hlFld-ContribAuthor">Thomas E. Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Reactivity and Synthetic Applications of Multicomponent Petasis Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (20)
                                     , 11245-11290. <a href="https://doi.org/10.1021/acs.chemrev.9b00214" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00214%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DReactivity%252Band%252BSynthetic%252BApplications%252Bof%252BMulticomponent%252BPetasis%252BReactions%26aulast%3DWu%26aufirst%3DPeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05042019%26date%3D27082019%26volume%3D119%26issue%3D20%26spage%3D11245%26epage%3D11290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ming Li, Wei Li, Cheng-Dong Lin, Jia-Hui Wang, <span class="NLM_string-name hlFld-ContribAuthor">Li-Rong Wen</span>. </span><span class="cited-content_cbyCitation_article-title">One Base for Two Shots: Metal-Free Substituent-Controlled Synthesis of Two Kinds of Oxadiazine Derivatives from Alkynylbenziodoxolones and Amidoximes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (11)
                                     , 6904-6915. <a href="https://doi.org/10.1021/acs.joc.9b00659" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00659%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne%252BBase%252Bfor%252BTwo%252BShots%25253A%252BMetal-Free%252BSubstituent-Controlled%252BSynthesis%252Bof%252BTwo%252BKinds%252Bof%252BOxadiazine%252BDerivatives%252Bfrom%252BAlkynylbenziodoxolones%252Band%252BAmidoximes%26aulast%3DLi%26aufirst%3DMing%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13032019%26date%3D23052019%26date%3D14052019%26volume%3D84%26issue%3D11%26spage%3D6904%26epage%3D6915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ning Tang, Arun K. Somavarapu, <span class="NLM_string-name hlFld-ContribAuthor">Kasper P. Kepp</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Recipe for γ-Secretase Modulation from Computational Analysis of 60 Active Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 18078-18088. <a href="https://doi.org/10.1021/acsomega.8b02196" title="DOI URL">https://doi.org/10.1021/acsomega.8b02196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02196%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DMolecular%252BRecipe%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%252Bfrom%252BComputational%252BAnalysis%252Bof%252B60%252BActive%252BCompounds%26aulast%3DTang%26aufirst%3DNing%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28082018%26date%3D10122018%26volume%3D3%26issue%3D12%26spage%3D18078%26epage%3D18088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepa  Nair</span>, <span class="hlFld-ContribAuthor ">Mamta  Dadwal</span>, <span class="hlFld-ContribAuthor ">Namrata  Rastogi</span>, <span class="hlFld-ContribAuthor ">Irishi N.N.  Namboothiri</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Oxadiazines and 1,2,4-Thiadiazines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00090-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00090-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00090-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00090-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Oxadiazines%252Band%252B1%25252C2%25252C4-Thiadiazines%26aulast%3DNair%26aufirst%3DDeepa%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin D.  Rynearson</span>, <span class="hlFld-ContribAuthor ">Ronald N.  Buckle</span>, <span class="hlFld-ContribAuthor ">R. Jason  Herr</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Mayhew</span>, <span class="hlFld-ContribAuthor ">Xinchao  Chen</span>, <span class="hlFld-ContribAuthor ">William D.  Paquette</span>, <span class="hlFld-ContribAuthor ">Samuel A.  Sakwa</span>, <span class="hlFld-ContribAuthor ">Jinhai  Yang</span>, <span class="hlFld-ContribAuthor ">Keith D.  Barnes</span>, <span class="hlFld-ContribAuthor ">Phuong  Nguyen</span>, <span class="hlFld-ContribAuthor ">William C.  Mobley</span>, <span class="hlFld-ContribAuthor ">Graham  Johnson</span>, <span class="hlFld-ContribAuthor ">Juinn H.  Lin</span>, <span class="hlFld-ContribAuthor ">Rudolph E.  Tanzi</span>, <span class="hlFld-ContribAuthor ">Steven L.  Wagner</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (22)
                                     , 115734. <a href="https://doi.org/10.1016/j.bmc.2020.115734" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115734%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bmethoxypyridine-derived%252Bgamma-secretase%252Bmodulators%26aulast%3DRynearson%26aufirst%3DKevin%2BD.%26date%3D2020%26volume%3D28%26issue%3D22%26spage%3D115734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shekar  Mekala</span>, <span class="hlFld-ContribAuthor ">Grady  Nelson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1003-1022. <a href="https://doi.org/10.1039/D0MD00196A" title="DOI URL">https://doi.org/10.1039/D0MD00196A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00196A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00196A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bof%252Bsmall%252Bmolecule%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMekala%26aufirst%3DShekar%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D1003%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya P.  Gupta</span>, <span class="hlFld-ContribAuthor ">Vaishali M.  Patil</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (13)
                                     , 1195-1213. <a href="https://doi.org/10.2174/1568026620666200416091623" title="DOI URL">https://doi.org/10.2174/1568026620666200416091623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200416091623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200416091623%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BStudies%252Bon%252BDesign%252Band%252BDevelopment%252Bof%252BDrugs%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%252B%252528AD%252529%252BBased%252Bon%252BInhibition%252Bof%252BBACE-1%252Band%252BOther%252BAD-causative%252BAgents%26aulast%3DGupta%26aufirst%3DSatya%2BP.%26date%3D2020%26volume%3D20%26issue%3D13%26spage%3D1195%26epage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  de Sena M. Pinheiro</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Rodolfo  do Couto Maia</span>, <span class="hlFld-ContribAuthor ">Sreekanth  Thota</span>, <span class="hlFld-ContribAuthor ">Carlos A.M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of Conformational Restriction in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1712-1733. <a href="https://doi.org/10.2174/1568026619666190712205025" title="DOI URL">https://doi.org/10.2174/1568026619666190712205025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712205025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712205025%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DThe%252BUse%252Bof%252BConformational%252BRestriction%252Bin%252BMedicinal%252BChemistry%26aulast%3Dde%2BSena%2BM.%2BPinheiro%26aufirst%3DPedro%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1712%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Gerlach</span>, <span class="hlFld-ContribAuthor ">Scott  Hobson</span>, <span class="hlFld-ContribAuthor ">Christian  Eickmeier</span>, <span class="hlFld-ContribAuthor ">Ulrike  Groß</span>, <span class="hlFld-ContribAuthor ">Clemens  Braun</span>, <span class="hlFld-ContribAuthor ">Peter  Sieger</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Niklas  Heine</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3227-3241. <a href="https://doi.org/10.1016/j.bmc.2018.04.053" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btetrahydroindazoles%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bin%252Bvivo%252Befficacious%252Bgamma%252Bsecretase%252Bmodulators%26aulast%3DGerlach%26aufirst%3DKai%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3227%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial amide design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Initial oxadiazine design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>S</i>)-Aryl Ether Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 4-Fluoro-2-methylphenol or 4-chloro-2-(trifluoromethyl)phenol, DIAD, PPh<sub>3</sub>, THF, 70% and 77%; (b) a. TFA, DCM, b. TEA, MgSO<sub>4</sub>, <i>p</i>-anisaldehyde, then NaBH<sub>4</sub>, 71 and 68% over two steps; (c) 4-bromo-3-methoxybenzoic acid, DMF/oxalyl chloride, DCM, 59% and 95%; (d) a. <i>N-</i>hydroxyphthalimide, DIAD, PPh<sub>3</sub>, THF, b. hydrazine hydrate, EtOH, 85% and 91% over two steps; (e) P<sub>2</sub>O<sub>5</sub>, <i>i</i>-PrOH, 45% and 55%; (f) 4-methylimidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, 67% and 57%; (g) (2-methylpyridin-4-yl)boronic acid, Cs<sub>2</sub>CO<sub>3,</sub> PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, 68% and 60%; (h) TFA, DCE, 59–84%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Methyl (<i>S</i>)-Aryl Ether Oxadiazine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) a. <i>p</i>-TsOH-H<sub>2</sub>O, MeOH, b. TBS-Cl, imidazole, DCM, c. MeI, KHMDS, THF/DMF, 63% over three steps; (b) a. HCl, MeOH/THF, b. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, THF, c. 4 N HCl in dioxane, DCM, 72% over three steps; (c) a. 4-bromo-3-methoxybenzoic acid DCM/DMF/oxalyl chloride, b. hydrazine hydrate, EtOH, 40% over two steps; (d) P<sub>2</sub>O<sub>5</sub>, <i>i</i>-PrOH, 29%; (e) 4-methylimidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, 53%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (<i>S</i>)-2-Methoxypyridine Aryl Ether Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 5-bromo-6-methoxypicolinic acid, DCM/DMF/oxalyl chloride, 78 and 59%; (b) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, THF, b. hydrazine hydrate, EtOH, c. P<sub>2</sub>O<sub>5</sub>, <i>i</i>-PrOH, 12 and 15% over 3 steps; (c) a. 4-methylimidazole or 4-chloroimidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, b. TFA/DCE, 77–47% over two steps; (d) a. heteroarylboronic acid, Cs<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, b. TFA/DCE, 86-31% over two steps.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategies incorporated into fused piperidine and piperazine scaffolds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Piperidine Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBDMS-Cl, imidazole, DMF, 48%; (b) H<sub>2</sub>, PtO<sub>2</sub>, EtOH, 87%; (c) Boc<sub>2</sub>O, TEA, DCM, 63%; (d) 4-fluoro-2-methylphenol or 4-chloro-2-(trifluoromethyl)phenol, DIAD, PPh<sub>3</sub>, DCM, 78 or 85%; (e) a. TBAF, THF, b. TFA, DCM, c. 5-bromo-6-methoxypicolinic acid, DMF/oxalyl chloride, DCM then TEA, THF, 32 and 57% over three steps; (f) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, toluene, b. hydrazine hydrate, EtOH, 69 and 87% over two steps; (g) POCl<sub>3</sub>, <i>I</i>-PrOH, 35 and 56%; (h) 4-methyl imidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, 74–65%; (i) (2-methylpyridin-4-yl)boronic acid, Cs<sub>2</sub>CO<sub>3,</sub> PdCl<sub>2</sub>(dppf), dioxane/H<sub>2</sub>O, 61–56%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of piperazine oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) a. TBDMS-Cl, imidazole, DCM, b. NaO<i>t</i>Bu, Pd<sub>2</sub>(dba)<sub>3</sub>, DavePhos, 2-bromo-5-chlorobenzotrifluoride, toluene, 70% over two steps; (b) a. HCl, MeOH/dioxane, b. 5-bromo-6-methoxypicolinic acid, DIEA, HATU, DMF, c. TBAF, DCM, 80% over three steps; (c) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, toluene, b. hydrazine hydrate, EtOH; (d) POCl<sub>3</sub>, DIEA, DMAP, EtOH; (f) 4-methyl imidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design strategies incorporated into heteroaryl oxadiazine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Asymmetric Synthesis of Heterocyclic Oxadiazine GSMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) a. glyoxylic acid monohydrate, (<i>S</i>)-2-methylpropane-2-sulfinamide, InBr<sub>3,</sub> DCM, b. LiAlH<sub>4</sub>, THF, 21 and 16% over two steps; (b) a. 4 N HCl, dioxane, b. TEA, MgSO<sub>4</sub>, <i>p</i>-anisaldehyde, then NaBH<sub>4,</sub> MeOH, 68 and 84% over two steps; (c) NaOMe, 5-bromo-6-methoxypicolinic acid, MeOH, 78 and 82%; (d) a. <i>N</i>-hydroxyphthalimide, DIAD, PPh<sub>3</sub>, toluene, b. hydrazine hydrate, EtOH, 68 and 51% over two steps; (e) a. TFA, DCE, b. POCl<sub>3</sub>, DIEA, DMAP, EtOH, 37 and 32% over two steps; (f) a. 4-methyl imidazole, K<sub>3</sub>PO<sub>4,</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, Me<sub>4</sub>-di-<i>t</i>-BuXPhos, toluene/dioxane, b. TFA, DCE, 51 and 43% over two steps.</p></p></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/medium/jm-2016-01620y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0005.jpeg" id="rightTab-GRAPHIC-d131e2252-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo time course profile of <b>47</b> in mouse brain. Aβ<sub>37</sub> (left) and Aβ<sub>42</sub> (right) in the brain of mice treated acutely with a single oral dose of 47 (30 mg/kg). Data represent the mean ± SEM of 5–8 animals per group, expressed as % vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01620/20170317/images/large/jm-2016-01620y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01620&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>2016 Alzheimer’s Facts and Figures; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Chicago</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span><a href="http://www.alz.org/facts/overview.asp" class="extLink">http://www.alz.org/facts/overview.asp</a> (accessed October 15, 2016.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2016+Alzheimer%E2%80%99s+Facts+and+Figures%3B+Alzheimer%E2%80%99s+Association%3A+Chicago%2C+2017%3B+http%3A%2F%2Fwww.alz.org%2Ffacts%2Foverview.asp+%28accessed+October+15%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3D2016%2520Alzheimer%25E2%2580%2599s%2520Facts%2520and%2520Figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid Deposition as the Central Event in the Aetiology of Alzheimer’s Disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+Deposition+as+the+Central+Event+in+the+Aetiology+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0lg6egl2lyEMQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520Deposition%2520as%2520the%2520Central%2520Event%2520in%2520the%2520Aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Amyloid Protein and Alzheimer’s Disease</span> <span class="citation_source-journal">Sci. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><div class="note"><p class="first last">74–76, 78</p></div><span class="refDoi"> DOI: 10.1038/scientificamerican1191-68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2Fscientificamerican1191-68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1785042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1991&pages=68-71&author=D.+J.+Selkoe&title=Amyloid+Protein+and+Alzheimer%E2%80%99s+Disease&doi=10.1038%2Fscientificamerican1191-68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid protein and Alzheimer's disease</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific American</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">68-71, 74-6, 78</span>CODEN:
                <span class="NLM_cas:coden">SCAMAC</span>;
        ISSN:<span class="NLM_cas:issn">0036-8733</span>.
    </div><div class="casAbstract">A review with 5 refs. of amyloid protein in the pathogenesis of Alzheimer's disease. .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGC6YlZFUtz7Vg90H21EOLACvtfcHk0ljlLgjSdVp80w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarsbo%253D&md5=a2dbf766d90dd2044d57a792faa87b82</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fscientificamerican1191-68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fscientificamerican1191-68%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAmyloid%2520Protein%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DSci.%2520Am.%26date%3D1991%26volume%3D265%26spage%3D68%26epage%3D71%26doi%3D10.1038%2Fscientificamerican1191-68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartier-Harlin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with Familial Alzheimer’s Disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1038/349704a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F349704a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1671712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1991&pages=704-706&author=A.+Goateauthor=M.+C.+Chartier-Harlinauthor=M.+Mullanauthor=J.+Brownauthor=F.+Crawfordauthor=L.+Fidaniauthor=L.+Giuffraauthor=A.+Haynesauthor=N.+Irving&title=Segregation+of+a+Missense+Mutation+in+the+Amyloid+Precursor+Protein+Gene+with+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1038%2F349704a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease</span></div><div class="casAuthors">Goate, Alison; Chartier-Harlin, Marie Christine; Mullan, Mike; Brown, Jeremy; Crawford, Fiona; Fidani, Liana; Giuffra, Luis; Haynes, Andrew; Irving, Nick; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">6311</span>),
    <span class="NLM_cas:pages">704-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">To avoid the problems that heterogeneity poses for genetic anal., the authors examd. the cosegregation of Alzheimer's disease (AD) and markers along the long arm of chromosome 21 in a single family with AD confirmed by autopsy.  In this kindred, which shows linkage to chromosome 21 markers, there is a point mutation in the APP gene.  This mutation causes an amino-acid substitution (Val→Ile) close to the carboxy terminus of the β-amyloid peptide.  Screening other cases of familial AD revealed a second unrelated family in which this variant occurs.  This suggests that some cases of AD could be caused by mutations in the APP gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv7EvQ1MkXVbVg90H21EOLACvtfcHk0ljlLgjSdVp80w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyhu7k%253D&md5=5b27eb7cea61e5121c8d9f3d27fc2c0b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F349704a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F349704a0%26sid%3Dliteratum%253Aachs%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DChartier-Harlin%26aufirst%3DM.%2BC.%26aulast%3DMullan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DF.%26aulast%3DFidani%26aufirst%3DL.%26aulast%3DGiuffra%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DIrving%26aufirst%3DN.%26atitle%3DSegregation%2520of%2520a%2520Missense%2520Mutation%2520in%2520the%2520Amyloid%2520Precursor%2520Protein%2520Gene%2520with%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNature%26date%3D1991%26volume%3D349%26spage%3D704%26epage%3D706%26doi%3D10.1038%2F349704a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A Mutation in APP Protects against Alzheimer’s Disease and Age-Related Cognitive Decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Joenssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+Mutation+in+APP+Protects+against+Alzheimer%E2%80%99s+Disease+and+Age-Related+Cognitive+Decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljlLgjSdVp80w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJoensson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520Mutation%2520in%2520APP%2520Protects%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Age-Related%2520Cognitive%2520Decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostaszewski, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberly, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Two Transmembrane Aspartates in Presenilin-1 Required for Presenilin Endoproteolysis and γ-Secretase Activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span><span class="refDoi"> DOI: 10.1038/19077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F19077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10206644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=513-517&author=M.+S.+Wolfeauthor=W.+Xiaauthor=B.+L.+Ostaszewskiauthor=T.+S.+Diehlauthor=W.+T.+Kimberlyauthor=D.+J.+Selkoe&title=Two+Transmembrane+Aspartates+in+Presenilin-1+Required+for+Presenilin+Endoproteolysis+and+%CE%B3-Secretase+Activity&doi=10.1038%2F19077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity</span></div><div class="casAuthors">Wolfe, Michael S.; Xia, Weiming; Ostaszewski, Beth L.; Diehl, Thekla S.; Kimberly, W. Taylor; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Accumulation of the amyloid-β protein (Aβ) in the cerebral cortex is an early and invariant event in the pathogenesis of Alzheimer's disease.  The final step in the generation of Aβ from the β-amyloid precursor protein is an apparently intra-membranous proteolysis by the elusive γ-secretase(s).  The most common cause of familial Alzheimer's disease is mutation of the genes encoding presenilins 1 and 2, which alters γ-secretase activity to increase the prodn. of the highly amyloidogenic Aβ42 isoform.  Moreover, deletion of presenilin-1 in mice greatly reduces γ-secretase activity, indicating that presenilin-1 mediates most of this proteolytic event.  Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1, Asp 257 (in TM6) and Asp 385 (in TM7), substantially reduces Aβ prodn. and increases the amts. of the carboxy-terminal fragments of 1-amyloid precursor protein that are the substrates of γ-secretase.  We obsd. these effects in three different cell lines as well as in cell-free microsomes.  Either of the Asp → Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 → TM7 cytoplasmic loop.  In a functional presenilin-1 variant (carrying a deletion in exon 9) that is assocd. with familial Alzheimer's disease and which does not require this cleavage, the Asp 385 → Ala mutation still inhibited γ-secretase activity.  Our results indicate that the two transmembrane aspartate residues are crit. for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenilin 1 is either a unique di-aspartyl cofactor for γ-secretase or is itself γ-secretase, an auto-activated intra-membranous aspartyl protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIBUrgEzFHtbVg90H21EOLACvtfcHk0lhLBFce4XtO3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7g%253D&md5=c7b52439e0e35003e8c20242b21da860</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F19077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19077%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DKimberly%26aufirst%3DW.%2BT.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTwo%2520Transmembrane%2520Aspartates%2520in%2520Presenilin-1%2520Required%2520for%2520Presenilin%2520Endoproteolysis%2520and%2520%25CE%25B3-Secretase%2520Activity%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D513%26epage%3D517%26doi%3D10.1038%2F19077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craessaerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrijvers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span> </span><span class="NLM_article-title">A Presenilin-1-Dependent γ-Secretase-like Protease Mediates Release of Notch Intracellular Domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.1038/19083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F19083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10206645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=518-522&author=B.+De+Strooperauthor=W.+Annaertauthor=P.+Cupersauthor=P.+Saftigauthor=K.+Craessaertsauthor=J.+S.+Mummauthor=E.+H.+Schroeterauthor=V.+Schrijversauthor=M.+S.+Wolfeauthor=W.+J.+Rayauthor=A.+Goateauthor=R.+Kopan&title=A+Presenilin-1-Dependent+%CE%B3-Secretase-like+Protease+Mediates+Release+of+Notch+Intracellular+Domain&doi=10.1038%2F19083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain</span></div><div class="casAuthors">De Strooper, Bart; Annaert, Wim; Cupers, Philippe; Saftig, Paul; Craessaerts, Katleen; Mumm, Jeffrey S.; Schroeter, Eric H.; Schrijvers, Vincent; Wolfe, Michael S.; Ray, William J.; Goate, Alison; Kopan, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">398</span>
        (<span class="NLM_cas:issue">6727</span>),
    <span class="NLM_cas:pages">518-522</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Signaling through the receptor protein Notch, which is involved in crucial cell-fate decisions during development, requires ligand-induced cleavage of Notch.  This cleavage occurs within the predicted transmembrane domain, releasing the Notch intra-cellular domain (NICD), and is reminiscent of γ-secretase-mediated cleavage of β-amyloid precursor protein (APP), a crit. event in the pathogenesis of Alzheimer's disease.  A deficiency in presenilin-1 (PS1) inhibits processing of APP by γ-secretase in mammalian cells, and genetic interactions between Notch and PS1 homologs in Caenorhabditis elegans indicate that the presenilins may modulate the Notch signaling pathway.  Here we report that, in mammalian cells, PS1 deficiency also reduces the proteolytic release of NICD from a truncated Notch construct, thus identifying the specific biochem. step of the Notch signaling pathway that is affected by PS1.  Moreover, several γ-secretase inhibitors block this same step in Notch processing, indicating that related protease activities are responsible for cleavage within the predicted transmembrane domains of Notch and APP.  Thus the targeting of γ-secretase for the treatment of Alzheimer's disease may risk toxicity caused by reduced Notch signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQagjvTdUe8rVg90H21EOLACvtfcHk0lhLBFce4XtO3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFGqt7k%253D&md5=b42222d870cb32d3093addb8ccb2a5a2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F19083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F19083%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DCupers%26aufirst%3DP.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DMumm%26aufirst%3DJ.%2BS.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DSchrijvers%26aufirst%3DV.%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DKopan%26aufirst%3DR.%26atitle%3DA%2520Presenilin-1-Dependent%2520%25CE%25B3-Secretase-like%2520Protease%2520Mediates%2520Release%2520of%2520Notch%2520Intracellular%2520Domain%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D518%26epage%3D522%26doi%3D10.1038%2F19083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacmias, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piacentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaducci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Familial Alzheimer’s Disease in Kindreds with Missense Mutations in a Gene on Chromosome 1 Related to the Alzheimer’s Disease Type 3 Gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1038/376775a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F376775a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=7651536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=775-778&author=E.+I.+Rogaevauthor=R.+Sherringtonauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=Y.+Liangauthor=H.+Chiauthor=C.+Linauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=S.+Sorbiauthor=B.+Nacmiasauthor=S.+Piacentiniauthor=L.+Amaducciauthor=I.+Chumakovauthor=D.+Cohenauthor=L.+Lannfeltauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St.+George-Hyslop&title=Familial+Alzheimer%E2%80%99s+Disease+in+Kindreds+with+Missense+Mutations+in+a+Gene+on+Chromosome+1+Related+to+the+Alzheimer%E2%80%99s+Disease+Type+3+Gene&doi=10.1038%2F376775a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene</span></div><div class="casAuthors">Rogaev, E. I.; Sherrington, R.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Liang, Y.; Chi, H.; Lin, C.; Holman, K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6543</span>),
    <span class="NLM_cas:pages">775-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">We report the cloning of a novel gene (E5-1) encoded on chromosome 1 which has substantial nucleotide and amino-acid sequence similarity to the S182 gene on chromosome 14q24.3.  Mutations, including three new missense mutations in the S182 gene, are assocd. with the AD3 subtype of early-onset familial Alzheimer's disease (AD).  Both the E5-1 and the S182 proteins are predicted to be integral membrane proteins with seven-membrane-spanning domains, and a large exposed loop between the sixth and seventh transmembrane domains.  Anal. of the nucleotide sequence of the open reading frame (ORF) of the E5-1 gene led to the discovery of two missense substitutions at conserved amino-acid residues in affected members of pedigrees with a form of familial AD that has a later age of onset than the AD3 subtype (50-70 yr vs. 30-60 yr for AD3).  These observations imply that the E5-1 gene on chromosome 1 and the S182 gene on chromosome 14q24.3 are members of a family of genes (presenilins) with related functions, and indicates that mutations in conserved residues of E5-1 could also play a role in the genesis of AD.  The authors results also indicate that still other AD susceptibility genes exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopES5CZyuo6LVg90H21EOLACvtfcHk0lhLBFce4XtO3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFChsL4%253D&md5=8566f773f8d12ab5339a9fb16cb8dfd5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F376775a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376775a0%26sid%3Dliteratum%253Aachs%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DPiacentini%26aufirst%3DS.%26aulast%3DAmaducci%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DFamilial%2520Alzheimer%25E2%2580%2599s%2520Disease%2520in%2520Kindreds%2520with%2520Missense%2520Mutations%2520in%2520a%2520Gene%2520on%2520Chromosome%25201%2520Related%2520to%2520the%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Type%25203%2520Gene%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D775%26epage%3D778%26doi%3D10.1038%2F376775a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sherrington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaev, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foncin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruni, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinessi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumakov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanseau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinsky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasco, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da, S. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haines, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkicak-Vance, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George-Hyslop, P. H.</span><span> </span><span class="NLM_article-title">Cloning of a Gene Bearing Missense Mutations in Early-Onset Familial Alzheimer’s Disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x"> (</span><span class="NLM_issue">6534</span><span class="NLM_x">) </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span><span class="refDoi"> DOI: 10.1038/375754a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F375754a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=7596406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=1995&pages=754-760&issue=6534&author=R.+Sherringtonauthor=E.+I.+Rogaevauthor=Y.+Liangauthor=E.+A.+Rogaevaauthor=G.+Levesqueauthor=M.+Ikedaauthor=H.+Chiauthor=C.+Linauthor=G.+Liauthor=K.+Holmanauthor=T.+Tsudaauthor=L.+Marauthor=J.+F.+Foncinauthor=A.+C.+Bruniauthor=M.+P.+Montesiauthor=S.+Sorbiauthor=I.+Raineroauthor=L.+Pinessiauthor=L.+Neeauthor=I.+Chumakovauthor=D.+Pollenauthor=A.+Brookesauthor=P.+Sanseauauthor=R.+J.+Polinskyauthor=W.+Wascoauthor=S.+H.+A.+Daauthor=J.+L.+Hainesauthor=M.+A.+Perkicak-Vanceauthor=R.+E.+Tanziauthor=A.+D.+Rosesauthor=P.+E.+Fraserauthor=J.+M.+Rommensauthor=P.+H.+St.+George-Hyslop&title=Cloning+of+a+Gene+Bearing+Missense+Mutations+in+Early-Onset+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1038%2F375754a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease</span></div><div class="casAuthors">Sherrington, R.; Rogaev, E. I.; Liang, Y.; Rogaeva, E. A.; Levesque, G.; Ikeda, M.; Chi, H.; Lin, C.; Li, G.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">6534</span>),
    <span class="NLM_cas:pages">754-60</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Some cases of Alzheimer's disease are inherited as an autosomal dominant trait.  Genetic linkage studies have mapped a locus (AD3) assocd. with susceptibility to a very aggressive form of Alzheimer's disease to chromosome 14q24.3.  The authors have defined a minimal cosegregating region contg. the AD3 gene, and isolated at least 19 different transcripts encoded within this region.  One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein.  Five different missense mutations have been found that cosegregate with early-onset familial Alzheimer's disease.  Because these changes occurred in conserved domains of the gene, and are not present in normal controls, they are likely to be causative of AD3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49ubD8AKFQ7Vg90H21EOLACvtfcHk0ljGZYlj2Mz5hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVymtbo%253D&md5=c68c5ca80245a13604d3710cb5e3ab28</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F375754a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F375754a0%26sid%3Dliteratum%253Aachs%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DRogaev%26aufirst%3DE.%2BI.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DRogaeva%26aufirst%3DE.%2BA.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHolman%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DT.%26aulast%3DMar%26aufirst%3DL.%26aulast%3DFoncin%26aufirst%3DJ.%2BF.%26aulast%3DBruni%26aufirst%3DA.%2BC.%26aulast%3DMontesi%26aufirst%3DM.%2BP.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DRainero%26aufirst%3DI.%26aulast%3DPinessi%26aufirst%3DL.%26aulast%3DNee%26aufirst%3DL.%26aulast%3DChumakov%26aufirst%3DI.%26aulast%3DPollen%26aufirst%3DD.%26aulast%3DBrookes%26aufirst%3DA.%26aulast%3DSanseau%26aufirst%3DP.%26aulast%3DPolinsky%26aufirst%3DR.%2BJ.%26aulast%3DWasco%26aufirst%3DW.%26aulast%3DDa%26aufirst%3DS.%2BH.%2BA.%26aulast%3DHaines%26aufirst%3DJ.%2BL.%26aulast%3DPerkicak-Vance%26aufirst%3DM.%2BA.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26atitle%3DCloning%2520of%2520a%2520Gene%2520Bearing%2520Missense%2520Mutations%2520in%2520Early-Onset%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNature%26date%3D1995%26volume%3D375%26issue%3D6534%26spage%3D754%26epage%3D760%26doi%3D10.1038%2F375754a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Decreased Aβ Secretion by Cells Expressing Familial Alzheimer’s Disease-Linked Mutant Presenilin 1</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1016/j.neures.2006.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.neures.2006.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=17210196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFOisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2007&pages=446-453&author=M.+Shimojoauthor=N.+Saharaauthor=M.+Murayamaauthor=H.+Ichinoseauthor=A.+Takashima&title=Decreased+A%CE%B2+Secretion+by+Cells+Expressing+Familial+Alzheimer%E2%80%99s+Disease-Linked+Mutant+Presenilin+1&doi=10.1016%2Fj.neures.2006.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased Aβ secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1</span></div><div class="casAuthors">Shimojo, Masafumi; Sahara, Naruhiko; Murayama, Miyuki; Ichinose, Hiroshi; Takashima, Akihiko</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">446-453</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Presenilin (PS) is a catalytic subunit of the γ-secretase complex that cleaves the intramembranous region of amyloid precursor protein (APP), producing amyloid β (Aβ) peptide.  Familial Alzheimer's disease (FAD) results from PS mutations, which may alter γ-secretase activity to enhance the prodn. of highly aggregable Aβ42.  The precise pathogenic effects of mutant PS remain unclear.  To exclude the effects of endogenous PS, we established cell lines from PS1/PS2-deficient (PS-/-) fibroblasts capable of stably expressing either wild-type (wt) PS1 or different mutant PS1s.  Although both wt PS1 and mutant PS1 formed γ-secretase complexes of the same size and contg. the same components, the amt. of Aβ secreted by FAD mutant PS1-expressing cells was significantly reduced.  The ratio of Aβ42 to Aβ40 (Aβ42/Aβ40) secreted by these cells, however, was significantly higher than that secreted by cells expressing wt PS1, which corroborated findings from a previous report.  The elevated Aβ42/Aβ40 ratio obsd. with mutant PS1-expressing cells may be due to reduced Aβ40 prodn. not increased Aβ42 prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroytSkAe6RD7Vg90H21EOLACvtfcHk0ljGZYlj2Mz5hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFOisrw%253D&md5=f255b1ebf67d719d3ef73e46c6d4f4db</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2006.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2006.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DMurayama%26aufirst%3DM.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DDecreased%2520A%25CE%25B2%2520Secretion%2520by%2520Cells%2520Expressing%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease-Linked%2520Mutant%2520Presenilin%25201%26jtitle%3DNeurosci.%2520Res.%26date%3D2007%26volume%3D57%26spage%3D446%26epage%3D453%26doi%3D10.1016%2Fj.neures.2006.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Shimojo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizoroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima-Kawashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichinose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span> </span><span class="NLM_article-title">Enzymatic Characteristics of I213T Mutant Presenilin-1/ γ-Secretase in Cell Models and Knock-in Mouse Brains: Familial Alzheimer Disease-Linked Mutation Imapris γ-Site Cleavage of Amyloid Precursor Protein C-Terminal Fragmant B</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">16488</span><span class="NLM_x">–</span> <span class="NLM_lpage">16496</span><span class="refDoi"> DOI: 10.1074/jbc.M801279200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1074%2Fjbc.M801279200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=16488-16496&author=M.+Shimojoauthor=N.+Saharaauthor=T.+Mizorokiauthor=S.+Funamotoauthor=M.+Morishima-Kawashimaauthor=T.+Kudoauthor=M.+Takedaauthor=Y.+Iharaauthor=H.+Ichinoseauthor=A.+Takashima&title=Enzymatic+Characteristics+of+I213T+Mutant+Presenilin-1%2F+%CE%B3-Secretase+in+Cell+Models+and+Knock-in+Mouse+Brains%3A+Familial+Alzheimer+Disease-Linked+Mutation+Imapris+%CE%B3-Site+Cleavage+of+Amyloid+Precursor+Protein+C-Terminal+Fragmant+B&doi=10.1074%2Fjbc.M801279200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801279200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801279200%26sid%3Dliteratum%253Aachs%26aulast%3DShimojo%26aufirst%3DM.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DMizoroki%26aufirst%3DT.%26aulast%3DFunamoto%26aufirst%3DS.%26aulast%3DMorishima-Kawashima%26aufirst%3DM.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DIchinose%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DA.%26atitle%3DEnzymatic%2520Characteristics%2520of%2520I213T%2520Mutant%2520Presenilin-1%252F%2520%25CE%25B3-Secretase%2520in%2520Cell%2520Models%2520and%2520Knock-in%2520Mouse%2520Brains%253A%2520Familial%2520Alzheimer%2520Disease-Linked%2520Mutation%2520Imapris%2520%25CE%25B3-Site%2520Cleavage%2520of%2520Amyloid%2520Precursor%2520Protein%2520C-Terminal%2520Fragmant%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D16488%26epage%3D16496%26doi%3D10.1074%2Fjbc.M801279200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bammens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersteen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cleynenbreugel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esselmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schymkowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broersen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The Mechanism of γ-Secretase Dysfunction in Familial Alzheimer Disease</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2274</span><span class="refDoi"> DOI: 10.1038/emboj.2012.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2Femboj.2012.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2261-2274&author=L.+Chavez-Gutierrezauthor=L.+Bammensauthor=I.+Benilovaauthor=A.+Vandersteenauthor=M.+Benurwarauthor=M.+Borgersauthor=S.+Lismontauthor=L.+Zhouauthor=S.+Van+Cleynenbreugelauthor=H.+Esselmannauthor=J.+Wiltfangauthor=L.+Serneelsauthor=E.+Karranauthor=H.+Gijsenauthor=J.+Schymkowitzauthor=F.+Rousseauauthor=K.+Broersenauthor=B.+De+Strooper&title=The+Mechanism+of+%CE%B3-Secretase+Dysfunction+in+Familial+Alzheimer+Disease&doi=10.1038%2Femboj.2012.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.79%26sid%3Dliteratum%253Aachs%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26aulast%3DBammens%26aufirst%3DL.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DVandersteen%26aufirst%3DA.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVan%2BCleynenbreugel%26aufirst%3DS.%26aulast%3DEsselmann%26aufirst%3DH.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DSchymkowitz%26aufirst%3DJ.%26aulast%3DRousseau%26aufirst%3DF.%26aulast%3DBroersen%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520Mechanism%2520of%2520%25CE%25B3-Secretase%2520Dysfunction%2520in%2520Familial%2520Alzheimer%2520Disease%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D2261%26epage%3D2274%26doi%3D10.1038%2Femboj.2012.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span> </span><span class="NLM_article-title">γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.celrep.2012.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=23291095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=42-51&author=M.+Okochiauthor=S.+Tagamiauthor=K.+Yanagidaauthor=M.+Takamiauthor=T.+S.+Kodamaauthor=K.+Moriauthor=T.+Nakayamaauthor=Y.+Iharaauthor=M.+Takeda&title=%CE%B3-Secretase+Modulators+and+Presenilin+1+Mutants+Act+Differently+on+Presenilin%2F%CE%B3-Secretase+Function+to+Cleave+A%CE%B242+and+A%CE%B243&doi=10.1016%2Fj.celrep.2012.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43</span></div><div class="casAuthors">Okochi, Masayasu; Tagami, Shinji; Yanagida, Kanta; Takami, Mako; Kodama, Takashi S.; Mori, Kohji; Nakayama, Taisuke; Ihara, Yasuo; Takeda, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deciphering the mechanism by which the relative Aβ42(43) to total Aβ ratio is regulated is central to understanding Alzheimer disease (AD) etiol.; however, the mechanisms underlying changes in the Aβ42(43) ratio caused by familial mutations and γ-secretase modulators (GSMs) are unclear.  Here, we show in vitro and in living cells that presenilin (PS)/γ-secretase cleaves Aβ42 into Aβ38, and Aβ43 into Aβ40 or Aβ38.  Approx. 40% of Aβ38 is derived from Aβ43.  Aβ42(43) cleavage is involved in the regulation of the Aβ42(43) ratio in living cells.  GSMs increase the cleavage of PS/γ-secretase-bound Aβ42 (increase kcat) and slow its dissocn. from the enzyme (decrease kb), whereas PS1 mutants and inverse GSMs show the opposite effects.  Therefore, we suggest a concept to describe the Aβ42(43) prodn. process and propose how GSMs act, and we suggest that a loss of PS/γ-secretase function to cleave Aβ42(43) may initiate AD and might represent a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJEYS_49n8hbVg90H21EOLACvtfcHk0liljQgqS7zV6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSrsLo%253D&md5=ca7695ce5fd0d6506b27ec00cd3a4918</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DTagami%26aufirst%3DS.%26aulast%3DYanagida%26aufirst%3DK.%26aulast%3DTakami%26aufirst%3DM.%26aulast%3DKodama%26aufirst%3DT.%2BS.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3D%25CE%25B3-Secretase%2520Modulators%2520and%2520Presenilin%25201%2520Mutants%2520Act%2520Differently%2520on%2520Presenilin%252F%25CE%25B3-Secretase%2520Function%2520to%2520Cleave%2520A%25CE%25B242%2520and%2520A%25CE%25B243%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D42%26epage%3D51%26doi%3D10.1016%2Fj.celrep.2012.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kretner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutsmiedl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luebbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-Generation Compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">15240</span><span class="NLM_x">–</span> <span class="NLM_lpage">15251</span><span class="refDoi"> DOI: 10.1074/jbc.M110.213587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1074%2Fjbc.M110.213587" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=15240-15251&author=B.+Kretnerauthor=A.+Fukumoriauthor=A.+Gutsmiedlauthor=R.+M.+Pageauthor=T.+Luebbersauthor=G.+Galleyauthor=K.+Baumannauthor=C.+Haassauthor=H.+Steiner&title=Attenuated+A%CE%B242+Responses+to+Low+Potency+%CE%B3-Secretase+Modulators+Can+Be+Overcome+for+Many+Pathogenic+Presenilin+Mutants+by+Second-Generation+Compounds&doi=10.1074%2Fjbc.M110.213587"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.213587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.213587%26sid%3Dliteratum%253Aachs%26aulast%3DKretner%26aufirst%3DB.%26aulast%3DFukumori%26aufirst%3DA.%26aulast%3DGutsmiedl%26aufirst%3DA.%26aulast%3DPage%26aufirst%3DR.%2BM.%26aulast%3DLuebbers%26aufirst%3DT.%26aulast%3DGalley%26aufirst%3DG.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DAttenuated%2520A%25CE%25B242%2520Responses%2520to%2520Low%2520Potency%2520%25CE%25B3-Secretase%2520Modulators%2520Can%2520Be%2520Overcome%2520for%2520Many%2520Pathogenic%2520Presenilin%2520Mutants%2520by%2520Second-Generation%2520Compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D15240%26epage%3D15251%26doi%3D10.1074%2Fjbc.M110.213587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Szaruga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veugelen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benurwar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lismont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepulveda-Falla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez-Gutierrez, L.</span><span> </span><span class="NLM_article-title">Qualitative Changes in Human γ-Secretase Underlie Familial Alzheimer’s Disease</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2013</span><span class="refDoi"> DOI: 10.1084/jem.20150892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1084%2Fjem.20150892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=2003-2013&author=M.+Szarugaauthor=S.+Veugelenauthor=M.+Benurwarauthor=S.+Lismontauthor=D.+Sepulveda-Fallaauthor=A.+Lleoauthor=N.+S.+Ryanauthor=T.+Lashleyauthor=N.+C.+Foxauthor=S.+Murayamaauthor=H.+Gijsenauthor=B.+De+Strooperauthor=L.+Chavez-Gutierrez&title=Qualitative+Changes+in+Human+%CE%B3-Secretase+Underlie+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1084%2Fjem.20150892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150892%26sid%3Dliteratum%253Aachs%26aulast%3DSzaruga%26aufirst%3DM.%26aulast%3DVeugelen%26aufirst%3DS.%26aulast%3DBenurwar%26aufirst%3DM.%26aulast%3DLismont%26aufirst%3DS.%26aulast%3DSepulveda-Falla%26aufirst%3DD.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DN.%2BS.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DChavez-Gutierrez%26aufirst%3DL.%26atitle%3DQualitative%2520Changes%2520in%2520Human%2520%25CE%25B3-Secretase%2520Underlie%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26spage%3D2003%26epage%3D2013%26doi%3D10.1084%2Fjem.20150892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. a</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterling, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A Subset of NSAIDs Lower Amyloidogenic Abeta42 Independently of Cyclooxygenase Activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1038/35102591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1038%2F35102591" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+L.+Eriksenauthor=P.+Dasauthor=S.+a+Sagiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+a+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+Subset+of+NSAIDs+Lower+Amyloidogenic+Abeta42+Independently+of+Cyclooxygenase+Activity&doi=10.1038%2F35102591"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSagi%26aufirst%3DS.%2Ba%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2Ba%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterling%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520Subset%2520of%2520NSAIDs%2520Lower%2520Amyloidogenic%2520Abeta42%2520Independently%2520of%2520Cyclooxygenase%2520Activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216%26doi%3D10.1038%2F35102591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-Secretase Modulators: A Review of Patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1517/13543776.2011.547479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-Secretase+Modulators%3A+A+Review+of+Patents+from+2008+to+2010&doi=10.1517%2F13543776.2011.547479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0ljinfTyIYT4gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-Secretase%2520Modulators%253A%2520A%2520Review%2520of%2520Patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226%26doi%3D10.1517%2F13543776.2011.547479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-Secretase Modulators for the Treatment of Alzheimer’s Disease: A Review Focusing on Patents from 2010 to 2012</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span><span class="refDoi"> DOI: 10.1517/13543776.2013.821465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1517%2F13543776.2013.821465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=23875696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1349-1366&author=M.+Petterssonauthor=A.+F.+Stepanauthor=G.+W.+Kauffmanauthor=D.+S.+Johnson&title=Novel+%CE%B3-Secretase+Modulators+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+A+Review+Focusing+on+Patents+from+2010+to+2012&doi=10.1517%2F13543776.2013.821465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012</span></div><div class="casAuthors">Pettersson, Martin; Stepan, Antonia F.; Kauffman, Gregory W.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: γ-Secretase is the enzyme responsible for the final step of amyloid precursor protein proteolysis to generate Aβ peptides including Aβ42 which is believed to be a toxic species involved in Alzheimer's disease (AD) progression. γ-Secretase modulators (GSMs) have been shown to selectively lower Aβ42 prodn. without affecting total Aβ levels or the formation of γ-secretase substrate intracellular domains such as APP intracellular domain and Notch intracellular domain.  Therefore, GSMs have emerged as an important therapeutic strategy for the treatment of AD.  Areas covered: The literature covering novel GSMs will be reviewed focusing on patents from 2010 to 2012.  Expert opinion: During the last review period (2008 - 2010) considerable progress was made developing GSMs with improved potency for lowering Aβ42 levels, but most of the compds. resided in unfavorable central nervous system (CNS) drug space.  In this review period (2010 - 2012), there is a higher percentage of potent GSM chem. matter that resides in favorable CNS drug space.  It is anticipated that clin. candidates will emerge out of this cohort that will be able to test the GSM mechanism of action in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFLi5hAAdKc7Vg90H21EOLACvtfcHk0ljinfTyIYT4gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fP&md5=6b43a8feb210fa87ded92a26397b754f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-Secretase%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Review%2520Focusing%2520on%2520Patents%2520from%25202010%2520to%25202012%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1349%26epage%3D1366%26doi%3D10.1517%2F13543776.2013.821465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span> </span><span class="NLM_article-title">γ-Secretase Modulators: Can We Combine Potency with Safety?</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">295207</span><span class="refDoi"> DOI: 10.1155/2012/295207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1155%2F2012%2F295207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=23365783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=295207&author=H.+J.+M.+Gijsenauthor=M.+Mercken&title=%CE%B3-Secretase+Modulators%3A+Can+We+Combine+Potency+with+Safety%3F&doi=10.1155%2F2012%2F295207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators: Can We Combine Potency with Safety?</span></div><div class="casAuthors">Gijsen Harrie J M; Mercken Marc</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">γ-Secretase modulation has been proposed as a potential disease modifying anti-Alzheimer's approach.  γ-Secretase modulators (GSMs) cause a product shift from the longer amyloid-beta (Aβ) peptide isoforms to shorter, more soluble, and less amyloidogenic isoforms, without inhibiting APP or Notch proteolytic processing.  As such, modulating γ-secretase may avoid some of the adverse effects observed with γ-secretase inhibitors.  Since the termination of the GSM tarenfurbil in 2008 due to negative phase III trial results, a considerable progress has been made towards more potent and better brain penetrable compounds.  However, an analysis of their lipophilic efficiency indices indicates that their increased potency can be largely attributed to their increased lipophilicity.  The need for early and chronic dosing with GSMs will require high-safety margins.  This will be a challenge to achieve with the current, highly lipophilic GSMs.  We will demonstrate that by focusing on the drug-like properties of GSMs, a combination of high in vitro potency and reduced lipophilicity can be achieved and does result in better tolerated compounds.  The next hurdle will be to translate this knowledge into GSMs which are highly efficacious and safe in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoRn2xTT3rypZoeNcnHOQ9fW6udTcc2ebftR9IzYRWCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szktVahtg%253D%253D&md5=f3c1425fa7619625bb4dc56ee2b5f5fb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1155%2F2012%2F295207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F295207%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3D%25CE%25B3-Secretase%2520Modulators%253A%2520Can%2520We%2520Combine%2520Potency%2520with%2520Safety%253F%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D295207%26doi%3D10.1155%2F2012%2F295207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blain, J.-F.</span><span> </span><span class="NLM_article-title">Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7389</span><span class="NLM_x">–</span> <span class="NLM_lpage">7409</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01960</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01960" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7389-7409&author=M.+G.+Bursavichauthor=B.+A.+Harrisonauthor=J.-F.+Blain&title=Gamma+Secretase+Modulators%3A+New+Alzheimer%E2%80%99s+Drugs+on+the+Horizon%3F&doi=10.1021%2Facs.jmedchem.5b01960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?</span></div><div class="casAuthors">Bursavich, Matthew G.; Harrison, Bryce A.; Blain, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7389-7409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The rapidly aging population desperately requires new therapies for Alzheimer's disease.  Despite years of pharmaceutical research, limited clin. success has been realized, with several failed disease modification therapies in recent years.  On the basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brain beta amyloid (Aβ) either through its removal via antibodies or by targeting the proteases responsible for its prodn.  In this Perspective, we focus on the development of small mols. that improve the activity of one such protease, gamma secretase, through an allosteric binding site to preferentially increase the concn. of the shorter non-amyloidogenic Aβ species.  After a few early failures due to poor drug-like properties, the industry is now on the cusp of delivering gamma secretase modulators for clin. proof-of-mechanism studies that combine potency and efficacy with improved drug-like properties such as lower cLogP, high central nervous system multiparameter optimization scores, and high sp3 character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEjGJ5oHdrrVg90H21EOLACvtfcHk0ljLGXvQt64kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVajsbk%253D&md5=8ba1b7de2ce64903c296b7cb63c1c5d3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DBlain%26aufirst%3DJ.-F.%26atitle%3DGamma%2520Secretase%2520Modulators%253A%2520New%2520Alzheimer%25E2%2580%2599s%2520Drugs%2520on%2520the%2520Horizon%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7389%26epage%3D7409%26doi%3D10.1021%2Facs.jmedchem.5b01960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljLGXvQt64kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+to+Enable+Alignment+of+Druglike+Properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljLGXvQt64kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagawa, T.</span><span> </span><span class="NLM_article-title">E2012: A novel gamma-secretase modulator-pharmacology part</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S242</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.jalz.2010.05.787" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S242&author=T.+Hashimotoauthor=A.+Ishibashiauthor=H.+Hagiwaraauthor=Y.+Murataauthor=O.+Takenakaauthor=T.+Miyagawa&title=E2012%3A+A+novel+gamma-secretase+modulator-pharmacology+part&doi=10.1016%2Fj.jalz.2010.05.787"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.787%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DMiyagawa%26aufirst%3DT.%26atitle%3DE2012%253A%2520A%2520novel%2520gamma-secretase%2520modulator-pharmacology%2520part%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS242%26doi%3D10.1016%2Fj.jalz.2010.05.787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nagy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rege, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logovinsky, V.</span><span> </span><span class="NLM_article-title">E2012, a Novel Gamma-Secretase Modulator, Decreases Plasma Amyloid-Beta Levels in Humans</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S574</span><span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.jalz.2010.05.1958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S574&author=C.+Nagyauthor=E.+Schuckauthor=A.+Ishibashiauthor=Y.+Nakataniauthor=B.+Regeauthor=V.+Logovinsky&title=E2012%2C+a+Novel+Gamma-Secretase+Modulator%2C+Decreases+Plasma+Amyloid-Beta+Levels+in+Humans&doi=10.1016%2Fj.jalz.2010.05.1958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1958%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DC.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DNakatani%26aufirst%3DY.%26aulast%3DRege%26aufirst%3DB.%26aulast%3DLogovinsky%26aufirst%3DV.%26atitle%3DE2012%252C%2520a%2520Novel%2520Gamma-Secretase%2520Modulator%252C%2520Decreases%2520Plasma%2520Amyloid-Beta%2520Levels%2520in%2520Humans%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS574%26doi%3D10.1016%2Fj.jalz.2010.05.1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Henderson, R. F.</span><span> </span><span class="NLM_article-title">Species Differences in the Metabolism of Olefins. Implications for Risk Assessment</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">135–136</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0009-2797(01)00170-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2FS0009-2797%2801%2900170-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=11397381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135%E2%80%93136&publication_year=2001&pages=53-64&author=R.+F.+Henderson&title=Species+Differences+in+the+Metabolism+of+Olefins.+Implications+for+Risk+Assessment&doi=10.1016%2FS0009-2797%2801%2900170-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Species differences in the metabolism of olefins. Implications for risk assessment</span></div><div class="casAuthors">Henderson, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">135-136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-64</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 22 refs.  Olefinic compds. are com. valuable because they form useful polymeric substances.  The same chem. property (presence of double bonds) that makes the olefins useful may also cause them to be toxic in the body.  The double bonds of olefins can be oxidized by cytochrome P 450 enzymes to epoxides, which are electrophiles that can react with DNA and may cause alterations in the genetic information carried by that macromol.  Epoxides can be rendered inactive toward DNA by binding to proteins, by hydrolysis to diols through epoxide hydrolase enzymes (EHs), or by forming conjugates with glutathione via glutathione S-transferase (GST) activities.  The balance between the oxidizing enzymic activities and the hydrolyzing or conjugating enzymic activities in the livers of different species can influence the potential toxicity of the olefins.  The location of the enzymes and the potential for concerted reactions in which epoxides are inactivated immediately after formation will also influence the potential toxicity of the olefins.  Cytochrome P 450 enzymes and EHs are in microsomes located in the rough endoplasmic reticulum surrounding the nucleus where the DNA is located.  GST is in the cytoplasm of the cell.  In the case of 1,3-butadiene (BD), such enzymic differences may strongly influence the toxicity in different species.  The mouse, in which BD is a potent multi-site carcinogen, has the lowest microsomal EH activity of any species.  This allows the monoepoxides formed in the microsomes by cytochrome P 450 enzymes to be further oxidized to the highly genotoxic diepoxide (DEB), and both epoxides can either be released into the blood for distribution throughout the body or can react with DNA in the nucleus.  The rat, in which BD is a weak carcinogen, has much higher levels of microsomal EH, and only trace amts. of DEB enter the bloodstream.  Major BD metabolites in primates suggest that the hydrolysis pathway is even more prominent in primates than in rats.  Data suggest that BD will be much less toxic in primates than in mice.  Considering these quant. differences in metab. may help to reduce the uncertainties in extrapolating animal data on olefin toxicity to health risk assessments for humans exposed to the compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQf50n60n2iLVg90H21EOLACvtfcHk0ljnZc3ei6VODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktV2ltb0%253D&md5=050db0848b3020f59c9d58f5774db520</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2801%2900170-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252801%252900170-3%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DR.%2BF.%26atitle%3DSpecies%2520Differences%2520in%2520the%2520Metabolism%2520of%2520Olefins.%2520Implications%2520for%2520Risk%2520Assessment%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2001%26volume%3D135%25E2%2580%2593136%26spage%3D53%26epage%3D64%26doi%3D10.1016%2FS0009-2797%2801%2900170-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navaratnam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Dihydrobenzofuran Amides as Orally Bioavailable, Centrally Active γ-Secretase Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2906</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+Synthesis+of+Dihydrobenzofuran+Amides+as+Orally+Bioavailable%2C+Centrally+Active+%CE%B3-Secretase+Modulators&doi=10.1016%2Fj.bmcl.2012.02.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0ljnZc3ei6VODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Dihydrobenzofuran%2520Amides%2520as%2520Orally%2520Bioavailable%252C%2520Centrally%2520Active%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911%26doi%3D10.1016%2Fj.bmcl.2012.02.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaroskova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Bicyclic Heterocycles as Potent γ-Secretase Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">–</span> <span class="NLM_lpage">4800</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2013.06.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4794-4800&author=D.+Oehlrichauthor=F.+J.+R.+Romboutsauthor=D.+Berthelotauthor=F.+P.+Bischoffauthor=M.+A.+J.+De+Cleynauthor=L.+Jaroskovaauthor=G.+Macdonaldauthor=M.+Merckenauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=A.+I.+Velterauthor=T.+Wuauthor=H.+J.+M.+Gijsen&title=Design+and+Synthesis+of+Bicyclic+Heterocycles+as+Potent+%CE%B3-Secretase+Modulators&doi=10.1016%2Fj.bmcl.2013.06.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.100%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DBischoff%26aufirst%3DF.%2BP.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DJaroskova%26aufirst%3DL.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Bicyclic%2520Heterocycles%2520as%2520Potent%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4794%26epage%3D4800%26doi%3D10.1016%2Fj.bmcl.2013.06.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ncube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Morin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumfelt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegley, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koegler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">Discovery of 2-Methylpyridine-Based Biaryl Amides as γ-Secretase Modulators for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6454</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2013.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=24139583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6447-6454&author=J.+J.+Chenauthor=W.+Qianauthor=K.+Biswasauthor=C.+Yuanauthor=A.+Amegadzieauthor=Q.+Liuauthor=T.+Nixeyauthor=J.+Zhuauthor=M.+Ncubeauthor=R.+M.+Rzasaauthor=F.+Chavezauthor=N.+Chenauthor=F.+De+Morinauthor=S.+Rumfeltauthor=C.+M.+Tegleyauthor=J.+R.+Allenauthor=S.+Hitchcockauthor=R.+Hungateauthor=M.+D.+Bartbergerauthor=L.+Zalamedaauthor=Y.+Liuauthor=J.+D.+McCarterauthor=J.+Zhangauthor=L.+Zhuauthor=S.+Babu-Khanauthor=Y.+Luoauthor=J.+Bradleyauthor=P.+H.+Wenauthor=D.+L.+Reidauthor=F.+Koeglerauthor=C.+Deanauthor=D.+Hickmanauthor=T.+L.+Correllauthor=T.+Williamsonauthor=S.+Wood&title=Discovery+of+2-Methylpyridine-Based+Biaryl+Amides+as+%CE%B3-Secretase+Modulators+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.bmcl.2013.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Chen, Jian Jeffrey; Qian, Wenyuan; Biswas, Kaustav; Yuan, Chester; Amegadzie, Albert; Liu, Qingyian; Nixey, Thomas; Zhu, Joe; Ncube, Mqhele; Rzasa, Robert M.; Chavez, Frank, Jr.; Chen, Ning; De Morin, Frenel; Rumfelt, Shannon; Tegley, Christopher M.; Allen, Jennifer R.; Hitchcock, Stephen; Hungate, Randy; Bartberger, Michael D.; Zalameda, Leeanne; Liu, Yichin; McCarter, John D.; Zhang, Jianhua; Zhu, Li; Babu-Khan, Safura; Luo, Yi; Bradley, Jodi; Wen, Paul H.; Reid, Darren L.; Koegler, Frank; Dean, Charles, Jr.; Hickman, Dean; Correll, Tiffany L.; Williamson, Toni; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6447-6454</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">γ-Secretase modulators (GSMs) are potentially disease-modifying treatments for Alzheimer's disease.  They selectively lower pathogenic Aβ42 levels by shifting the enzyme cleavage sites without inhibiting γ-secretase activity, possibly avoiding known adverse effects obsd. with complete inhibition of the enzyme complex.  A cell-based HTS effort identified the sulfonamide 1 as a GSM lead.  Lead optimization studies identified compd. 25 with improved cell potency, PKDM properties, and it lowered Aβ42 levels in the cerebrospinal fluid (CSF) of Sprague-Dawley rats following oral administration.  Further optimization of 25 to improve cellular potency is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfacRASb057Vg90H21EOLACvtfcHk0liLx4lqxQSeuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Grsb3F&md5=6282bfb2fc57efab5a32c15872e474b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DBiswas%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DNcube%26aufirst%3DM.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DChavez%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDe%2BMorin%26aufirst%3DF.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DReid%26aufirst%3DD.%2BL.%26aulast%3DKoegler%26aufirst%3DF.%26aulast%3DDean%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25202-Methylpyridine-Based%2520Biaryl%2520Amides%2520as%2520%25CE%25B3-Secretase%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6447%26epage%3D6454%26doi%3D10.1016%2Fj.bmcl.2013.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teranishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishihara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, M.</span><span> </span><span class="NLM_article-title">Design and Synthesis of an Aminopiperidine Series of γ-Secretase Modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1016%2Fj.bmcl.2013.10.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=378-381&author=T.+Kobayashiauthor=S.+Iwamaauthor=A.+Fusanoauthor=Y.+Katoauthor=A.+Ikedaauthor=Y.+Teranishiauthor=A.+Nishiharaauthor=M.+Tobe&title=Design+and+Synthesis+of+an+Aminopiperidine+Series+of+%CE%B3-Secretase+Modulators&doi=10.1016%2Fj.bmcl.2013.10.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.063%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DFusano%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DA.%26aulast%3DTeranishi%26aufirst%3DY.%26aulast%3DNishihara%26aufirst%3DA.%26aulast%3DTobe%26aufirst%3DM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520an%2520Aminopiperidine%2520Series%2520of%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D378%26epage%3D381%26doi%3D10.1016%2Fj.bmcl.2013.10.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">JChem Cartridge was used for structure based property calculation and reporting from Oracle</p></div>. JChem 5.9.0; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=JChem+Cartridge+was+used+for+structure+based+property+calculation+and+reporting+from+Oracle.+JChem+5.9.0%3B+ChemAxon%3A+Budapest%2C+2012%3B+http%3A%2F%2Fwww.chemaxon.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJChem%25205.9.0%26pub%3DChemAxon%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mccracken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ -Secretase Modulators in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/jm201407j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502&author=Z.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+Maccossauthor=M.+B.+Mandalauthor=T.+Mccrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+Hydroxyamidines+as+Amide+Isosteres%3A+Discovery+of+Oxadiazolines+and+Oxadiazines+as+Potent+and+Highly+Efficacious+%CE%B3+-Secretase+Modulators+in+Vivo&doi=10.1021%2Fjm201407j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaccoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMccracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520Hydroxyamidines%2520as%2520Amide%2520Isosteres%253A%2520Discovery%2520of%2520Oxadiazolines%2520and%2520Oxadiazines%2520as%2520Potent%2520and%2520Highly%2520Efficacious%2520%25CE%25B3%2520-Secretase%2520Modulators%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502%26doi%3D10.1021%2Fjm201407j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicarel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCraken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1021/ml300209g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300209g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=931-935&author=X.+Huangauthor=W.+Zhouauthor=X.+Liuauthor=H.+Liauthor=G.+Sunauthor=M.+Mandalauthor=M.+Vicarelauthor=X.+Zhuauthor=C.+Bennettauthor=T.+McCrakenauthor=D.+Pissarnitskiauthor=Z.+Zhaoauthor=D.+Coleauthor=G.+Galloauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=D.+Burnettauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=A.+Buevich&title=Synthesis+and+SAR+Studies+of+Fused+Oxadiazines+as+%CE%B3-Secretase+Modulators+for+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fml300209g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Huang, Xianhai; Zhou, Wei; Liu, Xiaoxiang; Li, Hongmei; Sun, George; Mandal, Mihirbaran; Vicarel, Monica; Zhu, Xiaohong; Bennett, Chad; McCraken, Troy; Pissarnitski, Dmitri; Zhao, Zhiqiang; Cole, David; Gallo, Gioconda; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Burnett, Duane; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Buevich, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-935</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fused oxadiazines such as imidazolylbenzylidene pyridooxadiazines I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) and imidazolylbenzylidene oxazinooxadiazines I (R = F; R1 = H, F; R2 = Me; X = O) were prepd. as selective and orally bioavailable γ-secretase modulators (GSMs) derived by analogy from pyridooxadiazoline GSMs.  The effect of structural modifications on pyridooxadiazoline GSMs differed significantly from the effects of modifications to pyridooxadiazine GSMs.  I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) were found to be highly efficacious in vitro and in vivo in a no. of animal models with highly desirable phys. and pharmacol. properties.  Fused morpholine oxadiazines such as I (R = F; R1 = H, F; R2 = Me; X = O) showed improved in vitro activities and selectivities as GSMs.  The shift in specificity of APP cleavage rather than a redn. in overall γ-secretase activity and the lack of changes in substrate accumulation and Notch processing as obsd. in the animal studies of compd. I (R = R1 = F; R2 = H; X = CH2) confirm that imidazolylbenzylidene pyridooxadiazines are potent GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLJKqS8YPSLVg90H21EOLACvtfcHk0lj7YjZ3T4taEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L&md5=42883463705abaa95287df4ea07f8936</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300209g%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DMcCraken%26aufirst%3DT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DBuevich%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520Studies%2520of%2520Fused%2520Oxadiazines%2520as%2520%25CE%25B3-Secretase%2520Modulators%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D931%26epage%3D935%26doi%3D10.1021%2Fml300209g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><div class="note"><p class="first last">For a recent report on the synthesis of oxadiazines, please see:</p></div><span class="NLM_contrib-group">Veerman, J. J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruseker, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Esseveldt, B. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heijne, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRiner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meulemans, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rijnsbergen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonneveld, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span> </span><span class="NLM_article-title">Strategic and Tactical Approaches to the Synthesis of 5,6-Dihydro-[1,2,4]oxadiazines</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2200</span><span class="refDoi"> DOI: 10.3987/COM-16-13570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.3987%2FCOM-16-13570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVyrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=2166-2200&author=J.+J.+N.+Veermanauthor=Y.+N.+Brusekerauthor=B.+C.+J.+van+Esseveldtauthor=R.+Glenauthor=B.+A.+Harrisonauthor=E.+H.+Heijneauthor=J.+McRinerauthor=T.+M.+Meulemansauthor=P.+van+Rijnsbergenauthor=W.+Zonneveldauthor=M.+G.+Bursavichauthor=D.+A.+Burnett&title=Strategic+and+Tactical+Approaches+to+the+Synthesis+of+5%2C6-Dihydro-%5B1%2C2%2C4%5Doxadiazines&doi=10.3987%2FCOM-16-13570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic and tactical approaches to the synthesis of 5,6-dihydro-[1,2,4]oxadiazines</span></div><div class="casAuthors">Veerman, Johan J. N.; Bruseker, Yorik B.; van Esseveldt, Bart C. J.; Glen, Rebecca; Harrison, Bryce A.; Heijne, Erik H.; McRiner, Andrew J.; Meulemans, Tommi M.; van Rijnsbergen, Peter; Zonneveld, Wim; Bursavich, Matthew G.; Burnett, Duane A.</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2166-2200</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">1881-0942</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">Three methods were developed for the synthesis of substituted 5,6-dihydro-4H-[1,2,4]oxadiazines, e.g., I.  The desired oxadiazine rings were synthesized via reductive amination, addn. to an iminium ion intermediate and by condensation of diamines, e.g., (1S,2S)-2-(aminooxy)cyclopentan-1-amine dihydrochloride with an imidate RC(=NH)OEt (R = CH3, C6H5, cyclohexyl, 2-pyridyl).  For all methods the scope with respect to the substituents that could be introduced was explored.  It was found that the imidate condensation route was the most versatile and the products could be isolated in yields up to 91%.  This route is also suitable for the introduction of chirality on the C5 and C6 position of the oxadiazine rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkE5kzRWXkb7Vg90H21EOLACvtfcHk0liRK7BQMOMxcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVyrurY%253D&md5=5eb0ca3e0ba79e4fb24193043afcb245</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3987%2FCOM-16-13570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-16-13570%26sid%3Dliteratum%253Aachs%26aulast%3DVeerman%26aufirst%3DJ.%2BJ.%2BN.%26aulast%3DBruseker%26aufirst%3DY.%2BN.%26aulast%3Dvan%2BEsseveldt%26aufirst%3DB.%2BC.%2BJ.%26aulast%3DGlen%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DHeijne%26aufirst%3DE.%2BH.%26aulast%3DMcRiner%26aufirst%3DJ.%26aulast%3DMeulemans%26aufirst%3DT.%2BM.%26aulast%3Dvan%2BRijnsbergen%26aufirst%3DP.%26aulast%3DZonneveld%26aufirst%3DW.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DStrategic%2520and%2520Tactical%2520Approaches%2520to%2520the%2520Synthesis%2520of%25205%252C6-Dihydro-%255B1%252C2%252C4%255Doxadiazines%26jtitle%3DHeterocycles%26date%3D2016%26volume%3D92%26spage%3D2166%26epage%3D2200%26doi%3D10.3987%2FCOM-16-13570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kimura, T.; Kitazawa, N.; Kaneko, T.; Sato, N.; Kawano, K.; Ito, K.; Takaishi, M.; Sasaki, T.; Yoshida, Y.; Uemura, T.; Doko, T.; Shinmyo, D.; Hasegawa, D.; Miyagawa, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Preparation of Polycyclic Compounds as Inhibitors of Amyloid β10 and 42 Production</span>. WO2009028588A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Kimura&author=N.+Kitazawa&author=T.+Kaneko&author=N.+Sato&author=K.+Kawano&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=Y.+Yoshida&author=T.+Uemura&author=T.+Doko&author=D.+Shinmyo&author=D.+Hasegawa&author=T.+Miyagawa&author=H.+Hagiwara&title=Preparation+of+Polycyclic+Compounds+as+Inhibitors+of+Amyloid+%CE%B210+and+42+Production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Polycyclic%2520Compounds%2520as%2520Inhibitors%2520of%2520Amyloid%2520%25CE%25B210%2520and%252042%2520Production%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.-H.</span><span> </span><span class="NLM_article-title">Lewis Acid Promoted Highly Diastereoselective Petasis Borono-Mannich Reaction: Efficient Synthesis of Optically Active B,γ-Unsatd. α-Amino Acids</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2062</span><span class="NLM_x">–</span> <span class="NLM_lpage">2065</span><span class="refDoi"> DOI: 10.1021/ol300581n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol300581n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=2062-2065&author=Y.+Liauthor=M.-H.+Xu&title=Lewis+Acid+Promoted+Highly+Diastereoselective+Petasis+Borono-Mannich+Reaction%3A+Efficient+Synthesis+of+Optically+Active+B%2C%CE%B3-Unsatd.+%CE%B1-Amino+Acids&doi=10.1021%2Fol300581n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol300581n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol300581n%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DM.-H.%26atitle%3DLewis%2520Acid%2520Promoted%2520Highly%2520Diastereoselective%2520Petasis%2520Borono-Mannich%2520Reaction%253A%2520Efficient%2520Synthesis%2520of%2520Optically%2520Active%2520B%252C%25CE%25B3-Unsatd.%2520%25CE%25B1-Amino%2520Acids%26jtitle%3DOrg.%2520Lett.%26date%3D2012%26volume%3D14%26spage%3D2062%26epage%3D2065%26doi%3D10.1021%2Fol300581n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Blain, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrdlicka, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgdon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadnis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patzke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">Characterization of FRM-36143 as a New γ-Secretase Modulator for the Potential Treatment of Familial Alzheimer’s Disease</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1186/s13195-016-0199-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;key=10.1186%2Fs13195-016-0199-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1-14&author=J.-F.+Blainauthor=M.+G.+Bursavichauthor=E.+A.+Freemanauthor=L.+A.+Hrdlickaauthor=H.+E.+Hodgdonauthor=T.+Chenauthor=D.+E.+Costaauthor=B.+A.+Harrisonauthor=S.+Kapadnisauthor=D.+A.+Murphyauthor=S.+Nolanauthor=Z.+Tuauthor=C.+Tangauthor=D.+A.+Burnettauthor=H.+Patzkeauthor=G.+Koenig&title=Characterization+of+FRM-36143+as+a+New+%CE%B3-Secretase+Modulator+for+the+Potential+Treatment+of+Familial+Alzheimer%E2%80%99s+Disease&doi=10.1186%2Fs13195-016-0199-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1186%2Fs13195-016-0199-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-016-0199-5%26sid%3Dliteratum%253Aachs%26aulast%3DBlain%26aufirst%3DJ.-F.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DFreeman%26aufirst%3DE.%2BA.%26aulast%3DHrdlicka%26aufirst%3DL.%2BA.%26aulast%3DHodgdon%26aufirst%3DH.%2BE.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DCosta%26aufirst%3DD.%2BE.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DKapadnis%26aufirst%3DS.%26aulast%3DMurphy%26aufirst%3DD.%2BA.%26aulast%3DNolan%26aufirst%3DS.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DPatzke%26aufirst%3DH.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520FRM-36143%2520as%2520a%2520New%2520%25CE%25B3-Secretase%2520Modulator%2520for%2520the%2520Potential%2520Treatment%2520of%2520Familial%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2016%26volume%3D8%26spage%3D1%26epage%3D14%26doi%3D10.1186%2Fs13195-016-0199-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">Aqueous compound solubility was determined using a kinetic solubility method in pH 7.4 phosphate buffer after 90 min incubation at room temperature.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">GreenScreen Human Cells [GADD45alpha] (growth arrest and DNA damage gene)-Green Fluorescent Protein (GFP)] assay from Gentronix, conducted at BioReliance Corporation.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i55"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01620">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54152"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01620">10.1021/acs.jmedchem.6b01620</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Full experimental procedures and characterization of compounds <b>9</b>, <b>11</b>, <b>16</b>, <b>20</b>–<b>24</b>, <b>32</b>, <b>33</b>, and <b>48</b> as well as biological assay protocols (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_001.pdf">jm6b01620_si_001.pdf (673.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01620/suppl_file/jm6b01620_si_002.csv">jm6b01620_si_002.csv (4.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01620%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01620" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679995e95ee424bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
